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Abstract 
 
This PhD thesis is the outcome of a range of activities and experimental results aimed to a better 
characterization of the risk that Escherichia coli and other microrganisms and parasites may pone 
to the health of animals and finally humans. One of the main activity of the present project was 
based on the test hypothesis that the virulence profile of E. coli strains toward bovine mammary 
gland can be modulated by the interaction with the host cells. These hypothesis were tested 
through a gene expression study of some virulence factors of six E. coli strains when co-cultured 
with a bovine mammary cell line, since the in vitro models represent both an essential tool to 
investigate the biological mechanistic of mastitis, and an efficient alternative to animal 
experiments. Preliminarly, a meta-analysis of existing literature studies on the available bovine 
mammary cell lines was performed, resulting in the selection of MAC-T as the most responsive cell 
line to bacteria causing mastitis. The E. coli strains used for the coculture experiments with MAC-T 
cells were isolated from different types of bovine mastitis (acute, chronic and undetermined) and 
from a VTEC food-borne strain associated to human clinical disease (O157). An upregulation of the 
virulence factor eae (intimin) in all but one the analyzed mastitis strains following co-culture with 
MAC-T cell line was detected through RT-reat time PCR, and also the adherence virulence factor 
ycd and the b12 gene were upregulated in some strains, overall suggesting the possibility that 
mastitic E. coli strains can acquire a more risky molecular profile when exposed to the bovine 
mammary cells. This finding may have clear implications on the risk assessment related to the E. 
coli strains in bovine mammary tissue and milk. In addition, with the aim to improve the current 
methodologies for foodborne risk analysis linked to E. coli, the project activity provided a 
preliminary research for the setup and validation of new protocols based on real time PCR-High 
Resolution Melting Analysis, a widely used technique to target sequence polymorphisms of the 
same gene in different species without the need to perform DNA sequencing or to use species-
specific probes, to help the identification of putative verocytotoxic status in E. coli strains of O26 
serogroup, and other serotypes, isolated from bovine milk.  
Since the applications of HRMA for the characterization of microorganisms can not be limited to 
food safety, but can be developed for a large number of issues linked to general veterinary 
diagnostics, among the objectives of this PhD project some new real-time PCR-HRMA coupled 
methods were also developed, providing a contribution to the advancement of the existing 
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molecular tools for sensitive and effective species identification, or variant/mutation screening, 
applied to different foodborne and veterinary pathogens. Thus, new HRMA-based protocols were 
designed and tested for the identification of Pseudomonas spp responsible for chromatic 
alterations in mozzarella cheese, for the detection and differentiation of Dirofilaria repens and D. 
immitis in canine blood samples, for the detection of the mutation site associated to FQ resistance 
in Staphylococcus pseudintermedius isolated from canine diagnostic samples, and for 
discrimination of the two most common microsporidial parasites in honeybees, Nosema apis and 
N. ceranae. Overall, these new HRMA-based assays could represent additional tools for 
epidemiological studies, routine disease assessment and therapeutical decisions. 
The possibility to identify the presence of risk-predictive SNPs in E. coli isolates using these newly 
established HRMA-based protocols is a novel, and simpler, opportunity with respect to the 
current, and more complex, surveillance strategies that are based on the amplification of stx genes 
together with other virulence factors for the evaluation of VTEC status. In the future, a possible 
way forward of this research is represented, on one side, by the deeper assessment of the 
reciprocal modulation between E. coli mastitis-derived strains and immortalized MAC-T cells using 
high-throughput RNA sequencing, and on the other side by a large scale validation of the HRMA-
based evaluation of risk-predictive SNPs in order to improve the current approaches. And overall, 
the established HRMA-based protocols when extensively validated would be highly suitable for 
routine veterinary diagnostics applied to field investigation, as quick and sensitive single step 
protocols allowing specific and sensitive detection of the targets with shorter analysis time and 
reduced cost, in parallel or in alternative to the classical approaches. 
 
  
 
 
Chapter 1: Foodborne risk linked to E. coli infection 
strains in the bovine model: expression analysis of 
virulence factors and HRMA-based methodology for 
the detection of predictive SNPs 
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1.1 Introduction 
 
1.1.1 Generality on Escherichia coli 
 
E. coli is a Gram-negative, non-spore-forming rod, which belongs to the family Enterobacteriaceae 
and was first isolated by a German paediatrician, Theodore Esherich, in 1884 from faeces of 
human neonates (Khan and Steiner, 2002). The cell of Gram-negative bacteria is made of three 
layers, the cytoplasmic membrane and the outer membrane, separated by a peptidoglycan layer. 
The external cell membrane contains phospholipids, membrane proteins and lipopolysaccharide 
(LPS). LPS comprises lipid-A, the lipopolysaccharide core and repeated polysaccharide units called 
O-antigens (Cullor, 1996). Lipid-A is the lipophilic, internal part of LPS. The toxic effects of LPS, also 
known as endotoxin, are caused by lipid-A (Cullor, 1996). On the outer surface, bacteria may have 
fimbrias which protrude from the surface. The external of the cell may be covered with a thick 
polysaccharide layer called capsule. E. coli strains can be divided into O:H:K serotypes based on 
the different antigenic structures of O-antigens, K-antigens (capsular) and H-antigens (flagellar) 
(Cullor, 1996). 
 
 
 
 
 
 
 
 
 
 
Table 1. Scientific classification of Escherichia coli. 
 
Escherichia coli is part of the normal intestinal flora of humans and animals. It is the most common 
facultative anaerobic bacterial species in the intestine and is regularly excreted in the faeces to the 
environment. Pathogenic E. coli bacteria can cause intestinal and extraintestinal infections in 
human and animals. Infections of the gastrointestinal tract may lead to various kinds of diarrhoeic 
Scientific classification 
Domain Bacteria 
Phylum Proteobacteria 
Class Gamma-Proteobacteria 
Order Enterobacteriales  
Family Enterobacteriaceae  
Genus Escherichia 
Species E. coli 
8 
 
diseases, which, in the case of shiga toxin, may even progress to systemic haemolytic ureamic 
syndrome in humans and oedema disease in pigs. E. coli is the predominant cause of urinary tract 
infection in humans. E. coli also causes invasive diseases, such as bacteraemia and meningitis, in 
humans and animals. In avian species, E. coli is an important cause of respiratory and ovarian tract 
infections (Cullor, 1996). 
Although being normally commensal organisms, E. coli also exist as pathogenic strains. These are 
distinguished as causing intestinal or extraintestinal disease and within these two groups they are 
further divided in different pathotypes. These different pathotypes of E. coli have several sets of 
virulence factors, resulting in a large spectrum of pathologies, including diarrhea, dysentery, 
septicemia, pneumonia, meningitis, urinary tract and bladder infections (Salyers and Whitt, 2002). 
E. coli is one of the most common causes of diarrhea, particularly in the developing world, where 
each year over one billion children under the age of five get diarrhea from E. coli resulting in over 
two million deaths (Bryce et al., 2005; Roche et al., 2010). In developed countries, bacteremia is a 
common cause of death and E. coli is responsible for 30% of those cases where a Gram-negative 
bacterium is implicated. It is one of the most common causes of neonatal meningitis and neonatal 
sepsis, which can often lead to death. The most common extraintestinal diseases caused by E. coli 
are urinary tract infections (UTIs), including cystitis and pyelonephritis. E. coli is the most common 
cause of UTIs (Johnson and Russo, 2002; Wiles et al., 2008). UTIs are potentially the most common 
bacterial infections of all those requiring antimicrobial therapy. One half of all women could be 
infected in their lifetimes. The economic consequences of UTIs in the United States have been 
estimated at $1.6 billion annually (Foxman, 2003). 
Pathogenic E. coli bacteria express different, disease-specific and host-specific virulence factors 
(China and Goffaux, 1999). Bacterial virulence factors are needed to colonize and infect the host 
and to fight against host defence mechanisms. Major groups of E. coli virulence factors include 
adhesins,toxins, polysaccharide capsules and O-antigens, proteins secreted into host cells and 
other mechanisms to resist killing by complement or to bind iron ions. Bacteria do not produce 
virulence factors continually but only when intercepting particular signals from the host or 
environment (China and Goffaux, 1999). The genes for virulence factors may be present in the 
bacterial genome or may reside extrachromosomally on plasmids, even though the virulence 
factor is not produced (Harel and Martin, 1999). 
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1.1.2 Escherichia coli and bovine mastitis 
 
 Epidemiology of bovine mastitis 
The inflammation of the mammary gland tissue is defined as bovine mastitis and it induced by 
microorganisms. Mastitis is caused when the pathogens enter the udder, multiply and produce 
metabolites or toxins that cause harm to the mammary gland tissue. Damaged tissue allows for 
increased vascular permeability. This causes alterations in milk composition and properties 
accompanied by a reduction in milk yield depending on the inflammatory response, mainly 
influenced by the causative pathogen (Hill, 1994; Kitchen, 2009; Seegers et al., 2003; Pyörälä, 
2003; Zadoks et al., 2011). A large spectrum of microrganisms has been identified as potential 
mastitis pathogens and they are distinguished into either major or minor pathogens. On one hand 
the main mastitis-causing pathogens are Escherichia coli, Streptococcus uberis and Staphylococcus 
aureus. These bacteria have been termed major pathogens because of their association to clinical 
mastitis (CM). On the other hand, other bacteria may be present in the udder and often have an 
overall beneficial effect by protecting against infection caused by major pathogens. These bacteria 
produce natural anti-bacterial substances or interfere with the growth of major pathogens and are 
thus termed minor pathogens. Because of their complex interactions with the mammary gland, 
these minor pathogens can contribute to increased somatic cell counts (SCCs) and thus to the 
incidence of sub-clinical mastitis (SCM), but they usually do not cause CM. 
 
 Severity and duration 
Mastitis can be acute or chronic, and this definition depends on how long the syndrome lasts. 
Chronic mastitis usually worsens over months and leads to the development of fibrous tissue in 
the breast (Gröhn et al., 1990). The most common forms of mastitis are CM or CM and they are 
usually classified according to the pathogenesis (Gianneechini et al., 2002; Akers, 2002). CM shows 
visible severe signs, like discoloration of the teat of the infected udder quarter, flakes or clots in 
the milk, whereas swelling is usually a mild sign. There are other severe signs, but not frequently 
as watery secretion as well as a hot and swollen udder. More systemic symptoms are fever, rapid 
pulse, loss of appetite, dehydration, depression and fatal consequences. In case of SCM, there 
aren't visible signs of infection and both milk and udder appear normal although stagnation in milk 
has been reported (Mungube et al., 2005). Finally, SCM can be harder to detect although the SCCs 
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in the milk increase in the same extent as in CM. Currently, the SCC proved to be the most useful 
diagnostic technique to detect the presence and occurrence of bovine mastitis and especially for 
bovine subclinical mastitis (Schukken et al., 2011).  
The infection Mastitis causing pathogens have been broadly classified into either environmental or 
contagious pathogens (Radostits et al., 2007). The bacteria could survive in intramammary tissue 
and are spread from bovine to bovine. Environmental pathogens originate from bedding materials, 
manure and soil and are considered to be opportunistic invaders with no specialized survival 
properties. E. coli are considered environmental pathogens, are indeed able to persist for 
prolonged periods within the udder and also cause either chronic or recurrent forms of mastitis 
(Döpfer et al., 2000; Döpfer et al., 2001; Almeida et al., 2011).  
The quarters of a cow include teat cistern, gland cistern, milk ducts and surrounding glandular 
tissue. The secretory tissue have millions of alveoli and are lined by milk-producing epithelium, 
which is supplied with nutrients by surrounding blood vessels. Muscle cells encircle each alveolus 
and squeeze the milk to the milk ducts and further through the teat canal and duct during milking. 
Milk accumulates in alveolar spaces, milk ducts and gland cistern (Figure 1). Bacteria might either 
invade the udder through lesions, as teat damage is known to increase susceptibility of mastitis, or 
more frequently breach the teat canal in several ways (Schroeder, 2010). During milking, the 
bacteria multiply inside teat duct and are introduced into the gland cistern via the teat canal by 
their motility properties or pressure placed on the teat end as caused by physical movement of 
the cow. Another opportunity is that bacteria may be propelled into or through the teat canal 
during machine milking. 
 
Figure 1: Scheme of the mammary gland modified from Schroeder, 2010. (A) Teat with gland cistern, milk ducts, and secretory 
glandular tissue. (B) Alveolus encircled by muscle cells and blood vessel. 
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 Factors increasing mastitis susceptibility 
Mastitis is defined a multifactorial disease, and it is influenced by many factors ranging from 
genetics, physiology and finally environmental (Hopster et al, 1998;. Waller, 2000). 
An example of an environmental factor is the season, in fact, it is reported an increase in the 
frequency of CM in the winter months (Olde Riekerink et al, 2007; Steeneveld et al, 2008). 
Other factors that are not directly related to infectious pathogens but increase the risk of 
developing mastitis are poor hygiene, high density of cows per unit, poor ventilation and bad 
management practices (Barkema et al, 1999 ;Schreiner and Ruegg, 2003, Barnouin et al., 2005; 
Ericsson et al., 2009 Parker et al, 2007). All these factors generate stress to animals and make 
them more susceptible to mastitis (Breuer et al., 2003). 
The factors related to cattle are genetic background and type of immune response, and other 
factors can be considered like: age, stage of lactation, nutritional and metabolic status. 
Intensive farming is concentrated on increasingly high production of milk. This causes a weakening 
metabolic status that compromises the resistance of the breast to the pathogenic factors causing 
mastitis (Waller, 2000; Seegers et al., 2003). It is known that cattle with high milk production are 
more sensitive to the development of CM rather than cows with less milk production (Gröhn et al., 
2004). Pathogens can infect cattle, both during the dry period and during lactation. Lactation has a 
significant impact on the susceptibility of cows to mastitis (Shafer-Weaver et al., 1996; Mallard et 
al, 1998; Rinaldi et al, 2008). The risk of developing CM is higher during early lactation (Steeneveld 
et al., 2008). Conversely, the risk of SCM increases with days of lactation (Busato et al., 2000). 
Within the periparturient period of the lactation stage, the cow´s defense mechanisms are 
impaired and therefore the cow is at higher risk of developing mastitis with impact on subsequent 
intramammary infections (Oliver and Sordillo, 1988; Kehrli et al., 1989; Breen et al., 2009). It is 
known that multiparous cows show higher incidence of mastitis and there is evidence that 
increasing parity correlates with increased susceptibility (Rajala-Schultz et al., 1999¸Steeneveld et 
al., 2008). Both environmental and cow factors are interdependent, whereas the relative impact of 
each factor is considerably influenced by the causative pathogen (Djabri et al., 2002; Zadoks et al., 
2011). 
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 Host defense mechanisms and pathogen recognition 
Several defense mechanisms protect the bovine mammary gland at the anatomical and cellular 
level. The teat end is considered to be the first line of defense against invading bacteria that cause 
mastitis. At the end of the duct, the sphincter muscles must be securely closed between milkings, 
this prevents the entry of bacteria into the udder. In addition, a coating keratin layer of the teat 
canal has a function of physical barrier against the entry of pathogens (Nickerson, 1987). Both, 
dysfunctional sphincter muscles and diminished keratin lining of the teat canal have been 
independently shown to increase the risk bacterial invasion and colonization (Capuco et al., 1992). 
Bacteria that have overcome the anatomical defense mechanisms are then in contact with the 
bovine immune system. The mammary immune factors have been characterized into cellular and 
soluble components (Sordillo and Streicher, 2002). More in details, the defense mechanisms the in 
mammary gland are  differentiated into innate immune and specific immune responses. The 
innate immune response eliminates bacteria before the specific immune system responds. This 
type of response is activated in the event of abnormalities, such as changes in the composition of 
milk. The non-specific responses are mediated by the physical barrier and involve macrophages, 
neutrophils, natural killer cells and particular soluble factors (Sordillo and Streicher, 2002). The 
innate immune response has soluble factors including defensins, lysozyme, lactoferrin and 
cytokines. The first line of defense is the complement system, and its function is to maintain 
homeostasis by recognition and removal of damaged or modified self-material and pathogenic 
microbes (Zipfel et al., 2013). Moreover, complement is also of importance in the specific immune 
response. The plasma proteins make up the complement system, these proteins are also present 
in milk and act by targeting the pathogen, after it has been recognized by the cells of the specific 
immune system. E. coli has been reported to be sensitive to lysis by complement (Korhonen et al., 
2000). Additionally, the defensins, also referred to as antimicrobial peptides (AMP), are an 
evolutionarily conserved component of the innate immune response. Defensins are diverse 
oligopeptides (<100 amino acids) contributing to the antimicrobial action of granulocytes, mucosal 
and epithelial host defense (Peschel and Sahl, 2006). 
Of the soluble mammary gland defense components, lactoferrin is a predisposing antimicrobial 
protein reported to increase in concentration when an inflammation occurs (Sordillo et al., 1987). 
Lactoferrin contributes to neutralization of cytotoxic effects mediated by lipopolysaccharides 
(Pecorini et al., 2010). Moreover, the main function of lactoferrin is to inhibit the growth of certain 
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bacteria by binding of iron, an essential factor required for bacterial growth. This growth hindering 
effect of lactoferrin has already been reported for Gram-negative bacteria such as E. coli in 
ruminants (Chaneton et al., 2008; Rainard, 1986). Cytokines are immunomodulating molecules 
that account for cell signaling. They are produced after antigen detection by certain cells of the 
immune system, mainly leukocytes. The different cytokines (e.g. TNFα and IL1β) have a matching 
cell-surface receptor triggering intracellular signaling cascades and consequently mediating 
alterations of cellular functions. Figure 2 shows the involvement of the inflammatory cytokines 
TNFα and IL1β in the immune response against putative mammary pathogenic E. coli as possibly 
induced by lipid A recognition by the TLR4-MD-2 receptor complex (Maeshima and Fernandez, 
2013).  
If the infecting bacteria evade the innate immune response or are not completely eliminated, the 
specific or acquired immune response is triggered. In contrast to the innate immune response, the 
specific immune system needs to recognize the pathogens by specific antigens and therefore it 
takes time to be mounted. Once a specific response is created, due to the immunological memory, 
the immunity state is quickly established, intensive and enduring when the same antigen is 
recognized again. This results in a more effective elimination of the pathogen. Thereby, the most 
important soluble effectors of the specific immune response are antibodies produced by B 
lymphocytes after antigen recognition. 
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Table 2: Cellular and soluble defenses of the mammary gland 
 
The pathogen recognition receptors (PRRs) allow rapid detection of pathogens and are essential to 
enable the two types of responses (innate and specific). These receptors can be displayed either 
on the surface or intracellularly, and recognize the so called pathogen-associated molecular 
patterns (PAMPs). PAMPs are small molecular motifs, which are conserved within a class of 
microbes such as lipoteichoic acids in Gram-positive and LPS in Gram-negative bacteria (Kumar et 
al., 2011). After binding to PAMPs, the PRRs subsequently initiate intracellular signaling cascades 
or directly promote the attachment, ingestion and destruction of the pathogens. In Table 2 these 
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pathogen recognition receptors are presented (Sordillo and Streicher, 2002). The extracellular 
PRRs are called Toll-like receptors (TLR) having an important role in the innate and and specific 
immune response (Doyle and O 'Neill, 2006). 
 
 
Table 3: Pathogen recognition receptors 
 
The interaction of a potential mammary pathogenic E. coli (MPEC hereafter) with the host immune 
cells is reported in Figure 2. TLR2 and TLR4 are the most significant receptors during bacterial 
mastitis and are primarily activated in response to Gram-positive and Gram-negative infections, 
respectively (Yang et al., 2008¸Günther et al., 2011). Notably, even though both S. aureus and E. 
coli are able to trigger TLR2 and TLR4, only E. coli is capable of inducing NF-κB signaling in 
mammary gland epithelial cells followed by quick induction of TNF-α.  
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Figure 2: Pathophysiological scheme of presumed mammary pathogenic E. coli (MPEC) replicating in the mammary alveolar space, 
modified from Shpigel et al., 2008. LPS/TLR4 signaling on alveolar macrophages (MΦ) elicits production of inflammatory cytokines 
(TNFα and IL1β) and chemokines (KC and MIP2), resulting in recruitment of blood neutrophils (PMN) trafficking across the polar 
alveolar epithelium (TJ, tight junction) into the alveolar space. Recruited neutrophils are killing the bacteria by phagocytosis and 
neutrophil extracellular traps (NETs). Bacterial epithelial invasion is abrogated by LPS/TLR4 signaling on MΦ possibly mediated by 
nitric oxide (NO) produced by MΦ and myoepithelial cells. Epithelial invasion by bacteria induce epithelial megalocytosis, necrosis 
and apoptosis. 
 
Regarding the pathogenic potential for cattle, E. coli is considered an environmental pathogen 
because of its ability to survive in the environment of dairy cows. In particular,  E. coli represent a 
group of microorganisms that are frequently associated with bovine mastitis and they are the 
bacteria most frequently in milk and milk-derivate, and in this last case the are dangerous for 
humans if associated to VTEC status as serotype 0157. In the past years, several studies have 
shown an increase in the importance of E. coli among all bovine mastitis pathogens. A study from 
Wisconsin reported an increased prevalence of E. coli intrammamary infections (IMI) from 17.7% 
in 1994 to 24.9% in 2001 of the total mastitis pathogens isolated (Makovec and Ruegg, 2003). In 
the United Kingdom, E. coli was also shown to be the most important pathogen in well managed 
dairies (Green et al., 2005). The parity number, season of the year, and lactation status affect 
susceptibility to clinical mastitis caused by E. coli. Results from some studies during the last decade 
indicated that the severity of clinical manifestations of E. coli mastitis is mainly determined by cow 
factors rather than by virulence factors of E. coli (Burvenich et al., 2003). On the other hand, 
recent studies demonstrated that virulence attributes of E. coli strains may explain the outcome of 
E. coli IMI (Almeida et al., 2011). There are preliminary evidences that the virulence profile of E. 
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coli strains causing mastitis in cattle can be modulated by the interaction with the mammary cells 
(Kerro-Dego et al., 2012). Further research is needed in order to define the effect of the host-
cell/pathogen interaction on the virulence pattern of E. coli and on the possible implications also 
for human health. With the aim to clarify this issue, in the present project a gene expression study 
of some virulence factors of E. coli strains isolated from bovine mastitis and co-cultured with an 
immortalized bovine mammary cell line, in comparison with a VTEC food-borne strain associated 
to human clinical disease, was designed.  
The use of in vitro cell-based models for screening and testing has the advantage that several 
concentrations of mixtures or speciﬁc compounds can be assayed at the same time in cells from 
speciﬁc tissues in a controlled environment. Monolayer culture models of mammary cells are easy 
and convenient in vitro systems, even if they do not recapitulate the glandular structure of 
epithelium in vivo and therefore cannot provide the optimal system for studying the regulation of 
proliferation, polarization and differentiation of the glandular epithelium. Furthermore, the use of 
in vitro models have the advantage that they represent a possible alternative to animal 
experiments, thereby saving the lives of laboratory animals and reducing costs for expensive 
animal experimentation (Purup et al., 2000).  
A suitable model for the study of mammary immunity needs the selection of a proper cell line. Cell 
cultures frequently used to understand the mechanisms underlying the function of the mammary 
gland are the primary lines of bovine epithelium (pMEC) derived from mammary biopsies and two 
continuous, stabilized cell lines: MAC-T and BME-UV1. Irrespective of the origin, the cells 
established in culture form a thick monolayer, which in 3 days develops into an epithelial island 
with a central cell cluster. Four days further, the cell cluster within the epithelial island develops 
into a dense cellular mass. 
Mammary epithelial cells have a strong innate immune defense capability and the capacity to 
attract circulating immune eﬀector cells such as neutrophils. Primary MECs show a constitutive 
secretion of IL-1 and IL-6, with different cytokine release pattern compared to MAC-T cells (Okada 
et al., 1997). Both pMEC and MAC-T cells respond to challenge with LPS through up-regulation of 
mRNA expression for a range of cytokines, chemokines and β-defensins, including mRNAs coding 
for several chemotactic proteins likely to promote inﬁltration of the mammary tissue by 
neutrophils and monocytes (Strandberg et al., 2005). A comparison of the results obtained with 
primary cells and MAC-T cells indicate some differences. As an example, the response obtained 
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with primary cells to exposure to LPS is much higher than the one reported using MAC-T cells 
regarding β-defensin, LBP (lipopolysaccharide binding protein) and IL-1β expression (Strandberg et 
al., 2005).  
On the other hand, the expression responses of TNF-α, IL-6, MCP-1 and PAI-1 genes in MAC-T cells 
are similar to primary mammary epithelial cells (Thorn et al., 2008). The reasons for these 
substantial diﬀerences in the responses of the two mammary cell types to LPS are still unclear but 
may relate to the length of time that cells have been in culture and the immortalization process 
for the MAC-T cells. Further, there are signiﬁcant diﬀerences in the propensity of each cell type to 
form globular structure (Stradberg et al., 2005). Also, BME-UV1 cells treated with LPS release a 
range of cytokines including TNF-α, IL-8 and IL-1β into the serosa compartment of the epithelial 
monolayer culture model (Fitzgerald et al., 2007). 
The exposure of primary mammary cells or established cell lines to physiological exogenous 
matrices that mimic the composition of the normal basement membrane is also relevant. In a 
recent study, the growth and transcriptomic proﬁle was studied in BME-UV1 cells cultured in 
traditional monolayers on a plastic surface, and on extracellular artificial matrix (Matrigel™). It was 
shown that BME-UV1cells grown on Matrigel™ form polarised acinar structures during 16 days of 
culture, and the difference in spatial architecture between mammary epithelial cells cultured in 
monolayer and a three-dimensional structure is reﬂected by differences in transcriptomic proﬁle. 
This study shows the importance of developing models with polarized mammary epithelial cells 
and that mammary cells may be a good model for studying, for example, developmental and even 
immunological processes of the bovine mammary gland in vitro (Kozlowski et al., 2009). 
Co-colture system is a model that in general can help to understand the mechanisms and 
communication between epithelial cells and white blood cells. This system is suitable also for 
studies on bovine mammary gland immunology, reflecting that mainly factors of innate immunity 
are active in mammary gland cells (Didier and Kessel, 2004). Furthermore, a mechanism of co-
culture of cells involves the use of supports inducing the cell to make a polarity and then being 
more comparable to the in vivo situation and could potentially be applied to mammary cells, 
studying transport or metabolism of blood borne substances across the epithelium (Shin et al., 
2006). An interesting applications for mammary cells of the two-compartment system has been 
described previously regarding polymorphonuclear neutrophil migration, and protein and 
plasminogen activator production in mammary epithelial cells after extracellular calcium 
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treatment (Smits et al., 1996; Cheli et al., 2001). Such two-compartment models also provide the 
possibility of applying epithelial cells in combination with immune cells (adhering or not) and 
bacterial cells. When microbiota is added to the apical side, this three-component model 
(epithelial cells, immune cells and microbiota) is close to the in vivo situation. 
In literature, there are many studies that investigate on the interaction of the molecular structures 
of pathogens between with mammary epithelial cells (MECs), which have provided interesting 
data on mammary immunity. 
At present, some researchers have been found in healthy and infected mammary gland a variety 
of cytokines, such as interleukins (IL-1b, IL-2, IL-6, IL-8, IL-12 and TNF-α) and cathelicidins involved 
in the mammary immunity response(Sordillo et al., 2002). 
For in vitro models the primary cell cultures can be used to identify the target organs or a sensitive 
cell lines for this pathologies. The cell line culture selected are treated using mixtures or speciﬁc 
compounds of different nature, data obtained showed different endpoints inherent to basal or 
more sophisticated cellular functions such as cell viability and proliferation, cell migration, 
regulation of gene expression, morphology or metabolic alterations (Purup and Nielsen, 2011). 
Primary cultures of bovine mammary epithelium (pbMEC), derived directly from the mammary 
gland, have also been used as models including both organoids, explants and epithelial cells for 
studies of effects of growth factors, steroids, lactoferrin, retinoids, cytokines, biogenic amines, 
mammary extracts, and in such studies endpoint parameters such as mitogenic activity and gene 
expression have been measured (Matitashvili and Bauman, 1999 and 2001; Weber et al., 1999; 
Akers et al., 2000; Ellis et al., 2000; Purup et al., 2000 and 2001; Weng et al., 2005; Thorn et al., 
2006 and 2008; Ernens et al., 2007; Fusi et al., 2008; Swanson et al., 2009; Wang and Baumrucker, 
2010). 
Some authors performed studies on bovine mammary mutagenic cell lines, and among these the 
MAC-T (Huynh et al., 1991) and the BME-UV1 (Zavizion et al., 1996) cell lines, both of which were 
immortalized by transfection with the SV40 T-antigen. The MAC-T cells have been used for 
bioactive studies, including fatty acids, growth factors, steroids, retinoids, cytokines and mammary 
extracts, also for individuate a specific parameters such as viability, proliferation, apoptosis, gene 
expression, epithelial transport, cell signalling and lipogenesis. Another cell line of the 
immortalized bovine mammary epithelial, BME-UV1, have been used for elaborating effects of a 
number of bioactives and parameters studies even more respect the MAC-T sush as mycotoxins, 
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lactoferrin proteins and retinoids. Until now, despite the numorous studies independently 
performed using bovine mammary cells, there is not a comprehensive analysis to identify which 
cell line is more responsive to interaction with bacteria causing mastitis. 
 
1.1.3. Verotoxin-producing Escherichia coli (VTEC) 
 
From the clinical-pathological point of view, E. coli pathogens are subdivided into different types 
associated with different symptoms and modes of pathogenesis (Kaper et al., 2004). These 
include, but are not limited to, enteropathogenic (EPEC), enterohemorrhagic (EHEC), 
enteroaggregative (EAEC), enteroinvasive (EIEC) and diffusely adherent (DAEC) E. coli strains which 
cause enteric diseases often resulting in diarrhea. Uropathogenic (UPEC) and meningitis associated 
(MNEC) E. coli cause urinary tract infections and meningitis/sepsis respectively, and are classified 
as extraintestinal pathogenic E. coli (ExPEC). EPEC, EHEC and ETEC cause disease in both humans 
and animals, whereas avian pathogenic E. coli (APEC) causes disease in birds. 
 Enteropathogenic E. coli (EPEC) is linked to many cases of diarrhea and there is a higher 
incidence in children (Trabulsi et al., 2002). It is the first E. coli pathogen described, is one 
of the most studied and the one most characterized. Its pathology is characterized by the 
formation of attaching and effacing lesions (A/E positive) on the epithelium of the human 
intestine and by the consequential bloody, watery diarrhea. The adhesin protein intimin 
binds to its receptor Tir (translocated intimin receptor). Tir is secreted by a type III 
secretion system (TTSS) into the cytoplasm of the epithelial cells from where it is inserted 
into the plasma membrane allowing binding of intimin. The binding causes the formation 
of actin at the site of adhesion on the intestinal cell membrane, creating a pili effaced 
pedestal upon which the bacteria perch. Genes responsible for this lesion, including 
elements of the TTSS, intimin (eae), tir, and other effector proteins are found in the LEE 
(locus of enterocyte effacement) pathogenicty island (McDaniel et al., 1995). The detection 
of LEE genes, intimin in particular, has been used to identify EPEC isolates. EPEC may be 
further divided into typical and atypical varieties. The EPEC adherence factor plasmid 
(pEAF) is found in typical EPEC isolates. When pEAF is absent, but the LEE is present, the 
isolate is termed an atypical EPEC (aEPEC). With the recognition that aEPEC isolates are 
capable of causing disease, it has been discovered that A/E forming isolates come from a 
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much wider, heterogenous range of serogroups. All serotypes are associated with the 
disease in developing countries, transmission is direct from person to person, less 
frequently by water (Hunter, 2003). In developed countries the occurrence of typical EPEC 
is rare (Ashbolt, 2004), while atypical EPEC does appear to be an emerging pathogen in 
developed countries (Trabulsi et al., 2002). 
aEPEC are very present in animals including cows, rabbits, monkeys, dogs, cats and birds 
(Trabulsi et al., 2002; Morato et al., 2009). Overall, the environmental distribution of aEPEC 
is not studied very well and waterborne outbreaks in developed countries have not been 
reported (Hunter, 2003). Studies in the Great Lakes and connecting channels found that 0-
4% of isolates from different sites were aEPEC (Hamelin et al., 2006, 2007). 
 Entheroemorrhagic E. coli (EHEC) which have the LEE pathogenicity island but do not make 
shiga-like toxin like EPEC. The secretion of shiga-like toxins (also called as verotoxins) marks 
an isolate as STEC (or VTEC). E. coli that include both the LEE and shiga toxin are 
enterohemorrhagic E. coli (EHEC). This is an example of how a difference of a few genes, in 
this case the addition of shiga-like toxins, can result in 8 different disease symptoms. In 
addition to diarrhea, a small number of infected people may develop hemolytic uremic 
syndrome (HUS), resulting in renal failure and hemolytic anemia. Children and the elderly 
are most severely affected. Severe, long-term impacts to health and death may follow. 
 Enterotoxigenic E. coli (ETEC) is the major cause of diarrhea in the world (Turner et al., 
2006). it is very frequent in the developing countries, one of the ways of spreading more 
likely it is the movement of tourists, in fact, the disease is called "traveler's diarrhea". It has 
been estimated that causes about 800,000 deaths worldwide, mostly children under the 
age of five years. Death is most frequently the effect of dehydration and loss of electrolytes 
in those places where sources of clean drinking water are inadequate. In addition to 
humans, its occurrence has been described in the developed world in pigs, chickens, 
Canada geese, dogs, sheep, goats and cattle (Hussong et al., 1979; Akashi et al., 1993; Nagy 
and Fekete, 1999; Khatib et al., 2003). 
 Enteroaggregative E. coli (EAEC) is another diarrheagenic pathotype that is primarily found 
in children of the developing world. It is characterized by adherence to epithelial cells in a 
stacked brick-like aggregation within a biofilm (Kaper et al., 2004). EAEC produce toxins, 
these contain the plasmid encoded toxin (Pet), EAST1, or ShET1 all of which may be found 
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in a minority of isolates and the latter two toxins may also be established in other 
pathotypes. It is uncertain if there are common factors of EAEC that contribute to the 
phenotype (Kaper et al., 2004). The existence of aggR, the aggregative adherence (AA) 
probe and aap may detect "typical" EAEC in most cases (Cerna et al., 2003). EAEC strains 
are present in animal feces from calves, piglets, Canada geese and horses based on their 
aggregative adherence phenotype or serogroup. Waterborne outbreaks outside of the 
developing world do not appear to have been reported. (Kullas et al., 2002; Uber et al., 
2006).  
 Enteroinvasive E. coli (EIEC) are responsible for enteritis, toxaemia and septicemic 
infections; thanks to the presence of different pathogenicity factors (capsule, adhesins, 
siderophore, α-hemolysin), they are able to adhere to the epithelium of the colon, to 
penetrate the enterocytes using the mechanism of endocytosis and to destroy them; then 
they propagate from cell to cell and may reach the lymphatic system; (Kaper et al., 2004). 
They are almost indistinguishable from Shigella spp. because they share the same essential 
virulence factors and EIEC infections result in the symptoms of Shigellosis, namely diarrhea 
and dysentery. Shigellosis is the third most common cause of bacterial gastroenteritis in 
the United States, with approximately 14 000 cases reported annually (Gupta et al., 2004) 
Due to the similarity of EIEC and Shigella symptoms and pathology, it is likely that EIEC 
outbreaks are underreported, having been reported as Shigellosis instead. Although human 
to human transmission is the major mode of spread for Shigella, food and water 
transmission also occur (Naimi et al., 2003; Craun et al., 2005). Shigella and EIEC are 
normally found only in humans and primates. 
 DAEC Diffusely adherent E. coli (DAEC) are so named for the pattern of diffuse adherence 
to the surface of epithelial cells. They do not invade cells or produce toxins, but they have 
been associated with diarrhea in a number of studies (Kaper et al., 2004). DAEC cause the 
epithelial cells to produce cellular extensions to which the E. coli binds. This is the result of 
binding by Dr fimbriae, however such Dr binding is not limited to DAEC and is also found in 
UPEC. Overall, what part DAEC play in gastrointestinal disease is not well understood, and 
unique genetic probes for its identification are still being investigated. DAEC do not appear 
to have been studied outside of humans and no outbreaks have been documented (Tacket 
et al., 1990). 
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 extraintestinal pathogenic E. coli (EXPEC). It is therefore expected that they should draw 
the greatest amount of attention from researchers, the press and the general public. They 
are guilty for damaging pathologies sometimes linked with high mortality and epidemics. 
These strains of E. coli could cause disease outside of the intestinal system, resulting in 
sepsis, meningitis, urinary tract infections (UTIs) and infection in a variety of other tissues. 
They result in a considerable amount of morbidity and expenses. This subgroup is 
estimated, in the United States, to cause the 11% of UTIs in women aged 18 and over, thus 
resulting in disease related expenses of over 1 billion dollars annually (George and Manges, 
2010). ExPEC strains do, in fact, contain sets of virulence factors (VFs) not found in 
representative commensal isolates. In animal studies, commensals do not cause disease 
when introduced extraintestinally as do ExPEC strains. ExPEC strains normally belong to 
phylogenetic groups B2 or D, rather than A and B1 to which commensals most typically 
belong. For these reasons, ExPEC strains are now thought of as true pathogens  although 
debate continues as to whether any genetic determinants can distinguish them from 
commensals (Finlay and Falkow, 1997; Russo and Johnson, 2000). ExPEC isolates contain an 
assortment of virulence factors including, but not limited to, adhesins that allow 
colonization of mucosal surfaces, toxins, iron acquisition systems, proteases, invasins and 
serum resistance proteins (Johnson and Russo, 2002). This particular collection of VFs may 
optimize an ExPEC strain for colonization of different tissues; uropathogenic E. coli (UPEC) 
colonize the urethra, bladder and kidneys, meningococcal E. coli (MNEC) the brain and 
nervous tissues, and septicemia associated E. coli (SPEC) the blood. Despite the existence 
of these classes of ExPEC, there is great overlap in the variety of VFs expressed by each 
class, making these designations somewhat artificial (Russo and Johnson, 2000). 
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Figure 3 Schematic representation of the pathogenic mechanisms characteristic of the six main histological types of E. coli: 
a) EPEC: attaching and effacing lesions at the level of the small intestine (1. initial adhesion, 2. injection of Tir by the TTSS, 3. 
cytoskeletal rearrangement and formation of the "pedestal"); 
b) EHEC: attaching and effacing lesions at the level of the colon, processing, secretion and systemic absorption of verocytotoxin; 
c) ETEC: accession all'enterocita (small intestine), secretion of heat-labile enterotoxin (LT1, LT2) and / or thermostable (STa, 
STb); 
d) CEAA (or EAggEC): adherence to epithelial cells of the small and large intestine, forming a thick biofilm, secretion of 
enterotoxin and cytotoxin; 
e) EIEC: invasion enterocyte (colon), lysis of the phagosome, multiplication inside the cell, migrate from cell to cell through the 
cell membrane basolateral; 
f) DAEC: stimulus to the formation of cellular fingerlike projections that wrap the same adherent bacteria (cells of the small 
intestine). 
AAF: aggregative adherence fimbriae; BFP: bundle-forming pilus; CFA: colonization factor antigen; DAF: Decay-accelerating 
factor; EAST1: enteroaggregative E. coli ST1; LT: heat-labile enterotoxin; ShET1: Shigella enterotoxin 1; ST: heat-stable 
enterotoxin. (Kaper et al., 2004) 
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 E. coli and food safety (VTEC/STEC  and EHEC) 
Some strains of Escherichia coli are characterized by the ability to produce exotoxins called 
verocytotoxin or verotoxin (verocytotoxins, Vtxs), causing the cytotoxic effect produced in vitro in 
VERO cell culture (Konowalchuk et al., 1977). Two distinct antigenic groups of these toxins, vtx1 
and vtx2, have been described. On the basis of almost identical antigenic structure of toxins 
belonging to the group vtx1 with Shiga toxin of Shigella dysenteriae, another denomination 
possible is “Shiga-like toxins (SLTs)” or “Shiga toxins (Shiga toxins, STXs)” (O'Brien et al., 1982). 
Since not all E. coli strains are necessarily pathogenic, the capacity to produce these toxins are 
referred to as Verocytotoxigenic E. coli or Verocytotoxic (Verocytotoxin-producing E. coli or 
Verocytotoxigenic E. coli, VTEC) or E. coli toxin-producing Shiga- like (Shiga toxins producing E. coli 
STEC). 
The EHEC (enterohemorrhagic E. coli) are a subgroup of VTEC with strong pathogenicity, thanks to 
the simultaneous presence in them of the genes encoding the verocytotoxin (stx1, stx2 or both) 
and the Locus of enterocyte Effacement (LEE), a  pathogenetic island of about 33,000 base pairs in 
the bacterial genome of E. coli, in which are encoded the pathogenic factors responsible for 
attaching and effacing lesions: the intimine (adhesins encoded by the gene eae, responsible for 
the tenacious bond between EPEC / EHEC and enterocytes), its receptor Tir and TTSS and other 
proteins involved in the formation of these lesions (EspF-H, EspZ, Map) (Figure 4) (Kaper et al., 
2004, Khan et al., 2003). 
 
Figura 4: Grafic rappresentation of VTEC, EHEC and EPEC group in base of shigatoxin (stx) and intimin (eae) genes. 
 
The Locus of enterocyte Effacement, characteristic of EHEC is not essential for pathogenicity; 
Indeed, there are some VTEC LEE-negative can cause serious diseases such as hemolytic uremic 
syndrome. (Nataro et al., 1998) These strains have other adhesion factors than intimine, as some 
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fimbriae and adhesion factors without fimbriae (eg Shigatoxigenic Autoagglutinating Adhesin , 
Saa). (Etcheverria et al., 2013) Some serotypes have also been isolated in cattle strains with LEE 
which have never been found in humans, suggesting the existence of other relevant factors of 
pathogenicity. (Karmali et al., 2003). 
Other virulence factors are important in the pathogenesis of diseases resulting from infection 
VTEC: the enteroemolisin, encoded by the gene ehxA, a "poreforming toxin" monomer capable of 
causing the formation of pores in the cell membrane of enterocytes and correlated to the ability to 
cause hemorrhagic colitis (Bonardi et al., 2006); the ESPP, a secretory serine protease which 
cleaves and inactivates pepsin and coagulation factor V (proaxelerin) in humans; catalase-
peroxidase, able to inactivate reactive oxygen species (ROS) produced by the host's immune 
system (Beltz book , 2011). 
 
 Verocitotoxin 
 
Figure 5: Crystallographic structure verocytotoxin type 2 (Stx2). In blue and blue sub-unit A, in green and red sub-unit B (Fraser et 
al., 2004). 
 
The verocytotoxin are the main and distinctive virulence factor of VTEC. The toxins of the two 
groups, Stx1 (vtx1) and Stx2 (vtx2), are encoded, respectively, by genes and genes stx1 stx2, 
carried by temperate bacteriophage λ which penetrate the bacteria and establish a lysogenic 
cycle, integrating their DNA with the DNA of the host cell. Several stressful factors, such as 
exposure to UV light, growth plate or contact with certain antibiotics, can induce the activation of 
the lytic cycle, with the replication, maturation and the liberation of bacteriophages that, infecting 
new bacterial cells, can lead to the appearance of new strains of verotoxigenic bacteria with new 
combinations of virulence factors. Shiga-like toxins are further divided into many variants: three 
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for the Stx1 subgroup (Stx1a, Stx1c, Stx1d) and seven for Stx2 subgroup (Stx2a, Stx2b, Stx2c, Stx2d, 
Stx2e, Stx2f, Stx2g), in accordance with the nomenclature established at the 7th International 
Symposium on Shiga Toxin Producing Escherichia coli Infections. The group of clinically more 
relevant toxins is the Stx2, within which the variants are present more frequently associated with 
cases of the disease with severe outcome in humans (Stx2a, Stx2c, Stx2d) (Farrokh et al., 2013). 
The toxin structure, verocytotoxin AB5 type, consists of a Domain A, in charge of toxic action, and 
a domain B, responsible for binding with the receptor cell. After cell binding of the holotoxin 
through its domain B, receptor-binding glycolipid GB3 (globotriaosil-ceramide), the domain A is 
internalized by endocytosis and enzymatically cleaved into two segments (A1 and A2). The 
segment A1, with N-glycosilase activity, is released into the cytosol, where acts through the 
removal of the eukaryotic 28S ribosomal RNA adenine, thus blocking the protein synthesis. The 
most affected cells are: endothelial cells (mainly enteric and kidney), enterocytes, platelets, red 
blood cells and B cells. (Doughari et al., 2009) 
 
 VTEC in bovine 
The most well known VTEC serotype is E. coli O157:H7, which has been implicated in many large 
outbreaks of HC and HUS. However, VTEC strains of other serotypes have increasingly been 
implicated in sporadic cases and outbreaks of serious illness in humans, e.g., serotypes O26, O111, 
O103, and O145 (Word Healt Organization, 1998). Among the most important sources of human 
infection are: direct contact with cattle and other ruminants and contaminated bathing water, 
beef products, unpasteurized milk, vegetables, fruits, and drinking water (Tozzi et al., 2001). 
In particular, the VTEC pathogens for humans have been found in many animal species, but only 
the gastrointestinal tract of ruminants, primarily cattle but also goats, sheep and wild ruminants 
can be considered with certainty as a reservoir of these bacteria (EFSA, 2012). Epidemics studied 
from 1982 to date have shown that ruminants, and in particular bovine, appear almost always 
involved in the transmission of these bacteria to humans. The intake of foods derived from cattle 
infected with VTEC is definitely the main route of transmission, also play an important role: the 
intake of other foods origin (such as horticultural products) or water contaminated with cattle and 
direct contact with infected animals or their environment (Caprioli et al., 2005). 
Studies on the presence of VTEC in cattle have been performed in several parts of the word. In 
North America, VTEC were isolated in both beef cattle and in dairy cattle (Hancock et al., 1994). 
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This study reported a prevalence of EHEC O157: H7 equal to 0.71% in beef cattle, and a prevalence 
of 0.28% in dairy cattle, with, respectively, 16% and 8.3% of infected herds; according to another 
study, the prevalence of VTEC in the US varies from 10 to 28% of the animals (Karmali et al., 2010). 
In Brazil, the genes encoding the verocytotoxin (stx) were found in the feces of 53% of beef cattle 
and 82% of dairy cows, and the strain EHEC O157: H7 was isolated from 1.5% of samples. In 
Australia, the stx genes were identified in 16.7% of fecal samples from dairy cows; from 1.9% of 
the samples the serotype O157: H7 was isolated, and from 1.7% the VTEC non-O157 serotype O26: 
H11. In Japan, fecal samples of 46% of the calves, 66% heifers and 69% of cows were positive for 
stx genes and EHEC strains belonging to serogroups O26, O111 and O157 were isolated from 9 out 
of the 78 tested herds (11.5%). In Europe, in the period 2007 - 2011 the VTEC were found in 2.1 to 
13.5% of the tested animals and E. coli O157 was identified in 0.2 to 2.3% of cases. The prevalence 
of VTEC in animals varies greatly between different Member States, reaching peaks of 53.8%. The 
prevalence in a herd ranged from 6.1 to 12.6% for VTEC and 1.5 to 13.7% for VTEC O157. At the 
slaughterhouse, the 13.0 to 20.2% and from 5.5 to 20.2% of the consignments of slaughter were 
positive, respectively to VTEC in general, and to O157 VTEC (EFSA, 2013). In Italy, 3.6% of 
slaughtered are positive for the non-O157 VTEC (Bonardi et al., 2004). 
Cattle are asymptomatic excretors of VTEC which are transient or permanent members of the 
normal intestinal flora (Caprioli et al., 2005) The persistence of VTEC in individual animals is due to 
the fact that these bacteria colonize the special traits of the gastrointestinal tract. The different 
possible interactions between the microrganism and its host affect the pattern of fecal elimination 
in the various subjects: low level (<103 CFU / g of feces) and short term (<10 days) elimination 
occurs when the colonization is limited to the rumen; if the colonization is extended to the colon, 
increasingly low levels of elimination but for prolonged periods (> 30 days) are observed (Duffy 
2014). Several authors have shown, for the serotype O157: H7, a particular tropism for a region of 
the rectum adjacent to the recto-anal junction of cattle. The localization between 3 and 5 cm 
cranial to the junction recto-anal has been speculated to be cause of eliminating high levels of 
fecal bacteria (106-8 CFU / g of feces) in animals so-called "super shedders". It is believed that 
"super shedders" individuals are responsible for the elimination of 95% of the total VTEC issued by 
a herd and may have, therefore, a very important role in the epidemiology of these 
microorganisms (Naylor et al., 2010). 
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Faecal elimination of VTEC in cattle is transitory and is undoubtedly influenced by age. Studies 
conducted in the US showed a low prevalence of shedding subjects in calves younger than two 
months (<1.5%), while the highest prevalence (1.8 to 5%) was detected in subjects aged 2 and 4 
months; then the proportion of VTEC shedding subjects decreases (Caprioli et al., 2005). Even the 
studies of experimental infections confirmed the increased elimination in young people than in 
adults and identify the necessary next step weaning the moment of maximum elimination. The 
amount of enterohemorrhagic E. coli O157 released by calves eliminators is generally between 102 
and 105 cfu / g of faeces. 
Excretion of VTEC in cattle was also influences by season. Several studies have reported an 
increased number of subjects eliminators and quantities of microorganisms emitted during the 
warmer months and an extension of the elimination period, albeit with lower emission amount of 
microorganisms, in the cold months (Caprioli et al., 2005). 
Some VTEC strains are able to persist in a herd for some time. Studies in the US have shown that 
certain strains of EHEC O157 have persisted in the dairy industry for more than two years. 
Furthermore, the introduction of new strains through food, water for the watering and the 
purchase of new animals, is always possible. The VTEC survive in the feces of animals, preserving 
their infectivity for periods ranging from a few weeks to a few months. Their survival is mainly 
influenced by the temperature and water activity (aw) in the stool, making it higher in conditions of 
high humidity and low temperatures. Overcrowding and poor housing conditions, such as 
pavements, litter or soil wet and accumulation of faeces and urine, can promote the persistence of 
VTEC in the herd of beef cattle. The same factors seem to influence their persistence even in dairy 
herds (Gautam et al., 2014). At this regard, in the stables where the removal of manure was 
performed via systems of flushing there was a higher prevalence of bovine excreting EHEC O157 
than in the stables where manure was removed by mechanical scraping. 
When contaminated feces with 108 CFU / g of EHEC O157 are laid on the surface of the pasture, 
the bacterial count decreases progressively; nevertheless, the micro-organism into the 
surrounding ground remains detectable for more than 99 days. The persistence of VTEC in the soil 
favors the infection of the animals, making environmental exposure a major risk factor in animals 
grazing. 
Manure and slurry from cattle farming are frequently used as soil conditioners and fertilizers in 
conventional farming practices for the production of animal feed and fertilization of meadows and 
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pastures. Therefore, the presence of VTEC in products intended for cattle represents a potential 
route of infection and reinfection of herds. The presence of VTEC in foods for cattle has recently 
been evaluated in the United States: in 504 food samples collected at 54 different fattening farms: 
E. coli O157 was found in 14.9% of cases (75 samples) and there was no correlation between the 
presence of EHEC O157 and enumerating total coliforms (Farrokh et al., 2013). Fecal 
contamination of fields, followed by inadequate management silage fodder, is a key risk factor for 
the persistence of VTEC in the herd. On the contrary, in correct conditions of ensiling, the lactic 
fermentation is able to eliminate these bacteria and it is therefore wrong to consider silages of 
good quality a possible source of E. coli Verocytotoxic. The inoculation of bacteria producing lactic 
acid during the ensilage, with the aim to accelerate the descent of the pH, can favor the 
elimination of VTEC from the product. 
Also the composition of the ration is able to influence the presence of VTEC. Several authors have 
hypothesized that a diet rich in grains may promote, through the lowering of the rumen pH, 
bacterial adaptation phenomena that can lead to the development of acid-resistance mechanisms 
able to increase the survival of VTEC and to increase their fecal elimination. However, studies 
carried out on animals subjected to different diets have often produced conflicting results: in 
some cases the animals fed with diets high in hay eliminated the EHEC O157 for longer periods 
than those fed rations high in cereals, while in other studies the subjects fed diets rich in 
concentrates have shed EHEC O157 for longer than those raised on pasture. Yet other studies have 
shown no differences between the parties subject to different diets. 
The water used for the watering can act both as a vehicle for the introduction of VTEC in breeding, 
when contaminated in origin, and as a reservoir for the maintenance and circulation of these 
microorganisms within the herd, due to the contamination of drinking troughs . The VTEC, in fact, 
are able to survive and multiply in the sediment of water subject to fecal contamination for long 
periods (LeJeune et al., 2001). 
When cattle manure are spread on land in periods of heavy precipitation, verocytotoxic E. coli may 
be transmitted over long distances via the sliding surface of the water or may contaminate 
groundwater reaching the deep layers of the ground by exploiting the phenomenon of 
percolation, and spreading infections to other herds and humans through the waters of rivers, 
lakes, wells and aqueducts. 
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Cattle farming is undoubtedly a major source of environmental contamination with VTEC; 
however, other possible sources are sewage contamination of human origin or through the 
spreading on land of sewage sludge resulting therefrom. 
 
 VTEC and human trasmission 
The VTEC original source are always the feces of ruminants, and there are many ways through 
these microorganisms can come to human. The major route of transmission consists of taking food 
from bovine: meat or meat products contaminated at the slaughterhouse and milk or dairy 
products made from raw milk, improperly pasteurized or contaminated after the last heat 
treatment. In addition to beef products, many other foods of various origins are associated with 
human infection: salami, mayonnaise and fruit or vegetables contaminated with cattle manure, as 
bean sprouts, lettuce, tomatoes, sprouts and unpasteurized juices (EFSA, 2007). The water 
contamination is a possible route for human infection, especially in developing countries, but not 
only these; in this regard, can be cited as an example the "Walkerton tragedy", a source of 
infection VTEC serotype O157: H7 occurred in 2000 in Walkerton in Ontario (USA), caused by 
contamination of the municipal water supply, during which were recorded 2,300 cases of the 
disease, hesitated in seven deaths. 
 
 VTEC in raw milk 
The possible ways to the entrance of VTEC in milk are fecal contamination and mammary 
excretion during E. coli mastitis. Between the two ways, the first is considered much more 
frequent in practice, but it can not be excluded that a small part of VTEC found in milk resulting 
from mammary gland. Indeed, a study conducted in Switzerland found VTEC in the milk of 3% of 
cows with mastitis from E. coli (Stephan and Kuhn, 1999), Besides, a study performed in Brazil 
found stx genes in 12% of 182 E. coli strains isolated from 2,144 samples of milk from cows with 
clinical and subclinical mastitis (Lira et al., 2004). 
Considering the different importanceof the two transmission ways, it is clear that the key point in 
the control of these pathogens at the farm level is the limitation of the faecal contamination of 
milk (Hussein et al., 2005). Managerial practices aimed at limiting the presence of VTEC in milk 
include: the reduction of faecal excretion (through the identification of those "super eliminators", 
the use of probiotics and vaccines, and minimization of stress for the animals), the limitation of 
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the spreading of VTEC within the farm (maintenance of hygiene in the housing, the proper 
management of litter, pest-control, limiting contact between animals of different age groups, 
limiting contact between raised animals and wild animals, proper management of manure, correct 
silage of fodder) among different farms (through carrier animals, sewage, water, contaminated 
food, wild animals and staff), and minimizing faecal contamination of milk during milking (Farrokh 
et al., 2013). 
Even under the best hygienic conditions, the skin of the udder and teats of dairy cattle is always 
contaminated by a certain amount of fecal material from the environment. The milk from the 
udder that are dirty and not subjected to cleaning of the teats during milking can reach more than 
105 CFU / mL. There is a close relationship between the total bacterial count in milk and the 
hygiene of the udder. The level of contamination of milk by bacteria present on the skin of the 
udder is influenced by the degree of contamination of the udder itself, the percentage of 
contaminated udder and by the grade of cleaning of the teats when milking. The contamination of 
the udder is in turn influenced by many environmental and management factors: housing type 
(fixed, free with bunks, free with permanent litter), management of litter (frequency of renewal), 
type of litter (straw, sawdust , sand, rubber mattresses), cleaning of the areas of feeding 
(mechanical scraping vs. flushing). Regarding milking, pre-dipping is particularly important to 
reduce the possibility of milk contamination. The cleaning of the teat with a detergent solution 
and disinfectant, followed by thorough drying, is able to reduce the bacterial load of the skin of 
75% and, therefore, contamination of the milk (Galton et al., 1989; Bade et al 2008). Also the 
wasting of the first jets of milk before the attack of the milking unit (forestripping), eliminating the 
milk portion closest to the orifice of the teat, allows to reduce the contamination of the milk in the 
tank. VTEC are also able to persist inside of the milking plant in the case in which the operations of 
washing and sanitizing are not carried out correctly (Farrokh et al., 2013). The result of the 
operations of washing of the milking plant is influenced by many factors: temperature, quantity 
and quality of water used, turbulence and pressure of the washing water, the type of detergent 
used and its concentration, as well as the duration of the different phases Process (Reinemann et 
al., 2000). 
As described above, in the raw milk is possible to find VTEC. The prevalence of these bacteria in 
raw milk cattle is generally low and it is usually comprised between 0 and 2%. The latest EFSA 
report, for the year 2013, shows data from nine member countries (Austria, Belgium, Estonia, 
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Germany, Greece, Czech Republic, Slovenia, Spain and Hungary); 18 samples out of a total of 860 
tested samples were positive for VTEC, equal to 2.09%, and 5 of them (0.58%) were contaminated 
with O157 serogroup; non-O157 VTEC belonged to serogroups O26, O103, O111 and O145. The 
prevalence of VTEC was higher in samples of milk taken from breeding (4.52%) and lower in 
samples taken at retail (1.52%) and in processing plants (1.19%) . In the report for the year 2012 it 
is not reported any data on VTEC in raw milk. The report showing the data of 2011 collects 
information from four Member States (Belgium, Germany, Slovenia and Hungary); 499 samples of 
raw milk were tested, of which 8 (1.6%) were positive for VTEC, and one (0.2%) of these was a 
serogroup O157 strain. For the year 2010 data were presented from four member countries 
(Bulgaria, Germany, Slovakia and Hungary), and the VTEC were detected only in Germany, where 
17.6% of 318 samples of raw milk destined to processing and none of 117 samples of raw milk 
destined to direct consumption tested positive for non-O157 VTEC.  Italy has provided the data for 
the years 2009, 2008 and 2007. In 2009, none of 994 samples tested positive for VTEC; in 2008 
0.6% of 161 samples of raw milk tested positive for VTEC O157; in 2007, there was no evidence of 
VTEC in the 436 tested samples. 
The reported prevalence of VTEC in raw milk are low, but their presence is always possible, both 
for  O157 and for non-O157 strains, and VTEC can be detected also in raw milk cheese. 
Because of the complexity and the enormous variability of the process leading to obtaining the 
many different cheeses and products all over the world, it is particularly difficult to fully 
understand the behavior of VTEC during the cheese and predict their survivability during ripening, 
maturation and commercialization. However, the microbial stability of the cheese is commonly 
determined by a number of factors that hinder the growth of bacteria; among these, the 
temperature reached during the production steps, the low pH, the water activity value (aw), the 
content of NaCl and the presence of competing flora, are those of greater importance for the 
achievement of neutralization of VTEC. Several authors have shown how each of these factors, 
when applied individually, may not be able to achieve the elimination of E. coli. Indeed, the 
survival of VTEC can be compromised only through the simultaneous or sequential application of 
these stressors. Nevertheless, it is reasonable to assume that in the cheese exists a synergy in the 
action of these factors and that the combined application of the stress is able to eliminate the 
VTEC in most cases. All dairy products made with pasteurized milk, since this procedure is effective 
in the elimination of VTEC, can be virtually considered as VTEC-free, with the exception of 
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pasteurization failure or contamination of milk in successive steps. It means that the VTEC assume 
particular relevance only in soft and semi-soft cheese made from raw, unpastorized milk, such as 
soft cheese. The low prevalence of VTEC in raw milk and effectiveness of most cheese making 
processes in neutralizing these bacteria, make the presence of VTEC in the cheese and dairy 
products as quite limited. The EFSA report on animal diseases in 2015, relative to 2013, shows 
data on VTEC for dairy products other than raw milk from eight Member States (Austria, Belgium, 
Germany, Greece, Ireland, Italy, Spain and Sweden ). Out of 1317 tested samples, 66 (5.01%) were 
positive for VTEC, and 2 of these were contaminated with O157 (0.15%) and 64 (4.86%) with non-
O157 VTEC. Regarding Italy, 796 samples of milk-derived products were tested, among which 24 
(3.01%) were positive for VTEC and 2 were O-157 strains. 
 
 O157 VTEC and non-O157 VTEC 
The strains of Escherichia coli are serologically classified based on antigenic differences of antigens 
O (somatic) and H (flagellar), based on the typing scheme introduced in 1994 by Kauffmann and 
still used internationally. More than 180 types of O-antigen and more than 60 types of antigen H 
are currently known (D’Souza et al., 2002). The set of bacterial strains characterized by the same 
antigen O constitutes a "serogroup" while a specific combination of O antigen and H antigen 
defines the "serotype" of a strain. Additional antigens taken into consideration in the classification 
scheme of Kauffmann are K (capsular) and F (fimbrial) antigens. 
The membership of a strain of E. coli in a given serogroup or serotype may be associated with the 
presence of certain pathogenic factors and the ability to cause specific clinical symptoms. 
However, determining only the serotype of a strain can not be useful to predict its genotypic 
characteristics or its pathogenicity, since the horizontal transfer of genetic material between 
different bacterial clones may allow strains with identical phenotypic trait (such as serotype) 
carrying many genotypic differences and different pathogenic factors (Nataro et al., 98, Wu et al 
2008). 
An extraordinarily important aspect concerning the Shiga-like toxins is their viral origin. In fact, 
they are encoded by viral genes belonging to prophage of temperate bacteriophage integrated 
into the bacterial genome by the mechanism of the conversion phage. In this form of genetic 
transfer the presence of the prophage and the simultaneous expression of viral genes constitute 
stable genetic alteration in the bacterium (Poli book, 2005). However, following a stressful factors 
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of different nature (antibiotics, UV rays, etc.), excision from the bacterial chromosome can occur, 
with the reactivation of the lytic cycle and release of mature viral particles, able to infect new 
bacterial cells and giving rise, potentially, to new VTEC (Poli book, 2005). The same 
enterohemorrhagic E. coli (EHEC) are, probably, the result of the evolutionary path followed by 
some enteropathogenic strains (EPEC) after the acquisition of the genes encoding the 
verocytotoxin (Reid et al., 2000). The most dramatic demonstration of this mechanism, was, 
probably, the epidemic which occurred in Germany in 2011. On May 26 of that year, Germany 
signaled a major outbreak of haemolytic uraemic syndrome (HUS) caused by E. coli producer 
verocytotoxin; in one week 470 cases were reported (Askar et al., 2000). The VTEC isolated strain 
was later characterized by researchers at the laboratory of the National Reference Centre for 
Salmonella and other Enterobacteriaceae at the Robert Koch Institute in Berlin. This bacteria, 
belonging to serotype O104: H4, proved capable of producing the verocytotoxin Stx2a but it 
turned out no characteristic of the classic markers of pathogenicity of EHEC; it was, in fact, LEE 
enteroemolisin negative; it had, instead, the plasmids encoding the pathogenic factors of 
enteroaggregative E. coli (EAEC), responsible of th autoagglutination and biofilm formation, so-
called "stacked-brick" (AATA, AGGR, aap, Agga and aggC) (EFSA, 2011 ) 
This unusual combination of virulence factors associating EAEC status and ability to produce 
verocytotoxin is extremely rare and it had been previously reported in one case, in a strain with 
serotype O111:H2 implicated in a small outbreak of hemolytic uremic syndrome in France 1998 
(Morabito et al.,1998). 
 
 EFSA and non-O157 VTEC 
The Panel on Biological Hazards of EFSA scientific opinion on the monitoring and identification of 
human pathogenic VTEC 2007, concludes that only a small group of serogroups is associated with 
a high risk to public health (O26, O103 , O91, O145 and O111). EFSA recommends the 
implementation of monitoring systems aimed at identifying VTEC belonging to these serogroups 
potentially at risk in food (meat of ruminants, meat products "ready-to-eat" vegetables, milk crude 
and products derived therefrom) and animal reservoir. 
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 Principal methods to detect VTEC status 
The VTEC include 400 different serotypes, and each serotype has its physiological characteristics, 
its own set of virulence factors and a different potential pathogenic for humans. This diversity is 
reflected by the complexity and variety of the methods used in their search, especially in the case 
of non-O157 VTEC. 
The large set of VTEC searching methods can be divided into two subsets based on the 
fundamental concept on which they are built serotyping-independent methods and serotyping-
employing methods. The serotyping-independent methods are based on the search of the 
pathogenicity factors of EHEC or genes coding for them; serotyping-employing methods, 
otherwise, are intended to identify strains of E. coli belonging to the serogroups most frequently 
implicated in human infections. Obviously, both approaches are not free from errors, in fact, with 
the first approach strains are frequently labeled as pathogenic VTEC strains but belonging to 
serotypes not able to cause disease in humans; with the second approach, on the contrary, strains 
of pathogenic VTEC belonging to serotypes are rare but can cause serious illnesses, such as O113: 
H21, O174: H21, O104: H4 and many others, could not be detected. 
For the identification of VTEC O157: H7, the main cause of pathogenic VTEC recorded in humans, 
there are several serotyping-employing methods bacteriological, serological and molecular 
methods; also for the VTEC non-O157, identification methods are available for different 
serogroups (such as O26, the O103, O111 or the O145) but, because of the greater variability 
existing between them, they are more difficult to be implemented and less accurate. 
The variability of the O antigen that is part of the lipopolysaccharide on the outer membrane of E. 
coli is due to differences in sugar composition and the sequences and linkages of these sugars 
(Wick et al., 2005). The O-antigen gene cluster consists of genes that are well conserved between 
O serogroups and also genes that differ across serogroups. These O-serogroup-specific genes are 
responsible for the synthesis and assembly of the O antigen (Wang et al., 1998). In a recent study 
(Norman et al., 2012), single nucleotide polymorphisms (SNPs) within the O-antigen gene cluster 
of non- O157 E. coli serogroups O26, O45, O103, O111, O121 and O145, were identified as 
predictive of  VTEC-status within a serogroup. In the study by Norman et al., differences in the 
genetic sequence of the O-antigen gene cluster corresponded well to the differences in the 
virulence gene profiles and provided evidence of separate clustering for the majority of VTEC and 
non-VTEC strains.  
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1.2 HRMA for polymorphism analysis 
 
1.2.1 Generality on High Resolution Melting Analysis (HRMA) 
Amplification product melting analysis is not a novel concept and exploits a fundamental property 
of DNA, called melting: the separation of the two strands of DNA with heat. PCR product melting 
analysis in combination with real-time PCR was first introduced with the LightCyclers and the 
stability of DNA duplexes was detected using intercalating dye, like SYBR Green I. This is able to 
detect primer-dimers or other non-specific products (Wittwer et al., 1997). This procedure, called 
Low Resolution Melting has been performed for over a decade. A Low Resolution Melt curve is 
produced when the temperature increases, normally in steps of 0.5 °C increment per second, 
thereby gradually denaturing a previously amplified DNA target. Since SYBR Green I is only 
fluorescent when bound to dsDNA, fluorescence decreases as the double strand of the DNA 
amplicon is denatured. The melting profile depends on the length, GC content, sequence and 
heterozygosity of the amplified target. The highest rate of fluorescence decrease is normally at the 
melting temperature of the DNA sample (Tm). The Tm is defined as the temperature at which 50% 
of the DNA sample is doublestranded and 50% is single-stranded. The Tm is typically higher for 
DNA fragments that are longer and/or have a high GC content. The fluorescence data from low 
resolution melting curves can easily be used to derive the Tm by plotting the derivative of 
fluorescence vs temperature (-dF/dT against T) as reported in Figure 6 (High Resolution Melt 
Analysis, Application Guide, www.kapabiosystem.com). 
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Figure 6: Low Resolution Melt profile derivative plot (-dF/dT against T). 
The steepest slope is easily visualized as a melt peak. In this example the Tm of the amplicon is 77 °C (High Resolution Melt 
Analysis, Application Guide, www.kapabiosystem.com). 
 
The principle of High Resolution Melting Analysis (HRMA) is the same as a Low Resolution Melt, 
except that the temperature difference between each fluorescence reading is reduced. During a 
Low Resolution Melt curve analysis, the temperature increases are typically in 0.5 °C steps, but for 
HRMA this is reduced to 0.008 - 0.2 °C increments, depend on the property of the instrument.  
Briefly, the first step of the HRM protocol consists in the amplification of the region of interest 
(usually, through a real-time PCR protocol), in the presence of a specialized double-stranded DNA 
(dsDNA) binding dye. This particular dye is highly fluorescent when bound to dsDNA and 
inadequately fluorescent in the unbound state. This change allows to monitor the DNA 
amplification during PCR (as in quantitative PCR). After completion of the PCR step, the amplified 
target is gradually denatured by increasing the temperature in small increments, in order to 
produce a characteristic melting profile; this is termed melting analysis. The DNA sequence is 
gradually heat-denatured, the dye is released from the amplicon and therefore resulting in a 
decrease of fluorescence. If tuned in the correct way, this process allows a much more detailed 
analysis of the melting behavior. HRMA is thus able to detect a single change in the nucleotide 
sequence. HRMA uses low-cost dyes and requires less optimization than similar systems based on 
TaqMan chemistry and fluorescence resonance energy transfer (FRET) probes. Besides, HRMA is a 
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simpler and more cost-effective way to characterize multiple samples (High Resolution Melt 
Analysis, Application Guide, www.kapabiosystem.com).HRMA sensitivity and reliability has been 
improved with the use of a variety of new dsDNA intercalating dyes and the availability of new 
instruments and more sophisticated analysis software. 
 
1.2.2 The intercalating dyes  
There are a variety of dsDNA intercalating dyes, which have particular different characteristics. 
The conditions of the dyes used for HRMA are different from dyes typically used for standard 
quantitative PCR (qPCR) assays. Factors critical in qPCR, such as the signal-to-noise ratio and 
amplification efficiency, are not essential requirements for HRMA. Instead, the dye must provide 
detailed information on the melting behavior of an amplified target. Ideally the dye should not 
bind preferentially to pyrimidines or purines, change the Tm of the amplicon, or inhibit DNA 
amplification (High Resolution Melt Analysis, Application Guide, www.kapabiosystem.com). The 
three main classes of dsDNA binding dyes currently available are: 
 Non-saturating dyes. SYBR® Green I is the most common non-saturating dsDNA intercalating 
dye. This type of dye is not very suitable to be used in HRMA. SYBR® Green I stabilizes the 
dsDNA when used at high concentrations, but it inhibits DNA polymerase. In contrast, low 
concentrations are not distributed in an appropriate way in the strand of DNA that results in 
poor discrimination-based difference (Figure 7). For a good performance the dye must be 
used at the right concentration. 
 Saturating dyes. These dyes, unlike the previous ones do not inhibit the DNA polymerase and 
do not alter the Tm of the fragment. These dyes in contrast to other can be added in higher 
amounts so that the entire sequence is full of dye. Unfortunately this dye is not able to 
redistribute during melting because the dsDNA is saturated. More accurate examination of 
the melting performance is therefore possible, as reported in Figure 7. Dyes such as SYTO9® 
and LCGreen® can be used at the saturating concentrations required for HRMA. 
 Release-on-demand dyes. The “release-on-demand” class of dyes, which include EvaGreen®, 
can be added at non-saturating concentrations. This characteristic depends on the new 
method of fluorescence emission. In fact, the dye signal turns off when the fluorescent is free 
in solution. After the dye is tied in with the filament dsDNA, when the temperature drops the 
dye starts to emit the signal. This allows non-saturating concentrations of the dye to be used, 
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ensuring that there is no PCR inhibition, whilst the unique dye chemistry provides highly 
sensitive HRMA analysis. 
 
 
Figure 7: Non-saturating, saturating and ‘release-on-demand’ dsDNA intercalating dyes (High Resolution Melt Analysis, Application 
Guide, www.kapabiosystem.com). Melting of the duplex as the temperature increases releases the intercalated dyes. At non-
saturating concentrations the dye rapidly rebinds to regions that remain double stranded; consequently there is no drop in 
fluorescence. Saturating and ‘releaseon-demand’ dyes do not redistribute from the melted regions of single-stranded DNA back to 
dsDNA, resulting in a reduction of fluorescence. This difference gives dyes such as EvaGreenR the high sensitivity required for HRM 
analysis. 
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1.2.3 HRM assay and reagent optimization  
 
The HRMA is a very sensitive technique and for this reason the development of the method is 
crucial. There are several factors that influence the behavior of melting, as genomic DNA (gDNA) 
quality, the background pattern, the concentration of MgCl2 and polymerase inhibitors. Small 
differences in the initial configuration can significantly impact the final results. Achieving specific 
amplification is critical to the success of an assay, since any non-specific amplification will greatly 
impair the melt analysis. The following most important aspects are listed (High Resolution Melt 
Analysis, Application Guide, www.kapabiosystem.com): 
 
 DNA quality and quantity: One of the main factors that can affect the quality of the results 
is the relationship between DNA samples and PCR preparation. Unsuitable purification techniques 
can distort the signal. The presence of salts can change the melting behavior of the PCR product, 
and may result in poor reproducibility, low sensitivity and incorrect genotype calls. 
Buffer carryover from the template DNA will not only modify the Tm and melting behavior during 
the HRM, but can encourage also nonspecific amplification during PCR. 
To avoid possible bias in the results, some tricks may be used, as for example: a) to extract the 
DNA to be analyzed using always the same kit, b) to check the concentration of salts in the kit 
because any excess can distort the signal, and c) to check that the DNA concentration is equal for 
all samples. Table 4 shows the recommended concentration of DNA for the different types of 
targets. At low concentrations of the target, there is a greater possibility of incorporating a 
mutation early in the PCR that will affect the melting behavior. By contrast, high concentrations of 
DNA can result in high fluorescence due to an increase in dsDNA intercalation of dye. The positive 
control(s) for all genotypes should be included if possible, preferably at the same concentration of 
their corresponding samples. Control DNA should also be eluted and/or diluted in the same buffer 
of the samples. 
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Table 4: Recommended concentration of DNA for different types of template (High Resolution Melt Analysis, Application Guide, 
www.kapabiosystem.com) 
 
 Primer design: the primers for HRM are not easy to draw, since they should adhere to 
several requirements. In fact, it should be noted that the HRM analysisis is preceded by a qPCR, 
then amplicons can not be very long to ensure high sensitivity. Potential primer sets and full-
length amplicons can then be tested for specificity using a BLAST search. Factors such as the 
position of the primer, the need for a GC region on the 3 'end, the presence of any secondary 
structures in the primers or target, and the specificity of the predicted amplification should be 
carefully considered. Software as Primer3 or Primer3Plus can be very useful for drawing of primer 
HRMA, because the user can specify the location, the length and any other characteristics that are 
needed (Figure 8). 
After the primers have been designed, the following factors must be checked: 
• The presence of a GC ‘clamp’ on the 3’ end. This is not essential, but usually improves 
amplification efficiency. 
• The specificity of the primers and the presence of known sequence variations. A BLAST search 
with both primer sets and the expected amplification product should be performed. If possible, 
sequence variations should also be checked.  
• The secondary structure of the primers and the expected amplification product. This should be 
examined using appropriate softwares, for example, m-fold, 
http://mfold.rna.albany.edu/?q=mfold/dna-folding-form, or operon, 
http://www.operon.com/tools/oligo-analysis-tool.aspx. Amplification of any secondary structure 
within the product may result in unusual melting profiles. Primers may need to be redesigned to 
avoid areas of secondary structure. 
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• Amplicon size. This must be optimal for the specific application, typically between 100 - 300 bp. 
 
 
Figure 8. Design of primers for amplification of a human SNP using Primer 3 (http://frodo.wi.mit.edu/primer3/). The target SNP is 
shown in square brackets (e.g. ... TTAA[A]TGTC...) and the product size is set to 50 – 300 (bp). 
Selection of the mispriming library ‘HUMAN’ helps reduce the chances of non-specific amplification (High Resolution Melt Analysis, 
Application Guide, www.kapabiosystem.com). 
 
 Primer concentration and purification: the concentration of primer does not significantly 
affect the overall result in HRMA, however the recommended primer concentration to avoid 
nonspecific amplification is between 0.05 and 0.5 μM final. For normal purposes, it can be used 
the final concentration of 0.3 μM as recommended by the Evagreen’s manufacturers. 
 
 Effect of MgCl2 on HRM analysis: different concentrations of MgCl2 influence the efficiency 
of amplification, as is the case with conventional PCR. The amount of MgCl2 leads to reduced non-
specific amplification, and allows a clearer distinction of sequence variations. It is important to 
realize that the optimum MgCl2 concentration for amplification efficiency Is not necessarily 
optimal sensitivity for HRM. The effect of MgCl2 is shown in Figure 9. As the concentration of 
MgCl2 is increased, the HRM difference graphs change distinctively. 
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 Amplicon length: in HRMA it is difficult to specify the optimal length of the amplicon, since 
there are many factors to be considered. For example, one factor is the number of nucleotide 
changes in the sequence, i.e. the less variations there are, the shorter should be the amplicon. 
Normally the amplicon length can vary from 50 to 300 bp. Clearer discrimination is usually seen 
with shorter amplicons. However, small amplicons can result in lower fluorescence values, 
presumably because of decreased incorporation dye. By contrast, very long amplicons are allowed 
to create complex structures resulting in melting behaviours that can be misinterpreted in the 
end. When screening for unknown sequence differences, longer amplicons (typically 200-500 bp) 
can be used. This is useful in gene scanning or determining the variation within at population (e.g., 
viral) and reduces the number of required primer sets. Furthermore, too short amplicons are 
difficult to sequence. 
 
 Effect of PCR enhancers on HRM analysis: PCR enhancers are commonly added to end-
point PCR in order to help reducing non-specific amplification and the number of reaction cycles, 
and increasing yield. These enhancers function by assisting the melting and annealing of primers 
and templates, and can affect HRMA performance. For GC-rich amplicons, the addition of DMSO 
appears not to affect the HRMA significantly, and is recommended if amplification is difficult. 
Overall, the addition of PCR enhancers is not recommended as they usually detract from HRM 
performance. 
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Figure 9. Effect of increasing MgCl2 on melting behavior. Three Difference Graphs are overlayed to demonstrate the dependence of 
amplicon melting on MgCl2 concentration. The effect of MgCl2 is most pronounced in the heterozygote samples (blue), a result of 
the magnesium stabilizing the annealing of mispairs. The MgCl2 concentrations are 1.5 mM, 2.5 mM and 3.5 mM final. G/G = green, 
G/A = blue, and A/A = red (High Resolution Melt Analysis, Application Guide, www.kapabiosystem.com). 
 
1.2.4 Instruments and software 
The capacity of HRM analysis depends upon the sensitivity of the instrument and the nature of the 
PCR reagents used. Certain instruments have been designed specifically for HRM analysis. These 
can be summarized into two distinct classes: 
1. Block based instruments – Samples are placed in a block for cycling and a scanning head or 
stationary camera is used for detection. 
2. Rotary – Samples reside in a single chamber and spin past an optical detector. 
There are advantages and disadvantages with each class, and the users should choose the type of 
instrument that best suits their needs. As a general rule, for high sensitivity and reproducibility a 
rotary-based instrument should be used, whilst for high-throughput and ease-of-handling, block-
type instruments are optimal. The HRM run can vary considerably between instruments; some 
take considerably longer than others. Every instrument should be calibrated regularly (as 
recommended by the manufacturer, typically every 6 months), kept in a clean area on a secure 
and stable benchtop, and checked daily for dust buildup around the optics. The computer 
hardware and software must be capable of handling the large quantities of data usually generated 
during a HRM experiment. Analysis of the data is relatively easy with the appropriate software. 
HRM specific software uses various algorithms to analyze the data and display the results in user-
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friendly formats to help discriminate between sequence variants. Additional software packages, 
designed for more detailed analysis, are available from some instrument manufacturers (High 
Resolution Melt Analysis, Application Guide, www.kapabiosystem.com). 
 
1.2.5 Analysis of results 
Data analysis is typically straightforward, with the correct software, allowing multiple samples to 
be analyzed at the same time. Low resolution melt plots are often viewed as a derivative plot 
(−dF/dT against T); however, HRM raw melting curves must be analyzed differently. It is important 
to know what to look for when interrogating results; unforeseen errors made during setup can be 
identified at this point. 
Amplification plots. For HRMA, the reproducibility of amplification is more important than 
efficiency amplification, compared with qPCR. As an example, the HRM analysis can still be 
performed if the product amplifies later than expected (for example due to limitations in the 
design of primers), provided that all the samples are constants, the no template control (NTC) 
does not amplify and the product is specific. 
Raw data melt curve. The data collected during the analysis HRM has a variety of (pre-melt) initial 
values of fluorescence. These variations make it difficult to interpret the results, even if different 
genotype groups can be visible. Figure 10A how to analyze the HRM results and a 124 bp product 
covering a Type IV SNP is used as an example (High Resolution Melt Analysis, Application Guide, 
www.kapabiosystem.com). The panel A of this figure illustrates how the selection of pre-and post-
melt regions is used to align data. It is important to adjust these bars so that the melt region is not 
selected. If the preor post-melt regions are not clearly defined, it is possible to repeat the HRM run 
only (without repeating the amplification step), and adjust the temperature range as required. 
Pre- and post-melt regions must be selected for each primer set, by positioning the parallel 
double-bars as shown.  
Normalization data. If the data is normalized correctly, it will appear as shown in the panel B of 
the Figure 10. This is termed ‘Normalization Data’. Here the fluorescence variance seen in the 
Figure has been eliminated, and only the temperature range between the outer bars of the pre- 
and post-melt regions is shown. The genotypes are now more distinct, but the two homozygote 
samples (in red and blue) are still difficult to distinguish. 
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Figure 10. Analysis of HRM data from a type 4 SNP (A/T). Different genotypes are highlighted in different colors. A/A = red, A/T = 
green, and T/T = blue. 
A. Raw data showing the pre-melt, melt and post-melt regions. Notice the fluorescence variance and the positioning of the pre- and 
post-melt identification bars. B. Normalization Data derived from the raw data plots in A. Positioning of the pre-melt, and post-melt 
bars provides a more detailed view of the melt region. C. Difference Graph derived from the Normalization Data (High Resolution 
Melt Analysis, Application Guide, www.kapabiosystem.com). 
 
Difference graph. Some HRM software applications allow calculation of the difference plot. This is 
achieved by subtracting the normalized fluorescence data of a user-defined genotype from that of 
each of the other samples in the HRM analysis. In panel C of Figure 10, the A/A genotype has been 
selected as a baseline (any genotype can be selected, but usually one of the homozygotes is used). 
The position of each sample relative to the baseline is plotted against the temperature. This 
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output of HRM analysis is an aid for visualizing the normalization data. Automatic calling of 
genotypes of sequence variants can usually be performed with most instrumentation softwares; 
sometimes confidence ratings are given. However, checking the difference to confirm the 
genotype is recommended. 
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1.3 Aim of the work 
One of the main activity of the present project was based on the test hypothesis that the virulence 
profile of E. coli strains toward bovine mammary gland is modulated by the interaction with the 
host cells. Besides, a comparison between mastitis E. coli strains and O157 E. coli strain might 
clarify if a similar modulation is induced by the host also on non-bovine strains causing human 
disease. These hypothesis were tested through a gene expression study of some virulence factors 
of six E. coli strains when co-cultured with a bovine mammary cell line, since the in vitro models 
are an essential tool to investigate the biological mechanistic of mastitis. Furthermore, the use of 
in vitro models have the possible advantage that they represent an efficient alternative to animal 
experiments, thereby saving the lives of laboratory animals and reducing the expensive costs of 
animal experimentation. The European Union legislation included an alternatives studies without 
the use of animals declaring that “authorities will have to assess the animal welfare implications of 
all scientiﬁc experiments involving animals with a view to promoting alternative testing methods 
where possible” (http://www.euractiv.com/en/science/eu-wantsfewer-animals-used-research-
news 497607) (Purup and Nielsen, 2011). For the purpose of the coculture experiment, a meta-
analysis of existing literature studies on the available bovine mammary cell lines was preliminarly 
performed, resulting in the selection of MAC-T as the most responsive cell line to bacteria causing 
mastitis. The E. coli strains used for the coculture experiments with MAC-T cells were isolated from 
different types of bovine mastitis (acute, chronic and undetermined) and from a VTEC food-borne 
strain associated to human clinical disease (O157). Among these strains, 727 and McGear strains 
were reported to be able  to induce mastitis in bovine host and were used extensively in the past 
for experimentally induced E. coli intramammary infection and to conduct studies focused on 
adherence to, internalization into, and trafficking in bovine mammary epithelial cells (Dopfer et al., 
2001; Dogan et al., 2006; Oliver et al., 2010; Almeida et al., 2011). The remaining strains were 
isolated from bovine mastitis (UK E. coli ECIMI, UK E. coli ECIMI 8 and UK E. coli ECIMI EK A) and a 
foodborne human clinical case (O157:H7). The target genes were selected on the basis of a 
previous publication preliminary reporting the comparative expression profile of two E. coli strains 
isolated from bovine mastitis, and co-cultured with primary bovine mammary cells (Kerro-Dego et 
al., 2012). 
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The experimental design was as follows: 1) E. coli strains isolation and growth, 2) DNA screening of 
strains for virulence genes, 3) MAC-T cell propagation, 4) co-culture assays, 5) bacterial RNA 
isolation, 6) quantitative RT-real time PCR, 7) data analysis. 
The  presence of VTEC in cattle and other ruminants calls for further analysis of the pathogenic 
potential for humans of VTEC strains isolated from non-human sources. An increasing number of 
putative virulence genes of VTEC have been characterized. To date, a food product found positive 
to genes VTEC is automatically deleted from production. The tests that are currently being put in 
place by the EU Reference Laboratory for E. coli (Department of Veterinary Public Health and Food 
Safety Unit of Foodborne Zoonoses ) and consequently by the Istituto Superiore di Sanità in Italy, 
are to verify the presence of stx1 , stx2 and eae . The data of the  Istituto Superiore di Sanità in 
Italy, show that about 60 % of the tested products has a positive test to the above targets but out 
of these, only a small percentage can actually cause HC and HUS (thus being classifiable as “true” 
VTEC). In fact, the positivity genes listed above are not automatically characterizing the bacterium 
as verotoxic. The SNPs discovered in the study by Norman et al., 2012, can in principle be used to 
develop tests that will specifically identify STEC strains within serogroups O26, O45, O103, O111, 
O121, and O145. Indeed , unlike the E. coli O157: H7 that is always pathogenic, the serotypes O26, 
O111 , O121 , O145 and O103 may not be pathogenic even if they have the stx1 , stx2 and eae 
genes, since also other genes like ehxA, efa1 and nleB contribute to virulence (Norman et al. , 
2012). One of the targets of this project is to design a new HRMA-based protocol for the 
evaluation of the risk linked to an isolated E. coli strain, based on the detection of virulence-
predictive SNPs, as discovered by Norman et al., 2012. 
The activity involves the following steps: 
1. Serotype-specific primers coding for O-antigen regions of the five major VTEC serogroups 
available in literature are used to perform conventional multiplex PCR on E. coli strains 
isolated from animals and food products, and preliminarly assessed as stx-positive strains, 
to assess serotype (Table 7): the wzx, which encodes for a flippase required for O-
polysaccharide export, was used to design primers for serogroups O26, O45, O103, O111, 
and O145 with resulting amplicons ranging from 200 to 900 bps (Paddock et al., 2012). The 
wbqE gene, which encodes for a putative glycosyl transferase, and wbqF, which encodes 
for a putative acetyl transferase, were used to design primers for O121. The primer set for 
rfbE, described in Bai et al. (2010), was included for the O157 serotype identification. The 
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mPCR conditions used are similar to that of Bai et al. (2010). The amplified DNA is 
separated on 1% agarose gel and stained with 0.5 µg/ml of ethidium bromide. 
2. At this step, the serotype of E. coli strain is known. If the analysis finds that it is the strain 
O157, it is useless to proceed with further analysis, as this serotype is considered the most 
dangerous between serotypes and the retaled product should always be removed from the 
market. For the other serotypes, the strains are assessed whether they are truly dangerous 
or not. The related analysis is carried out on target serotype-specific SNPs, already 
investigated in a MALDI-TOF pilot study to correspond with differences in virulence gene 
profiles, as in Norman et al., 2012. This step is carried out through SNP-specific HRMA 
protocols designed in this project that are currently under test for each representing 
serotype (Table 8). 
3. At this step, if SNP-specific HRMA turns positive, this result predicts that the related strain 
contains Shiga toxin-encoding genes and other virulence factors predictive of the risk 
status of the sample. Consequently, the source product should be permanently removed 
from the market.   
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1.4. Materials and methods 
 
1.4.1. Selection of the bovine mammary cell line for co-culture experiments 
1.4.1.1. Search strategy 
The selection strategy for the more suitable bMEC for coculture experiments with E. coli strains 
was performed following the assumption that the modulation of bacterial gene expression could 
be more evident when cocultured with a highly responsive cell line. Thus, meta-analysis started to 
response at one simple question: Who are the best cell line for the study of immune response in 
mammary gland? 
The papers was searched using Web of Science and PubMed as electronic databases, whose 
general settings were “All years” and “All databases”. Databases were consulted until December 
1st, 2014. 
No language restrictions were applied. The reference lists of retrieved articles were searched 
manually to identify all potential studies so that no articles were missed by the electronic 
searches. 
The first keywords for the selection of the paper were “bovine mammary epithelial cells”. In this 
analysis any Boolean operator has been used, but instead a second query: “immune response” 
was used. 
 
1.4.1.2. Inclusion and exclusion criteria 
The papers without quantitative data were excluded from the analysis. 
Further selection was based on the following specific criteria: Data originating from pure 
mammary lines (no co-cultures whit other mammary cell lines); Cultivation on standard substrates, 
No positive and/or negative control. 
The data of all authors were independently extracted from suitable studies using a standardized 
form. The information obtained were collected on the basis on surname of first author, year of 
publication, source of publication, study design, biological stimulus used, time of exposure, 
quantity of stimulus, method used, cell line response and quantity response (Table 5), for any cell 
line used. In the cases of conflicting evaluations, different data from the eligible studies were 
compared for availability of the full text and extensive discussions of the data by the authors.   
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Diagram 1:Grafic rappresentation of paper selection to choise the cell colture for co-colture 
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1.4.1.3. Statistical analysis.  
Data were collected on a database and results were compared when: 
– The assay technique was the same (i.e. RT-qPCR). 
– There was at least one valid quantitative value for each cell type. 
Other factors considered were: 
– Stimulating agent concentration and time. 
– Time of measurement 
In case outlier values were detected based on sufficient sample size, they were withdrawn from 
the analysis. Data were analyzed by general linear model (GLM procedure) on SPSS 20.0 
The model included as fixed factors: cell line, paper, time of assay and stimulus concentration. 
 
Information collected for any type of cell line 
General information 
Author First author present in the paper 
Year Year of publication 
Information in 
relationship of 
stimulus used 
Stimulus 
Type of stimulus used to induce the immune 
response 
Time Time to exposure of the stimulus 
Quantitative 
Concentration used of stimulus to induce the 
immune response 
Information in 
relationship of 
response analyzed 
Response 
Immune response considered in the paper 
(cytokine, interleukins…) 
Method used for the 
analysis 
Technique used to detect the response 
Quantitative data of 
response 
Concentration measured of the response 
TABLE 5: Information collected for any type of cell line. 
 
Actually, the studies (papers) were quite different from each other regarding: type of cells, type of stimulus, 
type of parameters, type of evaluation methods and type of statistical analysis. For this reason, the 
comparison was at the end limited to a reduced number of studies and targets, and thus the threshold for 
statistical significance was set at p≤0,10. 
 
1.4.2. Bacterial strains isolation and growth 
For coculture experiments, the E. coli strains for were grown in blood-agar plate for 1 day. The 
bacterial colonies were sub-cultured overnight at 37 °C in Luria Bertani broth (LBB, Becton-
Dickinson Company). Before co-culture experiments, the bacterial suspension was diluted at the 
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density of (∼107) colony forming units/ml (CFU/ml). in cell growth media (CGM) containing DMEM 
(Dulbecco's Modified Eagle's Medium - Lonza), FBS (Fetal Bovine Serum - Euroclone), L-
Glutammine (Euroclone), Hepes (Euroclone), insuline, cortisone and sodium bicarbonate. 
For HRMA experiments, ninety-five E. coli strains were isolated from bovine milk samples 
submitted for microbiological examination to the Laboratory of Malattie infettive of Prof. Alfonso 
Zecconi, DIVET Department at the University of Milan.  
 
1.4.3. Microbiological isolation 
The milk samples were brought to the following dilutions: 10-1, 10-2 and 10-3/ml, and as such were 
sown on plates for the enumeration of coliforms and of E. coli (EC 3M ™ Petrifilm ™). The plates 
were incubated for 24 hours at 37 °C. The reading of the plates was performed according to the 
directions of the product. About 97% of E. coli produce β-glucuronidase which reacts with a color 
indicator contained in the Petrifilm EC plate, turning blue or red-blue colony; about 95% of E. coli 
ferment lactose, causing the appearance of one or more gas bubbles in correspondence of the 
colonies. Therefore, on these plates the colonies of E. coli appear blue or red-blue and with one or 
more gas bubbles. Most strains of E. coli O157: H7, however, are glucuronidase negative and 
appear red with gas. 
The filters of the milking machine were chopped sterile, introduced in plastic bags with 50 mL of 
sterile peptone water and processed in Stomacher for 4 minutes. The preparation obtained was 
brought to the following dilutions: 10-1, 10-2 and 10-3/ml and as it were sown on Petrifilm EC 
plates. The plates were incubated for 24 hours at 37 ° C. The reading of the plates was performed 
according to the directions of the product. For each sample, up to a maximum of 10 colonies with 
appearance compatible with E. coli and E. coli O157: H7 were taken at random. These were plated 
on nutrient agar and, from the latter terrain, were subjected to biomolecular characterization. 
 
1.4.4. Dna extraction 
For HRMA screening, each single colony was tip-sampled and placed in an 0,5 ml Eppendorf 
containing 50 microliters of molecular grade water. Three alternate cicles of 5’ at 95 °C and 5’ at -
80°C were performed to obtain cells lysis and DNA extrusion from bacterial cells, and the lysate 
were subjected to direct PCR amplification. 
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1.4.5. DNA screening of strains for virulence genes 
For co-culture experiments, the DNA from bacterial strains was extracted using Wizard Genomic 
DNA Purification kit (Promega) following manufacturer’s instruction. To screen for the 
presence/absence of the virulence factors of interest in the selected strains, a conventional PCR 
was performed for each target gene on the extracted DNA using the primer pairs reported in Table 
6.  
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Gene Function 
Cdt Cytolethal distending toxin 
Cnf Cytotoxic necrotizing factor 
Eae Effector protein (Croxen and Finlay, 2010) 
iutA Iron acquisition (Beutin et al., 2005) 
Stx1/2 Shigatoxin 
Cif Cell cycle inhibiting factor 
Flic Iron acquisition (Beutin et al., 2005) 
tolC Involved in resistance to fusaric acid (Johnson and Church, 1999) 
yciD Outer membrane protein (Croxen and Finlay, 2010) 
Sdfla Succinate deidrogenase 
B12r Outer membrane protein (Croxen and Finlay, 2010) 
16s rRNA Ribosomal RNA (internal control) 
tufA  Elongation factor Tu (housekeeping gene) 
MFS1 Protein linked with transportation 
SK2 Periplasmatic chaperone 2 
Hly Hemolysin 
Ler Encodes the type III secretion system (Croxen and Finlay, 2010) 
Table 6: E. coli genes and relative function 
 
The PCR runs were performed in iCycler thermocycler (Bio-Rad), using GoTaq DNA Polimerase 
0.125 U, Buffer 1X, (Promega), dNTPs 0,2mM (Promega), each primer 1µM and water to the final 
volume (15 µL). The thermal profile was as follows: 2 min at 95 °C for DNA polimerase activation, 
followed by 35 cycles of DNA denaturation for 20 sec at 95 °C, annealing for 1 min at 55 °C, and 
elongation for 1 min at 72 °C; final elongation step for 7 min at 72 °C. 
 
1.4.6. MAC-T cell propagation 
MAC-T were grown in CGM in T75 tissue culture flasks (Corning Inc. Corning, NY, USA) as described 
(Calvinho and Oliver, 1998; Almeida et al., 1996). Incubation of MAC-T cells was performed at 37 
°C under 5% CO2/95% air until 90–100% of confluence was achieved. 
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1.4.7. Co-culture assays 
One ml (∼107 CFU) of bacterial suspension in CGM was added to MAC-T cell monolayers in T75 (75 
cm2) tissue culture flasks and incubated at 37 °C under 5% CO2/95% air for 1 hour.  
For each co-culture assay, a T75 flask with (∼107 CFU) of bacterial suspension in CGM but without 
MAC-T cells was incubated in parallel. 
 
1.4.8. Bacterial RNA isolation 
At the end of co-culture step, the supernatants were put into 50 ml Falcons after scraping the cell 
monolayers where present. The supernatants were centrifuged at 4000g for 5 min and the pellets 
were resuspended in 2ml of RNALater (Ambion Inc., Austin, TX, USA). The RNA of E. coli strains was 
isolated using RiboPure™-Bacterial RNA purification kit (Ambion Inc., Austin, TX, USA) following 
manufacturer's instructions. Contaminant DNA was removed from the extracted RNA using turbo 
DNAse (Ambion) following manufacter’s instructions. 
 
1.4.9. Quantitative RT-real time PCR 
The expression pattern of  the virulence-associated genes whose DNA sequence was detected in 
all the analyzed E. coli strains (see Milestones and deliverables, Table 4) was evaluated by RT-
quantitative real time PCR after 1 h co-culture with immortalized MAC-T cells using gene specific 
primer pairs (Table 7). 
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Gene Primer Sequnce Reference 
tufA-qRT-PCR- F:5’-TGCTCTGAAAGCGCTGGAAG-3’ 
R: 5’-TTGTCAATCGCACGCTCTGG-3’ 
Kerro-Dego et al., 2012 
16S rRNA E. coli qRT-PCR- F-5’-ATAACATCTCCACGCCGTTG-3’ 
R-5’GACCATACGCTTTGCTGTTTC-3’ 
Kerro-Dego et al., 2012 
iutA-qRT-PCR-A- F: 5’-ATGAGTCGTTGCGGTTCTAC-3’ 
R: 5’ATTTGCCAGCCGTCCATAAG-3’ 
Kerro-Dego et al., 2012 
flic-qRT-PCR-A- F: 5’-CCGGTGGTGATAACGATGGG-3’ 
R: 5’-CAGGTGTACCGCCTGAAGTG-3’ 
Kerro-Dego et al., 2012 
eae-qRT-PCR-A- F: 5’-AGGCAGCCGTTACGATCTGG-3’ 
R: 5’-ACCGCCCTGACTGCGTAATG-3’ 
Kerro-Dego et al., 2012 
tolC-qRT-PCR-chr- F:5’- GGAACTGGCTGCGCTGAATG-3’ 
R: 5’-TCCTGCGCCTGGCGAATTTG-3’ 
Kerro-Dego et al., 2012 
yciD-qRT-PCR-chr- F: 5’-CAACACTGATGGCGCAGTGG-3’ 
R:5’-CGGAAAGCCCTGCCTCTTTG-3’ 
Kerro-Dego et al., 2012 
sdfla-qRT-PCR-chr- F: 5’-TTATGCGCCGAACGCCAAAG-3’ 
5’-TGAGCGAAGGTACGGGAAAG-3’ 
Kerro-Dego et al., 2012 
B12r-qRT-PCR-chr- F: 5’-GCTGCGCTATAACGGCGAAC-3’ 
R:5’-GCCCACTGGACGGTGTATTG-3’ 
Kerro-Dego et al., 2012 
Table 7: E. coli primer to analyze the differen expression with/without MAC-T. 
 
The amplification was carried out in a total volume of 10μl in 96 well plates (Ambion) using an 
Quant Studio 6 Flex instrumentation (Ambion). The reactions were carried out coupling 
retrotranscription and amplification through iTaq Universal SYBR Green One-Step Kit (Bio-Rad) 
following manufacturer's instructions. The following steps were performed; retrotranscription: 50 
°C for 10 min; polymerase activation and DNA denaturation:  95 °C for 1 min; amplification: 40 
cycles at 95 °C for 10 sec, 60 °C for 1 min for denaturation, annealing/elongation respectively; 
melting analysis: 95°C for 15 s, 60 °C for 1 min and 95 °C for 15 s. The samples were run in 
triplicate. 
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1.4.10. Data analysis 
The cDNAs threshold cycle (Ct) values, obtained by RT-qPCR, were analyzed through the 
comparative ΔΔCT method (Giulietti et al., 2001). For each gene target, this method compares the 
Ct value of the test samples with the Ct value of the reference sample, in this case the 
corresponding strains not co-cultured with MAC-T cells acting as a control. For each target gene, 
expression Ct values are normalized according to the values of the housekeeping gene(s). In the 
present study, the Ct values obtained by RT-qPCR were preliminarly analyzed in order to assess 
the expression stability of the genes in all samples using the software geNorm (Vandesompele et 
al., 2002), available at http://www.medgen.ugent.be /jvdesomp/genorm/.as described in the 
corresponding Instructions for Users. The output of geNorm analysis was used to select the most 
stable gene(s) to be used as housekeeping gene(s) for data normalization. The relative expression 
of the target genes in the different samples were calculated according to the following formula: 
 
ΔCt = Ct (target gene) - Ct (housekeeping gene) 
 
where Ct (target gene) indicates the value of the threshold cycle for the gene of interest, and Ct 
(housekeeping gene) indicates the value of the threshold cycle for the housekeeping gene used as 
normalizer. Subsequently, the relative expression of all samples in comparison with the Ct values 
obtained from the corresponding strains not co-cultured with MAC-T cells (control) was calculated 
as follows: 
 
RE = 2-ΔΔCt[where ΔΔCt = ΔCt (sample) – ΔCt (control)] 
 
where RE indicates the relative expression, ΔCt (sample) indicates the difference between Ct 
values of the target gene and the housekeeping gene(s) calculated for the test sample, ΔCt 
(control) indicates the difference between the Ct values of the target gene and the Ct values of the 
housekeeping gene(s) obtained from the corresponding strains not co-cultured with MAC-T cells 
(control). 
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1.4.11. Vtec serotype identification with multiplex-PCR 
For the identification of serotypes, a multiplex PCR using primers published by Paddock and co-
workers in 2012, as reported in Table 8, was performed. The PCR reactions were performed with 
an initial DNA denaturation step at 94°C for 5 min, followed by a 30 cycle of denaturation at 94 °C 
for 30 seconds and annealing at 63 °C for 80 seconds. The procedure ends with a final elongation 
at 68°C for 8 min and incubation at 5°C for 5 min, and was performed on iCycler thermal cycler 
(Bio-Rad Laboratories Inc., Hercules, CA, USA). Amplification products were separated in a 2% 
agarose gel, stained with ethidium bromide and visualized under UV light. 
 
Serogroup Strain Primer sequences (5’ to 3’) Bps Reference 
O26 TW O1597 F:GGGGGTGGGTACTATATTGG 
R: AGCGCCTATTTCAGCAAAGA 
241 Paddock et al., 2012 
O145 KSU 1234-1 F: TGCTCGACTTTTACCATCAAC 
R: AACCAACACCATACACCTTGTCTT 
374 Paddock et al., 2012 
O103 KSU 15612-1 F: TAAGTACGGGGGTGCTTTTT 
R: AAGCTCCCGAGCACGTATAA 
716 Paddock et al., 2012 
O111 KSU 7726-1 F: CAAGAGTGCTCTGGGCTTCT 
R: AACGCAAGACAAGGCAAAAC 
451 Paddock et al., 2012 
O157 ATCC 43894 F: CAGGTGAAGGTGGAATGGTTGTC 
R:TTAGAATTGAGACCATCCAATAAG 
296 Bai et al., 2010 
Table 8: Primer sequences and strains used as positive control. Bps, amplicon size in basepairs. 
 
1.4.12. Primers design for the HRMA-based SNPs identification 
The design of the primers was performed by aligning all sequences used by Norman and 
collaborators in 2012 including the SNPs that determine the VTEC status in E. coli serotypes linked 
to food of animal origin, as already shown in Table 8.  
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Table 9: Gene and amino acid data for the single nucleotide polymorphisms identified in the O-antigen gene clusters of non-O157 
Escherichia coli (From: Norman et al., 2012). 
 
In Table 10 are reported the primers designed for each serotype.  
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O26 
 
Fnl1 
sequence (5'->3') 
Wzx 
sequence (5'->3') 
Forward ACTCGTTATCACTGGTGGC CAGTCTATAGCAACCCCG 
Reverse TGATACAGAAAATCGGCACC GGATGAACGCGCTTCTAATTTC 
Lengh 219 227 
SNP G (no VTEC) A (VTEC) T (no VTEC) G (VTEC) 
Annealing T° 56°C 56°C 
O111 
 
WbdK 
sequence (5'->3') 
Wzx 
sequence (5'->3') 
Forward TATCATGTATTGTTGTGCCTTCG GGAATTGGTAAATCTAAGCTTG 
Reverse AGTGGGCGAACATTGTATCC CCATAGATATTGCATAAAGGCC 
Lengh 140 109 
SNP C (no VTEC) T (VTEC) A (no VTEC) T (VTEC) 
Annealing T° 56°C 56°C 
O145 
 
wbtD 
sequence (5'->3') 
Forward CAAACGGTAAATGGCGCG 
Reverse GGTTAATGCATGACTCTAATGTC 
Lengh 218 
SNP C (no VTEC) T (VTEC) 
Annealing T° 51°C 
O103 
 
Wzy 
sequence (5'->3') 
Forward ATGATCCCGTTATATAAAATTC 
Reverse GCATTTAAGTAATATAACGAAG 
Lengh 123 
SNP A (no VTEC) C (VTEC) 
Annealing T° 56°C 
Table 10: primer designed for the identification of VTEC status with HRMA. 
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1.4.13. HRM analysis 
In this project, the Eco™ Real-Time PCR System instrument, Illumina Inc. (9885 Towne Centre Drive 
San Diego, CA 92121 USA), a block based instrument whose technical characteristics are shown in 
Table 11, was used. The main instrument specifications are: 
- Thermal system: silver block with Peltier-based system 
- Block format: 48-well block 
- Samples volumes: validated for 5-20 µl 
- Average ramp rate: 5.5°C/sec 
- Temperature range: 40-100°C 
- Temperature uniformity : ± 0.1°C 
- Optical system: dual LED excitation ($%”-486 nm and 542-582 nm), four emission filters (505-
545 nm, 562-596 nm, 604-644 nm, and 665-705 nm) and CCD camera 
- Calibrated dyes at shipment: SYBR Green, FAM, HEX, ROX, Cy5.  
- Passive reference dyes: use of ROX is supported, but optional 
- Data collection: data collection in all four filters for all wells regardless of plate setup; plate 
setup for data analysis can be altered after run completion. 
- Melt curve analysis supports continuous data acquisition in a single filter to provide increased 
data point collection and reduced run times 
- Real-Time PCR run time (40 cycles): less than 40 minutes 
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Table 11: Specifications and Environmental Requirements of Eco™ Real-Time PCR System, Illumina. 
 
The analysis was performed in 15 μL reaction mixtures containing 7,5 μL of Supermix SsoFast 
EvaGreen mix Biorad, 0.3 µM of each primer at, 1 μL and RNase-free distilled water (Invitrogen, 
Carlsbad, California, USA) to reach a total volume. The real time PCR conditions were as follows: 1 
cycle of 95 °C for 2 min followed by 35 cycles at 95 °C for 15 sec and at an appropriate annealing 
temperature for each primer pair (Table 10) for 30 sec. Reaction mixtures without the DNA 
template were used as negative controls. All reactions were performed in 48-well optical plates 
(Euroclone) that were covered with optical adhesive film (Euroclone). 
The HRMA step was performed immediately after real time PCR cycling. The amplicons were 
heated to 95 °C for 15 sec and then were cooled to 55 °C for 15 sec. The melting curves were 
generated by increasing the temperature from 56° to 95 °C with 15 sec increments and 
fluorescence was detected each 0.1 s. To make the data uniform, the raw melting curves were 
normalized by manually adjusting one region before the double-stranded product was melted 
(pre-melting region) and another region after the amplicon was completely melted (post-melt 
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region). The normalized melting curve data were analyzed with the Eco Illumina software program 
(Illumina, Inc., San Diego, CA, USA) according to the manufacturer's instructions. 
All non-O157 samples resulted positive in multiplex-PCR were tested by real-time PCR coupled to 
HRMA in duplicate, to ensure assay reproducibility. 
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1.5 Results and Discussions 
Selection of the bovine mammary cell line for co-culture experiments 
In table 12 the cytokines considered by the selected studies (papers) are reported. 
A comparison among the 3 cell lines was possible only for the following targets: IL-1, IL-1α, IL-1β, 
IL-6, IL-8 and TNF-α (Table 12). 
 
Cytokine BME-UV1 MAC-T Primary cells 
IL-1    
IL-1α    
IL-1β    
IL-2    
IL-6    
IL-8    
IL-10    
IL-12    
IL-15    
IL-17    
IL-33    
TNF-α    
TGF-β    
Table 12: cytokines considered in the papers. 
 
Many (149) other items as, for instance, specific gene transcripts were considered in the papers, 
and precisely: 
– 5 in BME-UV 
– 12 in MAC-T 
– 137 in Primary Coltures. 
But in these cases it was not possible to perform a comparison among the 3 cell lines because 
there were not common analytical targets among studies. 
The stimuli used in the papers were: 
• Bacterial origin: LPS, LTA, PGN, whole E. coli, whole S. aureus, PAM2CSK4 and PAM3CSK4. 
• Pro-inflammatory cytokines: ILs, TNF-α, HGF and EGF. 
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• Others: BMAP-27 and BMAP-28, CD12-iE-DAP, lactoferrin and prolactin, MDP, nonoate, 
proteinase K, and sodium butyrate 
• No stimulus 
The stimuli used for all 3 cell lines were: LPS, S. aureus, ILs, TNF-α and no stimulus (used as 
negative control). 
Several analytical methods used in the papers to assess cell line response regarding the 
abovementioned 6 targets, but only for RT-real time PCR and ELISA it was possible to compare the 
3 cell lines and only for TNF-α, IL-8 and IL-1. 
 
TNF-α Expression 
The comparison of TNF-α expression was reported in table 13. 
 
TNF-α EXPRESSION  
Stimulus LPS 
Assay qtPCR 
Papers included 3 (1 withdrawn) 
Values considered 11 
Table 13: parameter considered in TNF-α. 
 
In the table 14 was reported, for any type of cell coltures, mean, standard deviation (StdDev) and 
range of the analysis (Min and Max). 
 
Cell type Mean StdDev Min Max 
BME-UV 4.80 3.52 2.30 9.85 
MAC-T 16.4 2.71 14.00 19.40 
Primary cells 0.84 0.77 0.21 1.7 
Table 14: statistical parameter in TNF-α. 
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The datas of final general linear model (GLM) were expressed in tables 15. 
 
 FINAL GLM MODEL 
 MODEL  P= O,O27 
 R2 96.5% 
FACTORS 
CELL LINE P=0,013 
TIME P=0,174 
QUANTITE Not Considered 
Table 15: final glm model in TNF-α. 
 
It was statistically significant the difference among the 3 cell lines, in table 16 the difference 
between type of cells was reported, in particular the difference is linked to MAC-T. 
 
 BME-UV MAC-T P.C. 
BME-UV  0.07  
MAC-T 0.07  0.04 
P.C.  0.04  
Table 16: p-Value amon cell lines in TNF-α 
 
IL-8 
The comparison of IL-8 expression was reported in Table 17. 
 
IL-8 EXPRESSION  
Stimulus LPS 
Assay qtPCR 
Papers included 7 (1 withdrawn) 
Values considered 15 
Table 17: parameter considered in IL-8. 
 
In the table 18, for any type of cell coltures, mean, standard deviation (StdDev) and variability (Min 
and Max) were reported. 
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Table 19: statistical parameter in IL-8. 
 
The data of final general linear model (GLM) were expressed in Table 19. 
 
 FINAL GLM MODEL 
 MODEL  P= O,180 
 R2 62,4% 
FACTORS 
CELL LINE P=0,099 
TIME P=0,362 
QUANTITE P=0,38 
Table 19: final glm model in IL-8. 
 
It was statistically significant the difference among the 3 cell lines, in table 20 the difference 
among cell types was reported, in particular the difference is linked to MAC-T. 
 
 BME-UV MAC-T P.C. 
BME-UV  0.02  
MAC-T 0.02  0.03 
P.C.  0.03  
Table 20: p-Value among cell lines in IL-8. 
 
 
 
 
 
Cell type  Mean  StdDev  Min  Max  
BME-UV  2.78  1.93  1.07  4.59  
MAC-T  55.00  31.69  6.00  86.00  
Primary cells  10.83  12.04  2.00  32.00  
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IL-1 
The comparison of IL-1 expression was reported in Table 21 
 
IL-1 EXPRESSION  
Stimulus LPS 
Assay qtPCR 
Papers included 5 (1 withdrawn) 
Values considered 14 
Table 21: parameter considered in IL-1. 
 
In the Table 22, for any type of cell coltures, mean, standard deviation (StdDev) and range of the 
analysis (Min and Max) were reported 
 
 
 
 
 
 
 
Table 22: statistical parameter in IL-1. 
 
The data of final general linear model (GLM) were expressed in Tables 23. 
 
 FINAL GLM MODEL 
 MODEL  P= O,560 
 R2 77,3% 
FACTORS 
CELL LINE P=0,418 
TIME P=0,812 
QUANTITE P=0,432 
Table 23: final glm model in IL-1. 
 
The difference among the 3 cell lines wasn’t statistically significant, even for MAC-T, and this was 
probably linked to higher biological variability (Table 22). 
Cell type  Mean  StdDev  Min  Max  
BME-UV  1,56 0.31 1,15 1,87 
MAC-T  180.5 162,32 6,00 381,00 
Primary cells  55.00 84,33 3,00 225,00 
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Overall, the MAC-T line turned to have a significant higher response than other cell lines regarding 
TNF-α and IL-8, whereas BME-UV1 and Primary Cultures have similar response in this analysis. 
Thus, MAC-T were selected as best cell line for the coculture experiments with E. coli strains, 
assuming tha t more responsiveness of the cells would imply a more effective modulation of 
bacterial gene expression. 
 
Co-Culture 
The achieved milestones and deliverables are the following. 
The DNA profile of the strains justified the selection of the targets for gene expression study (Table 
24).  
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GENES STRAINS 
 Strain 1 
727 
 
Strain 2 
McG 
 
Strain 3 
UK E. coli 
ECIMI 
Strain 4 
UK E. coli 
ECIMI 8 
Strain 5 
UK E. coli 
ECIMI EK A 
Strain 6 
O157:H7 
Cdt - - - - - - 
Cnf - - - - - - 
Eae + + + + + + 
iutA + + + + + + 
Stx1/2 - - - - - + 
Cif - - - - - - 
Flic + - - + - + 
tolC + + + + + + 
yciD + + + + + + 
Sdfla + + + + + + 
B12r + + + + + + 
16s rRNA + + + + + + 
tufA  + + + + + + 
MFS1 - - - - - + 
SK2 - - - - - - 
Hly - - - - - + 
Lir - - - - - + 
Table 24: Results after conventional PCR of the gene target to detect the presence of the genes in E. coli samples. 
 
After co-culture experiments and RT-qPCR, the Ct values of the genes expressed in all samples 
were analyzed by geNorm software, thus identifying 16S rRNA and tolC as the most stable gene 
pair (Figure 11; the genes with the lowest M values are more stable). Thus, the geometric mean of 
the 16S rRNA and tolC Ct values were used as “Ct (housekeeping gene)” in the calculation of 
relative expression of the target genes. 
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Figure 11: Graphic output of geNorm analysis 
 
The relative expression of each target gene in the different co-cultured strains was obtained with 
reference to the corresponding strain without co-culture, and using the gene pair 16S rRNA and 
tolC for normalization. The corresponding values are reported in Table 25. 
 
Strain pair Sample tufaA eae ycd b12 iutA Flic Sdfla 
1S-1M E. coli 727 1,42 0,52 0,54 0,91 2,06 ND 3,00 
2S-2M Mc Gear E. coli 0,79 12,76 1,77 1,27 ND 1,15 ND 
3S-3M uk E. coli ECIMI  0,57 4,19 1,06 ND 2,08 ND ND 
4S-4M uk E. coli ECIMI 8 3,52 4,13 5,18 4,94 8,76 ND ND 
5S-5M uk E.coli ECIMI ekA 4,09 1,41 2,48 2,15 ND ND ND 
6S-6M 0157:H7 0,03 1,12 2,78 1,02 ND ND 0,17 
Table 25: Fold-change expression of the target genes in co-cultured strains (letters “M”) in comparison with the same strains 
without co-culture (letters “S”). The sample 6 corresponds to the reference foodborne VTEC strain O157:H7. 
 
A clear upregulation of the virulence factor eae (intimin) in all the analyzed mastitis strains 
following co-culture with MAC-T cell line can be appreciated, with the exception of the 727 strain 
that was isolated from an acute mastitis. In literature, the up-regulation of eae in 727 strain when 
co-cultured with a primary bovine mammary cell line was preliminarly reported (Kerro-Dego et al., 
2012). Also the adherence virulence factor ycd resulted to be upregulated in three co-cultured 
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strains (strain number 2, 4 and 5), and the b12 gene was upregulated in two strains (number 4 and 
5). Taken together, these results suggest the possibility that mastitic E. coli strains can acquire a 
more risky molecular profile when exposed to the bovine mammary cells. This finding may have 
clear implications on the risk assessment related to the E. coli strains in bovine mammary tissue 
and milk. 
 
Vtec serotype identification with multiplex-PCR 
The primers amplified correctly at the conditions used, and they were able to correctly 
discriminate the serotypes of interest. The sequencing confirmed the identity of the VTEC 
serotypes (figure 12). 
 
Figure 12: multiplex PCR results. 1) O157 (296bp), 2)O111 (451bp), 3) O103 (716bp), 4)O26 (241bp), 5)O145 (374bp), 6)O104 (N/A) 
 
Until now, 95 bovine isolates of E. coli were analyzed, and 3 out of these were positive for O157 
and one for O26 serogtype. Sequencing confirmed the obtained serotype. 
 
Identification of VTEC status 
As an example, in Figure 13 the result in HRMA serotype O26 is reported, in particular for the gene 
fnl1. 
The amplification profile was regular not showing any aspecific and/or primer dimers, no 
differences between lysed and DNA extracted samples can be appreciated, and the assay was 
reproducible as the samples were tested in duplicate with similar results (Figure 13). 
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Figure 13: amplification profile in qRT-PCR. In red O26 VTEC and in blue O26 noVTEC. 
 
Looking at the profile of melting by HRMA, it is possible to distinguish the isolates of O26 with 
VTEC status (Figure 14):, in red (on the left) there is the O26 VTEC serotype; in blue (on the right) 
there is the non-VTEC O26 serotype. 
 
 
Figura 14: Normalized profile in HRMA of the fnl1 gene in O26 serotype. In red VTEC strain and in blue noVTEC strain. 
 
For a confirmation of the HRM results, the isolated were tested in conventional PCR for positivity 
to stx genes (both stx-1 and stx-2). For further evidence, the amplified products were sequenced, 
and the results confirmed that the difference is related to a single SNP (Figure 15). 
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Figure 15: alignment of the sequences of the O26 serotype fnl1 gene analyzed and sequenced events. “A” is linked to the 
verotoxicity SNP and “G” to the no- verotoxicity. 
 
Currently, the collection and analysis of isolated is being increased in order to confirm 
predictability of the HRM assay also for the other serotypes. Besides, the HRM assay is being 
improved by including the analysis of predictive SNPs within the O45 and O121 serotypes, as 
possible VTECs that may be also found in food samples of animal origin.  
 
CLUSTAL 2.1 multiple sequence alignment 
O26 coli 
 
FNL1D5          TCTAGATACAGATATTACTGAAATACGAATATTTAGCAGGGATGAAAAAAAACAAGATGA 60 
FNL1E1          TCTAGATACAGATATTGCTGAAATACGAATATTTAGCAGGGATGAAAAAAAACAAGATGA 58 
                **************** ******************************************* 
 
FNL1D5          TATGCGGAAAAAATATAATAACTCAAAATTAAAATTTTATATAGGTGATGTGCGAGACTA 120 
FNL1E1          TATGCGGAAAAAATATAATAACTCAAAATTAAAATTTTATATAGGTGATGTGCGAGACTA 118 
                ************************************************************ 
 
FNL1D5          TAATTCCGTTCTAAATGCAACGCGTGGTGCCGATTT- 156 
FNL1E1          TAATTCCGTTCTAAATGCAACGCGTGGTGCCGATTTT 155 
                ************************************  
  
 
Chapter 2: High Resolution Melting Analysis for food safety and 
veterinary diagnostics 
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2.1. Introduction 
 
Since HRMA is increasingly used in microbiology for species identification and detection of 
resistance-carrying mutations, the present PhD project aimed, and as additional objectives, to 
establish some HRMA-based assays to improve the diagnostic tools currently available for 
different targets, highly relevant to food and animal health research. HRMA offers a low-cost, 
closed-tube approach to amplicon analysis with the capacity for single-nucleotide discrimination 
and easy integration with real time PCR, thus very promising for several possible applications in 
routine diagnostics (Reed et al., 2007). Some examples are reported here below. 
First, the phenomenon of pigmented mozzarella cheese is still a topical issue because, even if the 
initial emergency situation has been redimensioned, it remains a difficult to eradicate problem in 
Italian dairy farms. Improving identification and tracking methods for the microorganisms that 
cause chromatic alterations in mozzarella cheese samples in food production and processing 
systems is of great relevance to understand and reduce the frequency of contamination, as well as 
to eliminate niche populations in food processing systems such that contamination of food 
products can be prevented. In particular, bacteria of the genus Pseudomonas spp. are the main 
cause of this type of alteration (Martin et al., 2011).  
Second, Nosema apis and N. ceranae are honeybee parasites widely circulating inside the apiaries 
around the world (Sprague 1978; Becnel and Andreadis 1999). The infestation of Apis mellifera by 
N.apis represents a real danger to the health of the beehive. The type A nosemiasis caused by this 
parasite is a notifiable disease under the provisions of the Veterinary Police Regulations (Botìas et 
al. 2013). Only recently N.ceranae has been widely admitted as a pathogen of the honey bee. At 
present, the dynamics of the infection and the pathological consequences it may have on the host 
are not well defined and give rise to controversial opinions among experts in the sector. The rapid 
diffusion of the parasite caused emerging concern and for this reason careful monitoring of this 
phenomenon is required (Martin-Hernández et al. 2007). To take precautionary measures that are 
efficient and durable it is first necessary to make an accurate assessment of the pathogen at the 
apiary level. To do this it is important to develop methods of certain identification of the parasite 
that are able to correctly distinguish the two species of Nosema and to provide information on the 
degree of infestation of bees. 
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Third, Staphylococcus pseudintermedius  is  an opportunistic pathogen of dogs and cats, and 
fluoroquinolone (FQ)-resistant strains are isolated with increasing frequency from infection sites 
(Bannoehr et al., 2007; Devriese et al., 2009; Penna et al., 2010). Fluoroquinolone resistance in S. 
pseudintermedius and other Staphylococci is predominantly mediated by a mutation located at 
position 84 of the gyrA subunit of DNA gyrase enzyme (Ser84Leu), together with a mutation 
located at position 80 of the grlA subunit of topoisomerase IV enzyme (Intorre et al., 2007; 
Descloux et al., 2008). The standard methods for determining FQ resistance based on the CLSI 
guidelines (www.clsi.org) are tedious and time consuming. The molecular techniques currently 
used to characterize FQ resistance usually require sequence-specific probes or post-amplification 
processing such as gel electrophoresis and DNA sequencing (Kaltenboeck and Wang, 2005). Thus, 
there is a need for reliable and accurate methods allowing fast identification of gyrA-mediated FQ 
resistance in S. pseudintermedius strains isolated during veterinary clinical routine. 
And finally, Dirofilaria immitis and D. repens are the principal causative agents of zoonotic filariosis 
and, although the number of dogs subjected to specific prevention is increasing, the prevalence of 
these parasites remains high in many areas of the world (Genchi et al., 2011). The discrimination 
between the two Dirofilaria species using the classical diagnostic methods can be difficult and may 
lead to misdiagnosis especially on samples from areas where both Dirofilaria are present. Over the 
last years, several molecular methods with higher sensitivity and specificity compared to classical 
microscopy and ELISA assays were designed. Nevertheless, a need for simple, rapid and cost-
effective molecular protocols to accurately discriminate between D. immitis and D. repens still 
remains. 
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2.1.1. Pseudomonas spp 
Pseudomonas is a Gram-negative, aerobic gamma-proteobacteria, belonging to the family 
Pseudomonadaceae containing 191 validly described species.(Euzeby, 1997). The members of this 
family demonstrate a high metabolic diversity, and consequently are capable to colonize a wide 
range of biological niches. They are very easy to cultivate in vitro and their presence in different 
habitats has increased the interest in this bacterium. The most interesting species are: P. 
aeruginosa in his role as opportunistic human pathogen, the plant pathogen P. syringae, the soil 
bacterium P. putida, and plant growth promotion of P. fluorescens (Madigan and Martinko 2005). 
 
 
Figure 16: Pseudomonas aeruginosa(A) and Pseudomonas fluorescens in plate and as Pseudomonas species produces pyoverdin, 
which fluoresces in ultraviolet light when grown on Kings B agar. This pigment is watersoluble and diffuses into the agar around the 
colonies. (http://www.uvm.edu/~lwillett/picture3.htm and 
http://atlas.sund.ku.dk/microatlas/veterinary/pheno_tests/Kings_B_Agar/) 
 
Because of their widespread occurrence in water and plant seeds such as dicots, the 
pseudomonads were observed early in the history of microbiology. The generic name 
Pseudomonas created for these organisms was defined in rather vague terms by Walter Migula in 
1894 and 1900 as a genus of Gram-negative, rod-shaped and polar-flagellated bacteria with some 
sporulating species,the latter statement was later proved incorrect and was due to refractive 
granules of reserve materials. Despite the vague description, the type species, Pseudomonas 
pyocyanea (basonym of Pseudomonas aeruginosa), proved the best descriptor (Madigan and 
Martinko 2005). 
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Some species of this bacteria, such as P. aeruginosa, P. oryzihabitans, and P. plecoglossicida, are 
opportunistic infectious pathogens secreting extracellular proteases and adhere to and invade 
host tissue. Among the most interesting ones, Pseudomonas aeruginosa is an opportunistic 
pathogen and causes disease in immunocompromised individuals, old people and children. In 
hospitals, Pseudomonas is a leading cause of nosocomial infections via colonization of catheters, 
skin wounds, ventilator-associated pneumonia and it is also a cause of respiratory infections in 
individuals with cystic fibrosis (CF) (Pier 1998). The colonization by Pseudomonas spp. It occurs 
when the host cell fibronectin surrounding coat is destroyed due to trauma or infection 
(Hosseinidoust et al., 2013). Pets have symptoms identical to that of humans, and even in their 
incidence is higher in immunocompromised or impaired immune function. The bacteria are typical 
of the gastrointestinal tract, of the genital regions and upper respiratory tract, but rarely lead to 
clinical disease because competing with the normal microbial flora typical of these regions. 
(Hosseinidoust et al., 2013). Pseudomonas spp, like other gram-negative bacteria, have an outer 
membrane plus the inner cytoplasmic membrane and intermediate peptidoglycan layer 
(Hosseinidoust et al., 2013). This outer membrane is not present in gram-positive bacteria. The 
polysaccharide capsule (also known as the glycocalyx) sets the outside of the bacteria. Capsule is a 
virulence factor and acts to protect the outer membrane from attack by the attachment by 
phagocytic cells (Hosseinidoust et al., 2013). The outer layer of the membrane is composed of LPS, 
the ’O’ antigen is what determines the serogroup of the bacteria. There are approximately 11 
variants of this ‘O’ antigen for Pseudomonas spp. Pseudomonas are involved in more infections 
range from ear disease to sepsis and its pathogenicity can be influenced by the presence of 
virulence factors, such as the abovementioned LPS, and also toxins and adhesins (Pier 1998, 
Klemm et al 2000). In particular, the bacteria, to infect the host, must adhere on epithelium with 
particular adhesins on the bacterial cell binding to lectins on the host cell surface. Adhesins are 
structures situated on the bacterial out of the membrane and they are part of the bacterial 
fimbriae (an appendage on the outer surface of the bacterium). These proteins are very specific 
and only bind to certain molecules/proteins on the host cell surface (Hosseinidoust et al., 2013), 
thus activating phosphatidylinositol-3-kinase (PI3K). Protrusions that are enriched with 
phosphatidylinositol (3,4,5)-triphosphate (PIP3) and actin will accumulate at the apical surface as 
the site of binding. and at the cell-to-cell junction, to move and to attach on the apical surface. 
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Pseudomonas spp. live on a different range of substrates and it adapts to change in the 
environment. Pseudomonas have reduced nutritional requirements and colonize many different 
environments (Hosseinidoust et al., 2013).The bacteria have a wide range of secretion systems, 
which export numerous proteins relevant to the pathogenesis of clinical strains (Madigan and 
Martinko, 2005). A particular characteristic of Pseudomonas bacteria is the capacity to produce 
pyocyanin, a blue-green pigment. Pseudomonas fluorescens group are non pathogenic 
saprophytes that also produce a pigment, particularly under conditions of low iron availability. This 
pigment is a soluble, greenish, fluorescent pigment that led to the group's name. These bacteria 
are generally obligate aerobes; however, some strains can utilize NO3 instead of O2 as an electron 
acceptor. They have multiple polar flagella that assist in the bacteria's movement. Because they 
have simple nutritional requirements, they "grow well in mineral salts media supplemented with 
any of a large number of carbon sources". Some researches seek to exploit P. fluorescens to 
partially or completely degrade pollutants such as styrene, TNT, and polycyclic aromatic 
hydrocarbons. Several strains also have the ability to suppress plant diseases by "protecting the 
seeds and roots from fungal infection". This ability is due to secondary metabolites produced by 
these bacteria such as antibiotics, siderophores, and hydrogen cyanide as well as the ability of 
these bacteria to rapidly colonize the rhizosphere and out-compete some of pathogens 
(textbookofbacteriology.net/pseudomonas).  
In the last years, there is an increase of Pseudomonas spp in food. The estimated minimum 
infectious dose in food is 106 cfu/g, but to raise food-borne risks to humans is necessary that the 
bacterial load is at least 107 cfu/g (Lax et al., 2013). The comsuption of food with such bacterial 
load is very improbable, since this is usually accompanied by evident modifications of the look and 
sensory characteristics of the product, sufficient to dissuade the human from eating. Accordingly, 
these microrganisms are not considered food-pathogenic. At now, they are not considered 
dangerous for the European and Italian food legislation and so they have not been established any 
limits of acceptability in foods. The only reference legislation covering this kind of bacteria is 
contained in the Italian Legislative Decree 31/2001 which, although not considering Pseudomonas 
spp. among the criteria for potability of water intended for human consumption, it requires the 
absence of Pseudomonas aeruginosa in water offered for sale in bottles and containers (Lax et al., 
2013). Overall, foodborne Pseudomonas spp. should be considered more as an issue of quality 
than of safety. 
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PSEUDOMONAS IN MOZZARELLA CHEESE 
A problem emerged in recent years was concerning the presence of Pseudomonas in products of 
cheese making, as Mozzarella cheese. The problem seems related to the presence of the 
bacterium in the process water. Particularly sensitive are the cheeses produced by chemical 
acidification, as the mozzarella cheese. 
 
 
Figure 16: esample of blue mozzarella cheese affected of Pseudomonas fluorescence and Pseudomonas putida 
(http://www.lucianopignataro.it/wp-content/uploads/2010/07/mozzarella-blu.jpg and 
http://multimedia.coldiretti.it/Assemblea_Palalottomatica_2_Luglio_2010/Forms/AllItems.aspx) 
 
The water, however, is not the only source of contamination in a dairy company, because there 
are several environmental microorganisms that can contaminate the raw material or the finished 
product going to alter the final aspect. Among the most common defects there are blistering or 
swelling, often associated with the contamination of the milk or the derivate with coliform 
organisms, that could be resolved through a more accurate hygiene during processing.  
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2.1.2. Nosema spp 
Microsporidia are single-cell organisms and are possibly the smallest organisms with a true 
nucleus (eukaryotes). Mature spores measure 1.5 - 10 µm in length, depending on the species. The 
honey bee microsporidia, N. apis and N. ceranae, are about 4 µm in length. 
Many pathogens of insects, as some bacteria and fungi, can germinate and reproduce in the 
environment at least during certain life stages, but microsporidia are obligate pathogens, and can 
only multiply inside the cells of the host. The only phase that can survive for long period out of 
environment is the infective mature spore, which is essentially a dormant stage and must be 
ingested by a susceptible host and invade the tissue cells of the alimentary tract to reproduce 
once again. Most microsporidian species reproduce only in the cytoplasm of the host cells, but a 
few species have been known to utilize the cell nucleus. Nuclear invasion, however, rarely occurs 
in infections caused by Nosema species. 
The microrganism passes the active reproductive phase of its life cycle within the digestive cells 
lining the mid-gut of the adult bee. On entering one of these cells, the animal grows and multiplies 
rapidly, utilising the cell contents for its food supply. Reproduction ceases after several days with 
the formation of a large number of spores. The cell then reptures, shedding the spores into the 
mid-gut lumen (Liu, 1990). The spores pass down the gut into the small intestine and accumulate 
in the rectum from which they are voided at intervals in the bee's faeces. Within the spore, the 
parasite enters its passive, resting stage until swallowed by another bee. When this happens, the 
spore "germinates" as it enters the ventriculus from the crop. It enters an epithelial cell and begins 
to grow (El-Shemy, 1986 and De Grof et al, 1994). 
Nosema spores contain simple but important and interesting organelles. These structures, which 
are only visible using transmission electron microscopy at a magnification of more than 5,000X, 
are nearly all related to invasion of host cells and reproduction. Figure 17 reports a longitudinal 
section of a mature spore containing a double nucleus (all true Nosema species have double nuclei 
called diplokarya; other groups may have a single nucleus), layers of membranes at the apical end 
of the spore deominated polaroplast, a vacuole at the distal end of the spore and, most 
spectacularly, a polar filament that is attached at the apical end of the spore and winds like a 
spring around the inside spore wall. The mature spore is covered by an outer exospore formed of 
protein and an endospore that is composed of a protein-chitin matrix. This thick, tough spore wall 
protects the spore once it leaves the host cell and is exposed to environmental conditions. 
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Figure 17: Major organelles inside an infective microsporidian spore. Photo of the Society for Invertebrate Pathology. 
 
There are two forms of the microsporidian (fungus) Nosema associated with clinical signs of 
disease in honeybees: Nosema apis and Nosema ceranae (Figure 19). Nosema spp. invade the 
intestinal cells coating the mid-intestine of the bee, then they multiply fastly and within a few days 
(3-7 days) the cells are full of spores, the resting phase of the parasite. When the bee intestine cell 
ruptures, it sheds the spores into the gut where they accumulate in masses, to be later excreted 
by the bees. If spores from the excreta are picked up and swallowed by another bee, they can 
germinate and once more become active, starting another round of infection and multiplication. 
Nosema apis is endemic having been first described over 100 years ago, but N. ceranae appears to 
have been a more recent move from the Asian honeybee Apis ceranae being first reported in 
Europe in 2005, soon being established in many European countries: Denmark, Finland, France, 
Germany, Greece, Italy, Serbia, Spain, Sweden, Switzerland  and United Kindom (Paxton et al 2007; 
Antunez et al 2009; Botias et al 2012a). 
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Figure 18: life cycle of Nosema (Scanning electron micrograph of germinating spore courtesy the Society for Invertebrate 
Pathology; transmission electron micrographs of other stages courtesy Wiley Publishing Co.) 
 
 
 
Figure 19: Mature infective spores of Nosema apis (a) and Nosema ceranae (b), pathogens of the honey bee. Photos by W.-F. 
Huang 
 
Nosema infection has been associated with impact on pheromone production, immune response, 
flight behaviour, energetic stress, behavioural fever and hunger mediated conduct (the bees are 
less inclined to share their food with other bees), effects on brood care, thermoregulation, 
defence and foraging (Gaulthier et al 2011, Botias et al 2012). All these factors may have an impact 
not only at the individual but also at the social level and have detrimental effects on colony 
homeostasis (Botias et al 2012). 
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N. apis is more prevalent in cooler climates and affects honeybees primarily in the spring and early 
summer. it has been referred to as “Spring dwindling”, with dysentery and fouling of the outside 
of hives with faeces and it is known to age bees more rapidly in that they take on the duties of 
older bees and subsequently die sooner than non-infected bees (Fries 2010). These precocious 
foragers have been shown to be less effective and resilient than normal foragers (Oskay 2007). 
Infection with N. apis has also been shown to raise Juvenile Hormone III (JHIII) levels in bee 
hemolymph which is associated with behavioural changes (Ares et al 2012). There is also evidence 
that colonies infected with N. apis collect significantly less pollen than uninfected colonies due to 
the reduction in their adult bee population (Andersen and Giacon 1992). Although feeding pollen 
supplements in the laboratory increases the lifespan of bees infected with N. apis, feeding field 
colonies with supplemental pollen has been reported not to counter the reduction in worker 
lifespan, presumably as it was used primarily for brood rearing (Rinderer and Elliott 1977, Mattila 
and Otis 2006). In two races of European bee. It was observed that N. apis colonizes the entire gut 
in approximately 2 weeks after infection and an average of 3-5 x 106 spores are present at the end 
of this period, although there was no apparent relationship between bee longevity and spore dose 
(Malone and Stefanovic 1999, Czekonska 2007). 
N. ceranae is more adaptable and less host specific than N. apis (Botias et al 2012). There is 
evidence that N. ceranae is far more virulent than N. apis, causing colony deaths in warmer drier 
climates, is more stable at warmer temperatures and that it has a greater effect on longevity 
(Fenoy et al 2009). The stress may be an important factor contributing to the increased virulence 
of N. ceranae observed. In a recent study, feeding experiments on caged bees showed that both 
mortality and sugar syrup consumption were higher in N. ceranae infected bees than in N. apis-
infected and control bees (Martin-Hernandez et al., 2011). The mortality and sugar syrup 
consumption were also higher in N. apis-infected bees than in controls, but less than in N. 
ceranae-infected bees. With both microsporidia, mortality and sugar syrup consumption increased 
in function of the increasing spore counts administered for infection, from 103 to 105 spores/bee. 
The differences in energetic requirements between Nosema spp. confirms that their metabolic 
patterns are not the same, which may depend critically on host– parasite interactions and, 
ultimately, on host pathology. The repercussions of this increased energetic stress may even 
explain the changes in host behaviour due to starvation, lack of thermoregulatory capacity, or 
higher rates of trophallaxis N. ceranae appears to be more prevalent in the summer than N. apis 
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but seasonal infection peaks appear to differ between geographical zones (Martin-Hernandez et al 
2011, Chen et al 2012). Although there is no apparent relationship between bee longevity and 
spore dose in two races of European bee (Malone and Stefanovic, 1999). There are some 
suggestions that N. ceranae is more adaptable and less host specific than N. apis (Botias et al 
2012). 
Infection with N. ceranae has been shown to significantly elevate JHIII titre in infected bees 
beyond that observed following N. apis infection. There are strain differences as N. ceranae 
isolated from Spain had a greater effect on JHIII titres than N. ceranae isolated from the 
Netherlands (Ares et al 2012). However, there were no differences in virulence of strains isolated 
from Spain and France (Dussaubat et al 2012) and it was considered that the response of the strain 
of honeybee to infection may be more critical, e.g. susceptibility of A. mellifera iberiensis.  
The biological cycle of Nosema spp. in honeybees has been reported to depend on temperature. 
When expressed as total spore counts per day after infection (2 weeks old bees infected with 
10,000 spores), the biotic potentials of N. apis and N. ceranae at 33°C were similar, but a higher 
proportion of immature stages of N. ceranae than of N. apis were seen. At 25 and 37°C, the biotic 
potential of N. ceranae was higher than that of N. apis (Figure 20). The better adaptation of N. 
ceranae to complete its endogenous cycle at different temperatures clearly supports the 
observation of the different epidemiological patterns and supports the increased incidence of 
problems associated with N. ceranae infections in warmer climates (Martin-Hernandez et al 2009). 
In contrast the viability of N. ceranae spores is significantly reduced following one week in a deep 
freezer, which is not the case for N. apis (Fries and Forsgren, 2009). 
 
 
Figure 20: Biotic Potential of N. apis and N. ceranae (Fries and Forsgren, 2009). 
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N. ceranae has been reported in a number of European countries, including Spain, France, 
Germany, Switzerland, Denmark, Finland, Greece, Hungary, Holland, United Kingdom, Italy, Serbia, 
Poland, Slovenia, Bosnia Herzegovina and Sweden (Higes et al 2010). A multiplex PCR assay was 
used to detect coinfections by the two species of Nosema in a screening approach in Europe. 
Screening of bee samples from Spain, Switzerland, France, and Germany using the PCR technique 
revealed a greater presence of N. ceranae than of N. apis in Europe, although both species are 
widely distributed. From the year 2000 onward, statistically significant differences have been 
found in the proportions of Nosema spp. spore-positive samples collected between and within 
years. In the first period examined (1999 to 2002), the smallest number of samples diagnosed as 
Nosema positive was found during the summer months, showing clear seasonality in the 
diagnosis, which is characteristic of N. apis. From 2003 onward a change in the tendency resulted 
in an increase in Nosema-positive samples in all months until 2005, when a total absence of 
seasonality was detected (Martin-Hernandez et al 2007). 
The diagnosis of Nosema disease has been traditionally done by detecting spores of Nosema spp. 
through microscopic analyses (Shimanuki and Knox, 2000). However, with the recent finding that 
both Nosema ceranae and Nosema apis affect western honey bees (Apis mellifera), molecular 
techniques are required that can reliably differentiate between these different species of 
microsporidia, because the spores of the two Nosema spp cannot be reliably distinguished by their 
morphology (Fries et al., 2010). Moreover, microscopic examination of Nosema spores is costly, 
laborious and time-consuming. In addition, microscopic analyses are not as sensitive at detecting 
low levels of Nosema infection as molecular methods, such as PCR, can be. In the last years, 
several molecular protocols have been published for thes identification of N. ceranae and N. apis, 
including species-specific PCR assays, or simultaneous detection of the Nosema species using 
multiplex PCR (Higes et al., 2006; Chen et al., 2008). Until now, published real time PCR-based 
assays capable of simultaneous identification and quantification of both species in the same 
reaction mostly use separate primers pairs and species-specific probes (Burgeois et al, 2010). 
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2.1.3. Staphylococcus Pseudintermedius and fluoroquinolone resistance 
The genus Staphylococcus belongs to the family of Micrococcaceae, and is the only of its kind that 
includes pathogens of medical and veterinary concern. Staphylococci are Gram-positive, spherical 
in shape (cocci), with a diameter of about 0.5-1,5 μm aerobic and facultative anaerobic, 
motionless, catalase-positive and oxidase-negative bacteria (Poli G. And Cocilovo A., 2005). The 
taxonomic classification of staphylococci has changed a lot over the years thanks to new 
applications of microbiological and enzymatic techniques but especially of molecular methods. 
Staphylococci are ubiquitary bacteria widely distributed in the environment, and they can be 
found in water, air, soil, dust, and a wide diversity of inanimate objects (Martino P.A. et al., 2005). 
Staphylococci can also be considered the most common saprophytic of humans and animals skin. 
As well as on the skin, Staphylococci can be isolated from mucous membranes of various 
apparatuses, including the respiratory, gastrointestinal and urogenital. Many people can be 
healthy carriers which are then considered a likely source of infection for themselves and for 
others (Cox H.U. 2006).  
Staphylococci are now classified into forty different species on the basis of genotype, habitat, and 
the related pathological process (Martino P.A. et al., 2005). One of the best criteria to classify 
staphylococci is the production of coagulase. In fact the various species can be divided in 
coagulase-positive and coagulase-negative, according to their capacity to coagulate rabbit plasma. 
Many author considered coagulase a factor closely related to pathogenicity, as it promotes the 
spread and survival of the bacteria in the body. Coagulase is present in many staphylococci and its 
main action is to coagulate the plasma resulting in activation of fibrinogen and its subsequent 
transformation into fibrin. The clot protects the bacteria from the immune system that fails to 
reach, for which bacteria who develop this enzyme are more resistant to the immune defenses of 
the host (Cox H.U. 2006). The coagulase is also defined as “free coagulase” to distinguish it from 
clumping factor, an enzyme that is bound to the bacterial cells and which has the same function. 
These bacteria then act as opportunistic pathogens (except Staphylococcus aureus, a real 
pathogen). Each species of staphylococci can therefore be considered as potentially pathogenic, 
although showing a wide and varied spectrum of virulence as well as host preference. Moreover, 
given their strong environmental resistance, they can survive the toughest conditions for months, 
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as they persist for months outdoors (if protected from sunlight), and in the laboratory after 
transplantation in fresh medium or freezing. They are also relatively resistant to heat (about thirty 
minutes at 60 °C), drying and, if properly protected from organic material (pus, mucus, milk, 
serum, debris), also to the common disinfectants (Martino P.A. et al., 2005; Cox H.U. 2006). In 
addition to being very resistant, these bacteria have developed several factors which allow the 
colonization and infection of host tissues. They in fact, after a decrease in immune function, 
invade the epithelium. This colonization can be stimulated by various conditions such as: 
mechanical insults of the skin (eg., wounds, abrasions, etc.), other infections (eg., demodicosis, 
dermatophytosis, pyoderma, etc.) or even particular changes (eg., seborrhea, hypothyroidism, 
Cushing's disease and Addison’s disease). In addition, persistently immunosuppressed subjects are 
more affected and develop more violent and persistent clinical forms. When bacteria invade the 
skin they may cause from light (acne, impetigo) to severe (furunculosis) local infections or, as a 
result of colonization of the bloodstream with bacteremia, may develop purulent processes of 
various kinds (especially abscesses) in different locations: liver, kidneys, lungs, joints. In dogs they 
can be associated to specific diseases such as otitis, pyoderma and metritis (Cox H.U. 2006). 
Staphylococcus pseudintermedius is frequently found on the skin or in the nose or intestinal tract 
of 50% of more of healthy dogs, and a smaller percentage of healthy cats. Usually this 
microrganism doesn’t cause problems at all, but sometimes it behaves as an opportunistic 
pathogen. Staphylococcus pseudintermedius can infect almost any tissue, but skin and soft tissue 
infections are more common, particularly when the skin have been damaged by something else 
(e.g. allergies, scratching, chronic wetness, wounds, surgery). The bacteria easily grow on common 
growth media, without the need of particular substances or pH indicators, as colonies with color 
from gray to yellow to orange (Figure 21) (Cox H.U. 2006). 
Ear infections are very commonly caused by S. pseudintermedius. Infections of other body sites 
and organs are much less common, but can be very severe. Staphylococcus pseudintermedius can 
also be found in the nose of up to 4% of healthy animal owners. MRSP stands for methicillin-
resistant S. pseudintermedius, which is a variant that is highly resistant to many antibiotics, 
including most of the drugs that are commonly used to treat bacterial infections in dogs and cats. 
Non-MRSP variants of S. pseudintermedius are methicillin-susceptible (MSSP). People and animals 
that carry MRSP without any signs of infection at all are said to be colonized. When infection with 
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S. pseudintermedius (either MRSP or MSSP) occurs, this causes signs of inflammation (e.g. heat, 
pain, swelling, discharge, fever) (www.wormsandgermsblog.com).  
 
 
Figure 21. Colonies of Staphylococcus aureus in a growth medium common Agar (ASM Microbel library.org®) 
 
Staphylococci are halophilic, being able to withstand high concentrations of sodium chloride (also 
10%), and they can use the ground (MSA-Mannitol Salt Agar-) those contain a large percentage of 
this salt (approximately 7.5%). As regards instead the condition of incubation and growth, being 
staphylococci bacteria mesophilic their growth temperature is between 18 and 40 ° C with an 
optimum at 37 ° C; also being aerobic-anaerobic facultative they can grow both under normal 
conditions and in modified atmosphere (10% of carbon dioxide) (Martino P.A. et al., 2005; Cox 
H.U. 2006). 
When grown in liquid media, the colonies  appear to macroscopical analysis as a uniform turbidity, 
while in solid media after incubation for 24 hours at 37 ° C, they show up as large colonies 
roundish of about 2-3 mm in diameter, opaque, smooth and convex; encapsulated strains can 
form colonies of mucoid appearance (Martino P.A. et al., 2005). The colonies may vary from gray 
to yellowish, to orange depending on the pigmentation of the cell membrane, and coloring is not 
associated with pathogenicity. Agar-blood culture can be useful for identification, because some 
staphylococci, according also to the type of red blood cells used for the ground, show a well clear 
halo of hemolysis (Figure 22). 
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Figure 22. Clear area of hemolysis around the colonies of S. aureus on blood-Agar (ASM Microbel library.org®) 
 
There are different cultural and biochemical methods to identify the colony. 
The examination of the morphology, to see size, shape, color, odor and presence of hemolysis of 
the colonies. Staphylococci have a tendency to aggregate in irregular clusters, but occasionally can 
be found arranged individually, in pairs (diplococci) or in groups of four (tetrads) (Figure 23) 
(Martino P.A. et al., 2005). 
 
 
Figure 23. Staphylococci in electron microscopy arranged in small clusters of several subjects. (ASM Microbel library.org®) 
 
The Bacterioscopic examination of stained preparations is another possible application. This test 
provides further information on the morphological characteristics of the isolated bacteria and also 
on how they react to certain differentials colors (eg, Gram, Ziehl-Neelsen). In the case of these 
bacteria, the test with an optical microscope is preceded by Gram dye, which, for Gram-positive 
bacteria, allows detection of blue-violet microorganisms (Figure 24). 
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Figure 24. Staphylococci with Gram stain 
 
The catalase proof is based on the detection of the presence of this enzyme. The catalase 
presence or absence help to distinguish staphylococci catalase-positive and catalase negative. 
There are several commercial kits but more simply is to dissolve a colony in one drop of water 3% 
hydrogen peroxide placed on a glass slide (Poli G. and Cocilovo A., 2005). 
The oxidase proof is based on the detection of the presence of this enzyme. The procedure 
prescribes to dissolve the bacterial colony into a drop of saline placed on a glass slide; the 
suspension is subsequently immersed in a disk of paper, impregnated with a solution of 
tetramethyl-p-phenylenediamine dihydrochloride (the disks are commercially available). In case of 
positive reaction, within 10-20 seconds is observed the appearance of an intense purple color. 
There are also commercial kits, which allow the simultaneous execution, in vitro, of the catalase 
and oxidase tests. Obviously, in the presence of colonies of staphylococci, this test must be 
negative (Figure 25) (Poli G. and Cocilovo A., 2005).  
 
 
Figure 25. Outcome of the catalase test: on the right a positive sample, on the left a negative sample (www.mesacc.edu) 
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The proof of coagulase is another enzymatic test. This is an easy test to determine the presence of 
coagulase, as follows. A drop of anticoagulated (using lyophilized citrate or EDTA) rabbit plasma is 
deposited on a glass slide and a colony is dissolved; the occurrence, within 5 seconds, of 
microscopic flakes is a sign of positivity (Poli G. and Cocilovo A., 2005).  
Biochemical tests and API-System®. API-System ® (bioMérieux) is a miniaturized and standardized 
system for the identification of microorganisms by biochemical tests. Thanks to this test, it is 
possible to identify and classify the bacteria according to the final products or intermediates of 
various biochemical reactions of which they are capable.The testt is used when the first phase of 
identification has narrowed down the possibilities to a few genera or it only remains to identify 
the species. It consists of a gallery with 20 wells, each containing a different soil and appropriate 
chromogenic indicators; therefore it allows the simultaneous execution of 20 biochemical tests. 
Some reactions are read immediately, according to the spontaneous color changes of the 
substrates used in the individual well; in other cases, only after the addition of specific reagents. 
Through this analysis it is possible to simultaneously detect the ability of the microorganism to 
metabolize various sugars to produce acids or gas, to liquefy the gelatine, to use citrate, to reduce 
nitrate, etc. There is a version of this identification system, called API-Staph ® specifically targeted 
to the genera Staphylococcus and Micrococcus. 
 
 
Figure 26: Example of a biochemical test API-System ® (www.jlindquist.net) 
 
Antibiotic resistance is a phenomenon by which a bacterium is immune to the effects of one or 
more antimicrobial drugs. This phenomenon can be considered as an evolutionary and adaptive 
biological process that bacteria carry out to escape the selection (Levin B.R. et al., 2000). The 
selection pressures reach maximum levels when bacteria are exposed to sub-optimal doses of the 
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drug. The antibiotic resistance may be natural or acquired: the first is determined by the innate 
characteristics of the microorganism, for example a Gram-negative bacterium is naturally 
resistant, thanks to the porosity characteristics of their membrane, to glycopeptide antibiotics 
such as vancomycin. The second appears when occurring genetic modifications that allow to 
changed subjects the survival and transmission of the modifications (Levin B.R. et al., 2000).  
There are two tipe of changes, divided into chromosomal and plasmidic. The chromosomal 
mutations, also known as endogenous, occur primarily at the level of nuclear DNA by spontaneous 
phenomena of substitution, insertion and deletion of base pairs (point mutations) or more pairs of 
bases repeated (mutations for repeated sequences) within the colony to each replication cycle 
with a frequency of 1:103 - 1:109 for cell division. This type of mutation occurs more slowly and 
rarely compared to plasmid-mediated mutations but usually gives to the changed population a 
permanent resistance to antimicrobial agents. Obviously, being this mutation spontaneous and 
random, it does not mean that, once completed, a mutation affects exactly the portion of DNA 
that contains sequences related to molecules or structures that are antibiotic targets. The genic 
modifications mediated by plasmids, however, are caused by fragments of double-stranded 
circular cytoplasmic DNA. This type of filament is common in bacteria and promotes the exchange 
of genetic information between phylogenetically related micro-organisms. The plasmids are small 
DNA fragments of different size: the smaller ones (approximately 10kb) are generally present in 
large number in the cytoplasm (10-20); those more bulky (100-150kb) are usually present in single 
or double copy. The plasmids replicate with the aid of specific proteins and are divided among the 
daughter cells during binary fission. They are able to transmit genetic information that are used to 
develop new features dangerous for the host: virulence factors, the production of new proteins or 
enzymes for the survival, detoxification, antibiotic-resistance, etc. (Smillie C. et al., 2010).  
There are mainly three other mechanisms that bacteria can use for the exchange of genetic 
material, with both chromosomal and plasmid nature: a) transformation; in this process the genes 
are acquired by the recipient cell in the form of naked extracellular DNA. Basic assumption is the 
death of another microorganism which, after analysis of their structures, releases the DNA into the 
surrounding environment. The recipient cell adsorbs the free DNA through the cell wall and, as a 
result of recombination with a homologous segment, it incorporates into its DNA acquiring new 
characters; b) conjugation; this is a process in which a direct exchange of genetic material takes 
place from a donor cell to a recipient through the formation of a particular structure called pilo 
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sexual, which allows the horizontal passage of chromosomal DNA or, more frequently, plasmid 
DNA; c) transduction, a processes where the gene transfer is mediated by bacteriophages (or 
phages), as from viruses that infect bacteria. A phage infects a bacterium, basically, and takes 
control of the genetic processes of the bacteria to replicate. During this process, inadvertently, 
bacterial DNA (genomic or plasmid) can replace and/or become incorporated into the newly 
formed phage DNA. Only the phages characterized by dsDNA can be transducing. After bacterial 
death, which follows the lysis, the new phages are released and go on to infect other bacteria, 
carrying to them genetic material from previously infected bacteria (an example of transfer by 
transduction regards the plasmid carrying the gene for β-lactamase in S. aureus). 
 
The appearance of antibiotic resistance is related to three main categories of mechanisms (Walsh 
C. 2000): 
1) Alteration of the binding site between the target protein and antibiotic. The alteration of the 
binding site occurs via chromosomal and/or plasmid-mediated genetic mutations, which alter the 
affinity for the drug by changing the nucleotide sequence of a certain protein. In this way even if 
the antibiotic reaches the cytoplasm, it fails to exert its bacteriostatic action or bactericidal 
activity. Examples of this mechanism are provided by PBPs (Penicillin Binding Proteins), that are 
target enzymes of β-lactam antibiotics. 
2) Production of enzymes that destroy the drug. The production of enzymes that break down the 
drug is definitely one of the most studied and known mechanisms of antimicrobial resistance. The 
best known case is undoubtedly that of beta-lactamase enzymes produced by many 
microorganisms that destroy the antibiotic belonging to the group of β-lactam (penicillins and 
cephalosporins). These enzymes are encoded both by plasmids, such as the R plasmid which also 
contains the TEM-lactamase, and by chromosomal sequences such as AmpC, characteristic of 
many Gram-negative bacteria (Nikaido H. 2009). The beta-lactamases cause hydrolysis and 
subsequent destruction of antibiotics and have become increasingly refined and perfected by the 
great use of β-lactam antibiotics. These antibiotics are increasingly improved over the years to 
escape the enzymes produced by bacteria, but inexorably microorganisms develop resistance by 
producing and adapting their defense mechanisms. 
3) Decrease in the concentration of the antibiotic in the cytoplasm. 
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The production of pumps for the cytoplasmic efflux is a very refined mechanism of resistance 
whose transmission to other bacteria is quite difficult because of the complexity of the genes that 
encode them. Antibiotics enter into the cell through pores of the membrane, but can be extruded 
from the cytoplasm due to  the presence of these pumps which are nothing more than 
transmembrane proteins that actively expel the drug. This system, developed by both Gram-
positive and Gram-negative bacteria, has been particularly studied in E. coli, but also in 
staphylococci, especially S. aureus, and is responsible for resistance to multiple antibiotics, 
especially the fluoroquinolones (NorA), tetracyclines, macrolides and β-lactam antibiotics (Nikaido 
H. 2009). 
All chemoantibiotics compounds are effective only towards certain bacterial species while have no 
effect on others species. Furthermore, the emergence of resistance makes immune some bacterial 
strains that commonly fall in the spectrum of action of the antimicrobial. Precisely for this reason 
when you are in front of a pathogenic micro-organism you should, before embarking on empirical 
therapy, perform at least one antibiogram that not only gives information about the strain in 
question but also general information about the antibiotic resistance. The antibiogram, performed 
according to the Kirby-Bauer technique, is certainly one of the most used techniques in clinical 
practice and is a standardized method for the amount of bacteria seeded (using a bacterial 
inoculum equal to Section 0.5 of the McFarland scale, i.e. to 5 x 108 CFU / ml) and the type of soil 
used (Mueller-Hinton, devoid of para-amino acid -benzoic acid). This occurs by the inoculums 
seeding for inclusion in agar or slither on the surface by swab. Are then deposited, on the surface 
of the sown soil, a number of cellulose diskettes impregnated with known amounts of 
antibacterial drugs. After the incubation period of the plates (typically 37 ° C for 24 hours), 
proceed to the reading of the halos: the chemoantibiotics spread by disks into the surrounding soil 
and, if effective, inhibit bacterial replication in a much larger area, the greater is their activity. It is 
observed, thus, the appearance of zones of inhibition of growth around the diskette antibiotic, 
whose diameter is proportional to the antibacterial activity of the antibiotic content. The absence 
of a halo is, instead, a sign of ineffectiveness of the drug. With this technique it is therefore 
possible to classify the bacteria susceptible, intermediate or resistant to several antibiotics tested 
(Figure 27). 
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Figure 27. Antibiogram performed according to the Kirby-Bauer technique (www.wikipedia.org) 
 
MIC (Minimum Inhibiting Concentration), is the minimum concentration of antibiotic capable of 
inhibiting bacterial growth. The most common technique of execution involves dilution in liquid 
media (or broth): the technique can be performed in a test tube (macromethod) or in 96-well 
plates (micromethod). It starts from a bacterial inoculum concentration equal to 104 CFU/ml, 
which is mixed at scalar concentrations of antibiotic. The technique performed in a test tube 
provides the twofold dilution, from 128 micrograms/ml of the antibiotic, in volumes of 1 ml. The 
micromethod instead provides for the mixing of 100 µl of BHI for growth of the bacterium, 100 µl 
of bacterial suspension and, in the first tube, 100 µl of stock solution of antibiotic (equal to 1 
mg/ml, obtained by dilution of the powder of the principles active in distilled water and filtration), 
then serial dilutions in base 2. Following incubation at 37 ° C for 18-24-48 hours. The MIC is the 
highest dilution, i.e. the smallest amount of antibiotic, capable of visibly inhibit bacterial growth. 
 
Quinolones are a class of chemotherapy (i.e. chemical synthesis) antibiotics discovered at the end 
of the fifties of the last century, whose progenitor may be considered nalidixic acid. Given their 
spectrum of activity, Gram-negative aerobes and anaerobes, their rapid renal excretion and the 
achievement of high urinary concentrations were usually used to treat infections of the genito-
urinary tract. However, given their narrow spectrum of activity and the emergence of significant 
resistance phenomena, they have slowly fallen into disuse. In more recent years, starting from 
quinolones, novel compounds called fluoroquinolones have been synthesized with a broader 
spectrum of action and smaller phenomena of resistance, due to the presence of a fluorine atom 
in their structure. These drugs show a good intestinal absorption, good tissue distribution and 
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prolonged half-life of elimination (Carli et al., 2009). Lately there is a growing series of antibiotic 
resistance even against this class. Currently, in Italy, enrofloxacin, danafloxacin, difloxacin, 
flumequine, marbofloxacin and norfloxacin are registered for use in veterinary medicine. 
The fluoroquinolones are synthesized starting from the same chinolonic structure, from time to 
time amended with different chemical substituents (such as fluorine) and with side chains. These 
modifications, as a rule, do not change the spectrum of action of fluoroquinolones but instead 
modify the kinetic characteristics, in particular the bioavailability, the ability of tissue distribution 
and excretion rhythms (Carli et al., 2009). These chemotherapeutics show a bactericidal, very 
rapid and dose-dependent mechanism of action, mainly targeting two enzymes of the class of 
topoisomerase: DNA gyrase and topoisomerase IV. The DNA gyrase is an enzyme composed of two 
GyrA subunit and two GyrB subunits respectively transcribed by gyrA and gyrB genes, and has a 
crucial role as being the only enzyme able to rotate the DNA windings negative; this ability is 
important during the step of replication and synthesis of the DNA (Drlica K. and Malik M. 2003). 
The topoisomerase IV is a type II isomerase being the main enzyme responsible to the separation 
of DNA strands at the end of the replication process. It consists of two subunits ParC (calls grlA in 
Staphylococcus aureus) and two subunits ParE. The main targets of fluoroquinolones are GyrA and 
parC, respectively; bonding to these molecules hampers the separation and rejoining of DNA 
strands and this results in inhibition of bacterial DNA synthesis, poor reparative ability of the 
genetic material and cell death (Drlica K. and Malik M. 2003). More precisely, the link between 
drug, enzyme and open DNA, called ternary complex, prevents the progression of replication and 
transcription, and it is this that causes fragmentation of the chromosome which will lead to cell 
lysis. The high selective toxicity that these compounds have towards prokaryotic cells is justified by 
the fact that the eukaryote DNA-gyrase is inhibited at much higher concentrations than those of 
the bacterial cell (about 100-1000 micrograms/ml against 0.1-10 micrograms/ml) (Carli et al., 
2009). For Gram-negative bacteria, the primary target of fluoroquinolones is the DNA gyrase 
enzyme, while for Gram-positive is the topoisomerase IV enzyme. 
The resistance against these drugs is predominantly of chromosomal type, then it is stably 
transmitted to progeny, and its appearance is directly related to the concentrations of the 
chemotherapeutic in the site of infection. A repeated exposure to sublethal concentrations of 
fluoroquinolones can then produce a dangerous and stable resistance; which usually, being of 
cross-type, makes ineffective the other drugs of the same class (Carli et al., 2009). The onset of 
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this phenomenon against fluoroquinolones implies the onset of defensive mechanisms by the 
bacterial cell, which can implement two main strategies: the expression of transmembrane pumps 
that actively expel the drug outside of the cytoplasm, and the modification of the enzymatic target 
of the antibiotic. The first mechanism encounters for several efflux systems associated to genes 
with chromosomal and extra-chromosomal localization coding for transmembrane proteins that 
are able to reduce the cytoplasmic concentration of the drug (Table 26). 
 
Antibiotic drug Working 
Resistance 
genes 
Genes 
location 
Bacteria 
Tetracyclines Outflow Tet P, T, C 
Gram-positive 
Gram-negative 
Macrolides Outflow mefA P, T, C 
Salmonella spp 
E.coli 
Chloramphenicol, 
Fluoroquinolones 
Outflow blt, norA C 
Bacillus spp. 
Staphylococcus spp. 
Chloramphenicol, 
Fluoroquinolones,  
β-lactams, Macrolides, 
Tetracyclines 
Outflow 
MexA, MexB 
AcrA, AcrB, 
oprM, tolC 
C 
Pseudomonas spp. 
E.coli 
Salmonella spp. 
Table 26: Examples of microbial resistance through development of transmembrane pumps. P= Plasmids, T= Transposons, C= 
Chromosomes. (Carli et al., 2009). 
 
Over the years, many bacteria have thus developed a tenacious resistance to these 
chemotherapeutic thanks to the modification of the target enzymes of these antibiotics. As usual, 
the microorganisms did not implement a single common process but have adapted different 
strategies according to their features. The resistance usually occurs due to modifications in the 
chromosomal genome, and its appearance is directly proportional to the concentrations of the 
drug in the site of infection as mentioned above, especially when the microrganism is exposed to 
sub-lethal concentrations of the drug for a long time. Typically, the resistance is of cross-type, for 
which its appearance makes the bacterial strain immune, or at least not very sensitive, to all drugs 
in the same category. 
Fluoroquinolone resistance in S. pseudintermedius and other Staphylococci is predominantly 
mediated by a mutation located at position 84 of the gyrA subunit of DNA gyrase enzyme 
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(Ser84Leu), together with a mutation located at position 80 of the grlA subunit of topoisomerase 
IV enzyme (Ser80Ile) (Intorre L. et al., 2007; Descloux S. et al., 2008). All these amino acid 
substitutions are caused by point mutations (substitution of a single nucleotide) on particular 
chromosomal genes, gyrA and grlA, which encode for the production of these enzymes. This 
causes a different reading of the nucleotide triplet and then the change in the protein sequence of 
the enzyme. The modification of the enzyme structure is the cause of lower affinity which occurs 
between target enzyme and quinolone that fails to form the ternary complex and thus to cause 
cell death (Intorre L. et al., 2007; Descloux S. et al., 2008). 
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2.1.4. Dirofilaria spp 
The etiological agents of disease defined generally "filariasis" fall into two subfamilies of parasites 
belonging to the Onchocercidae family and to the Filarioidea superfamily (Table 27). These 
subfamilies are represented by: Dirofilarinae, which includes Dirofilaria immitis and Dirofilaria 
repens (Nochtiella repens), and Onchocercinae, which includes Dipetalonema reconditum 
(Acanthocheilonema reconditum), Dipetalonema dracunculoides (Acanthocheilonema 
dracunculoides) and Dipetalonema grassii (Cercopithifilaria grassii) (Chauve C.M., 1990; Euzeby J., 
1990; Urquhart G.M. et al., 1996). 
 
Reign Animalia 
Phylum Nemathelmintes 
Class Nematoda 
Order Spirurida 
Suborder Spirurina 
Superfamily Filarioidea 
Family Onchocercidae 
Subfamily Dirofilarinae 
Gender Dirofilaria 
Species Immitis e Repens 
Table 27: Classification of D. immitis and D. repens. (Urquhart G.M. et al., 1996) 
 
Dirofilaria immitis (Figure 27a) is a filiform parasite that as an adult measures approximately 20-30 
cm in length and 1 mm in diameter; the male is distinguished by the female for the smaller size 
and to the caudal ends wound in a spiral. The mouth is surrounded by eight papillae median and 
two lateral. The caudal area of the male presents from 4 to 6 pairs of voluminous, pedunculated 
and ovoid papillae, of which 2-4 are pre-cloacal and 2 post-cloacal and fingerlike, and 3-4 pairs of 
conical papillae small and located in terminal position. The spicules measure respectively 315 and 
200 microns. In the caudal edge of the female, in sub-ventral position, there is a conical structure 
and papilliforme facing backwards (Euzeby J., 1990). 
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Figure 27: a) Adult specimens of D. immitis (cal.vet.upenn.edu/merial/hrtworm/hw_1a.htm). 
b) Microfilaria of D. immitis (left) and D. repens (right). (Photo kindly provided by Dr. Marco Genchi). c) Tapered cephalic-end of D. 
immitis. (Photo kindly provided by Dr. Marco Genchi). d) Caudal ends with shape of umbrella handle of D. repens. 
(http://www.personalweb.unito.it/ezio.ferroglio/atlante/parassiti_cane/dirofilaria/d_repens/foto/coda_rep1.jpg) 
 
Dirofilaria (Nochtiella) repens has smaller dimension than D. immitis: in fact the female measures 
10-17 cm long and 460-650 microns wide, while the male measures 5-7 cm long and 370-450 
microns wide. The male has from 2 to 4 pre-anal papillae on one side (with spicules which 
measure from 465 to 590 microns) and 5 or 6 on the other (with spicules which measure from 185 
to 206 microns). In the female the vulva is distant from 1.15 to 1.60 mm from the front end 
(Chauve C.M., 1990). 
The larval forms of the parasite are represented by the microfilariae (L1): these are found in the 
circulating blood of the definitive host and, like the adult parasites, their characterization is 
necessary to reach a proper etiologic diagnosis. The morphological elements that allow the 
identification of microfilariae are the length and the shape of the cephalic and caudal end. 
a b 
c 
d 
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The microfilariae of Dirofilaria immitis (Figure 27b) measures 300-330 x 5-7 microns and are not 
equipped with sheath: the caudal part is straight and sharp while the cephalic end is tapered and 
blunt-ended (Figure 27c) (Chauve C.M, 1990; Euzeby J., 1990; Manfredi M.T., 1998; Urquhart G.M. 
et al., 1996). 
The microfilariae of Dirofilaria (Nochtiella) repens (Figure 27b) measures 207-360 microns in 
length and 5-8 microns in width; does not exhibit sheath, the cephalic end is rounded and the 
caudal end has a shape similar to an umbrella handle (Figure 27d) (Chauve C.M., 1990; Manfredi 
M.T., 1998). 
The microfilariae are identified, as well as on the basis of morphology, also with histochemical and 
immunological methods, as described later. 
Dirofilaria immitis depends on insect vectors for the completion of the biological cycle, for 
transmission to the definitive hosts and for its dissemination (Euzeby J., 1990; Urquhart G.M. et 
al., 1996). It is a hematophagous parasite that can remain for years within the definitive host, 
continuing to produce microfilariae (Euzeby J., 1990). It is a viviparous parasite: the female lays the 
microfilariae that circulate in the blood of the host. The microfilariemia has a monthly and 
seasonal circadian periodicity that is highest in July and August and lowest in winter. To become 
adult, the larvae make various moults and part of their evolutionary cycle takes place in a 
hematophagous Diptera (mosquitoes of the genera Aedes, Anopheles, Coquillettidia, Culex, 
Culiseta and Mansonia) which acts as a carrier and as the intermediate host (Cancrini G., 1998). 
The first stage larvae (L1, microfilariae) are taken from the Diptera during the blood meal and 
remain viable in his gut. Subsequently, they migrate towards the Malpighian tubules and are 
transformed, through two changes, in second stage (L2) and third stage (L3) larvae. These become 
infesting in two weeks, after reaching the cephalic space and the labium. The infesting ability 
depends on the temperature: if this is too low larval development stops and may then resume in 
more favorable climatic conditions. The cycle in the final host begins when L3 are inoculated by 
the mosquito during a blood meal. The L3 remain in the skin for about six days, then turn in the 
fourth stage larvae (L4) that are localized in the capillaries of the abdominal wall (about 20 days 
after the bite of the insect) and thoracic (after about 40 days from inoculation of L3). In 60-80 days 
form the fifth stage larvae (L5) that migrate through the venous system to localize in the 
pulmonary artery (between 70 and 120 days after infestation). They persist in this location up to a 
length of 8-11 cm and subsequently perform, after about 110 days infestation, a retrograde 
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migration into the right ventricle, where they become adult individuals (Euzeby J., 1990; Urquhart 
G.M. et al., 1996). The prepatent period, i.e. the interval between infection of an individual by a 
parasitic organism and the first ability to detect from that host a diagnostic stage of the organism, 
is about 6 months, after which the adult females begin to produce the microfilariae. The 
infestation of the dog can take place between June and October, and during the first infestation 
usually L5 reach the pulmonary artery in late August and persist here until December, and then 
migrate into the right ventricle and start producing microfilariae. In an already parasitized subject, 
however, the larvae can be found in the blood throughout the year. In the pregnant dog, 
microfilariae can cross the placenta and reach the fetus, while the larvae infesting (L3) are not able 
to perform this migration, and for this reason intrauterine transmission of heartworm disease 
does not occur (in this case microfilariae are not able to evolve because it must spend part of their 
cycle in the mosquito) (Euzeby J., 1990) (Figure 28). 
 
 
Figure 28: Biological cycle of D. immitis. (http://www.capcvet.org/capc-recommendations/canine-heartworm) 
 
Dirofilaria (Nochtiella) repens, like D. immitis, to evolve to adult parasite needs a phase of 
development in an intermediate host (the mosquito) in which processing takes place from L1 to 
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L3. This is followed by the final inoculation into the host (dog, cat, man, other canids and wild 
felines) where the parasite is localized in the subcutaneous connective tissue and connective 
bands of skeletal muscle. In these locations it makes two changes, becoming first L4 and 
subsequently L5 and reaching then the sexual maturity (Chauve C.M., 1990). 
The principal location of D. immitis are pulmonary arteries and heartworm must be considered as 
a pulmonary disease, that during the last stage also affects the heart chambers (Figure 29). A few 
days after the arrival of the parasite in the caudal pulmonary arteries, the endothelial cells 
become swollen, the intercellular junctions become dilated in response to trauma and activated 
neutrophils adhere in the space between endothelial cells. It is also found adhesion and platelet 
activation. The damaged surface arterial allows to albumins, to the fluid plasma and blood-cells to 
reach the perivascular space inducing a persistent perivascular inflammatory edema. After the 
changes endothelial, the tunica intima thickens and leukocytes invade the wall of the smooth 
muscle cells; these latter multiply within the tunica media and migrate to the surface endovascular 
as a response to the growth factor released from platelets. The proliferation and migration of 
smooth muscle cells determines the presence, on the inner surface of the arteries, of villi that are 
made from smooth muscle cells, collagen and lined by endothelial cells. The surface of the arteries 
of infected dogs and cats appear to be strongly rough and smooth and the lumen of the 
pulmonary arteries resulting decreased. Lung disease is secondary to vascular changes; the 
leakage of liquids and proteins through the wall of the arteries affected produces an edema in the 
parenchyma. Moreover, the spontaneous death of some filariae is capable of producing 
pulmonary thromboembolism and severe inflammatory reactions. The reduction of conformity 
and caliber of the pulmonary arteries, which may also be occluded by a thromboembolism or 
severe villous proliferation, causes a state of pulmonary hypertension and, consequently, in an 
increase of the post load in the right ventricle, which can induce the cor pulmonale syndrome and 
congestive heart failure. The leaking of fluid and protein through the wall of the arteries affected 
produces further swelling and inflammation in the lung parenchyma.  
The clinical evolution of heartworm disease in dogs is usually chronic. Most dogs infected have no 
symptoms of the disease for a long time, months or years, depending on the amount of 
heartworms, the individual reactivity and exercise, as it is more serious damage in dogs that 
perform strenuous exercise in respect dogs at rest. The disease develops gradually and can begin 
with occasional coughing. The cough may be followed by dyspnea, moderate to severe, weakness, 
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and sometimes fainting after exercise or excitement. Sound of crackling can be found at lung 
auscultation. Later, when congestive heart failure is developing occur: swelling of the abdomen 
and legs, fluid accumulation, anorexia, weight loss and dehydration. At this stage, there is a 
cardiac murmur on the right side of the chest, because of insufficiency of the tricuspid valve, and 
the heart rhythm is altered because of atrial fibrillation. Sudden death occurs rarely and usually 
occurs as a result of respiratory distress or cachexia. In the course of this chronic disease 
sometimes there is an acute symptomatology due to a severe thromboembolism following the 
natural death of heartworms, dogs may show acute dyspnea and hemoptysis (Genchi C. et al., 
2007). In small dogs, it is also a common event the movement of adult worms from the pulmonary 
artery to the right chambers of the heart due to pulmonary hypertension and a sudden drop in 
right cardiac output. In this case, the affected dogs show the so-called superior vena cava 
syndrome. This syndrome shows, as well as dyspnea, cardiac murmur due to the presence of 
microfilariae in the vicinity of the tricuspid valve. This syndrome is also called intravascular 
hemolytic, because accompanied by hemolytic anemia and hemoglobinuria for mechanical 
intravascular hemolysis (red blood cell fragmentation occurs for the continuous movement 
between atrium and ventricle of filarial intertwined). This implies a systemic hemodynamic 
decompensation and shock with consequent death of the affected animal (Venco L., 1993). 
Disseminated intravascular coagulopathy often accompanies the superior vena cava syndrome, 
being secondary to hemolysis and metabolic acidosis. In addition, you may experience liver lesions 
characterized by hepatomegaly, with expansion venous thrombosis, centrilobular necrosis and 
fibrosis. Finally, there may be serious kidney disease, resulting from the hemoglobinuria with renal 
tubular necrosis and cylindruria. 
In subcutaneous filariasis, caused by D. repens, the adult parasite is localized in the subcutaneous 
tissues of the dog and cat. This disease presents with minor clinical signs such as itching, swelling 
of the skin, subcutaneous nodules or remains asymptomatic (Genchi C. et al., 2007).  
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Figure 29: Adult of Dirofilaria immitis in dog heart. 
(http://www.stanford.edu/group/parasites/ParaSites2001/dirofilariasis/Synonyms.html) 
 
There are several method to detect dirofilaria: 
- Knott test to microfilariae search in the peripheral blood 
The circulating microfilariae can be detected with the Knott test. The microfilariae are detected 
and identified under the microscope on the basis of morphological criteria, and this is considered 
as a definitive proof of infection (specificity 100%). However up to 30% of dogs may be oligo-or 
amicrofilaremic, despite presenting adult worms, due to the presence of worms only of the same 
sex (quite unusual in dogs), a host immune reactivity towards microfilariae, or administration of 
microfilaricidal drugs. SThus the sensitivity of the test for microfilariae is not considered sufficient 
to rule out infection in the event of a negative result. Furthermore, in certain cases the 
identification based on morphology may be made more difficult by the presence of artifacts 
and/or intermediate morphologies, especially if the operator is not very experienced or if they are 
not put in place procedures of sampling and analysis perfectly reproducible (Genchi C. et al., 
2007). 
- Blood test for the antigens research of adult females of D. immitis 
Different ELISA kit for detect the presence of circulating antigens of Dirofilaria immitis adult 
female in serum, plasma or whole blood of a dog are commercially available. Most tests are very 
specific, sensitive, rapid and easy to perform. The sensitivity is actually very high, but false 
negatives may occur during the prepatent period, very light infestations or when there are only 
males (male filariae are not detectable by this test). Most kits are for the clinical diagnosis of a 
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single sample, but are also available multi-test ELISA plates. Manufacturers claim that for a 
positive result parasite is sufficient 1 female adult, although many factors may influence the 
sensitivity of the test as the age of the parasite, the number of parasites female depending on the 
number of males and the size of the dog. Reliable and reproducible results can be obtained when 
there are 2-3 or more adult female worms. A detectable antigenemia develops after 5 to 6.5 
months from the infestation. After the death of adult parasites, antigens circulating dissolve rather 
quickly, for this reason, this technique can be used to evaluate the efficacy of a therapy adulticide. 
To confirm the success of adulticide therapy, dogs must be reassessed at 5 and 9 months after 
treatment. If the test is negative at 5 months, the test at 9 months can be avoided (Genchi C. et 
al., 2007). 
- Chest radiographs 
Chest radiographs may show, in an advanced stage, the enlargement of the pulmonary arteries, 
abnormal lung pattern and, in the worst cases, right cardiomegaly. In the event of congestive 
heart failure are found right payments and peritoneal effusions. Radiographs are useful for 
assessing the severity of lung injury, but not for assessing the parasite. The radiographic signs of 
pulmonary vascular disease in advanced stages may persist long after the infestation has run its 
course and some of the most severely ill dogs may have a low number of parasites. In contrast, 
some dogs can host large parasites remained clinically asymptomatic with light or absent 
radiographic lesions (Genchi C. et al., 2007). 
- Electrocardiography 
Only at the last stage of the disease, when the heart chambers are seriously damaged, the ECG 
may show a deviation to the right of the axis cardiac and / or atrial fibrillation (Genchi C. et al., 
2007). 
- Echocardiography 
Echocardiography allows direct visualization of the cardiac chambers and of communicating 
vessels. It can also allow the visualization of parasites in the cardiac chambers, the caudal vena 
cava, the main pulmonary artery and in the proximal portion of both pulmonary  caudal arteries. 
The heartworms are highlighted as floating objects in the right cardiac chambers or in the lumen 
of the vessels. It is performed mainly in cases where the clinical and radiographic results suggest a 
severe type of the disease. The cardiac ultrasound can increase the accuracy in the staging of the 
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disease and in the estimation of filarial influencing the treatment plan and prognosis (Genchi C. et 
al., 2007). 
- Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) is a sensitive and specific technique that allows to detect the 
presence of DNA belonging to a given organism, and as such can be used to identify the different 
species of heartworm. During the last years several researchers have developed different 
molecular protocols with diagnostic and epidemiological purposes. In particular, specie-specific 
PCR assays for single species identification, and multiplex PCR and PCR-RFLP assays, single and 
multistep, for simultaneous detection of the different Dirofilaria species either in the vector or in 
peripheral blood of infected dog have been designed (Favia G. et al., 1996; Mar P.H. et al., 2002; 
Casiraghi M. et al., 2006; Rishniw M. et al., 2006; Gioia G. et al., 2010). For diagnostic purposes, 
are particularly useful protocols applicable to the identification of microfilariae in the peripheral 
blood, in cases where the morphological recognition of microfilariae same proves to be difficult, or 
even in the case of mixed infections (Genchi C. et al., 2007). In addition, for clinical diagnostics use, 
is critical to have fast procedures and simple and clear results, including a precise assessment of 
the level of sensitivity and specificity in the peripheral blood. 
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2.2. Aim of the work 
As stated above, the applications of HRMA for the characterization of microorganisms are 
obviously not limited to molecular characterization of E. coli strains, but can be developed for a 
much larger number of issues and targets linked to food safety and general veterinary diagnostics. 
The purpose of this work was to develop some HRMA protocols, fast and relatively inexpensive, 
able to detect and identify unambiguously a range of foodborne and veterinary pathogens, 
exploiting the nucleotide differences that exist between the sequences of the different species 
and/or variants. First, the aim of this work was the development of a novel real time PCR-HRMA 
method able to identify, in a fast and effective way, the microorganisms that cause chromatic 
alterations in mozzarella cheese samples. As a second objective, during this PhD project, the 
research activity was focused on the development of a new real-time PCR- HRM coupled analytical 
method for the identification and quantification of the Nosema ceranae and Nosema apis 
pathogens in honey bees, that could show improved performance for the analysis of Nosema spp 
also in mixed infections when compared to the currently available methods (Martin-Hernandez et 
al., 2007). As a further activity, two real time PCR-HRMA -based assays were developed for the 
identification of fluoroquinolone (FQ) resistance in Staphylococcus pseudintermedius isolated from 
dogs, respectively through the analysis of specific mutations of DNA gyrase and topoisomerase IV 
enzymes as molecular determinant of FQ resistance (Intorre et al., 2007; Descloux et al., 2008). 
Finally, among the activities of the project, a new real-time PCR- HRMA based method for the 
identification and discrimination of the filarial pathogens Dirofilaria immitis and D. repens in dogs 
was extensively validated. 
 
  
114 
 
2.3. Materials and methods 
2.3.1. Sampling procedures 
2.3.1.1 Pseudomonas 
Twenty-seven samples chromatically altered of mozzarella cheese submitted for microbiological 
examination to the Laboratory of Animal Origin Food Inspection, VESPA Department at the 
University of Milan were selected for this study. 
Briefly, for each mozzarella they were taken 12 g and then laid out in a sterile Stomacher bag. 
After adding the sterile diluent (1: 5), the samples were placed in 'homogenizer (150 strokes / min 
for 60 seconds). The compound was put on Petri dishes containing selective medium for 
Pseudomonas spp.: Pseudomonas DFD Agar (Oxoid). The plates were subsequently incubated at 30 
°C for 48 hours. 
After the bacterial growth, characterized by pigmentation (blu-green, brown or with fluorescent), 
the plates where the growth was not excessive were selected (min 15 colonies and maximum 
number of 50 colonies/plate). Twenty colonies was tipped from each plate and plated individually 
on the ground Agar Mascarpone and left to incubate at 30 °C for 48 hours. 
 
2.3.1.2 Nosema 
For the methodology’s development, control positive samples of Nosema ceranae and Nosema 
apis were kindly provided by Istituto Zooprofilattico Sperimentale di Lazio e Toscana (dr. Giovanni 
Formato). In order to test the specificity of the method, mixed samples were obtained 
experimentally by mixing different concentrations (1:10, 1:1, 10:1) of N. ceranae and N. apis 
samples. Honeybees without Nosema spp were included as negative control. 
To validate of the new biomolecular method, honeybee samples from 55 field apiaries were used. 
Forty samples were collected from beehives placed under observation by the monitoring network 
of Lombardy (Progetto Stranova, Regione Lombardia DG Agricoltura), and 15 samples were 
collected from apiaries from Lazio. Each sample was consisting of a pool of 5 intestines of foraging 
bees from 5 different colonies of each apiary, for a total of 25 intestines/pool. Sampling took place 
in a period between 2011 and 2013. Honey bee crushings underwent preliminary microscopic 
examination to assess the presence of Nosema spp. spores as described in OIE reference manual 
(www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.02.04_NOSEMOSIS.pdf). 
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2.3.1.3 Staphylococcus pseudintermedius 
In this study, 30 S. pseudintermedius strains were screened for the presence of gyrA Ser84Leu 
mutation and of grlA Ser80Ile mutation through specifically designed real time PCR-HRMA 
protocols. The strains were obtained as the unique or prevalent bacterial isolate from canine skin, 
external ear and conjunctive clinical samples submitted for microbiological examination to our 
Department during 2009. Isolation was performed through cultivation on tryptone soy agar plates 
containing 5% sheep blood (Oxoid S.p.A, Rodano, Italy) for 24 h at 37°C under aerobical conditions. 
Isolates were identified as S. pseudintermedius by morphology, Gram staining, catalase activity, 
growth in mannitol salt agar selective medium, and API-Staph® analysis.  
The strains were tested for FQ susceptibility to enrofloxacin and marbofloxacin by the disc 
diffusion method on Muller Hinton agar (Oxoid).  
For each bacteria was evaluated the profile of antimicrobial susceptibility to enrofloxacin and 
marbofloxacin. The method used was that of diffusion in agar medium or technique Kirby-Bauer 
with land Muller-Hinton (Oxoid, Italy). 
The bacterial suspension was obtained by drawing a colony pears from cultures grown on blood 
agar plates and putting in 5 mL of sterile saline to obtain a solution of density equal to the point 
0.5 on the McFarland scale. The sowing of land Muller-Hinton has been established through the 
use of a sterile swab dipped in the suspension, and later affixing to the diskettes containing 
enrofloxacin and marbofloxacin. 
After incubation (37 °C for 18-24 hours) horizontal diffusion of bacterial growth was measured and 
the results were interpreted on the basis of the framework provided by the manufacturer for: 
 enrofloxacina marbofloxacina 
Sensible ≥ 22 mm ≥ 18 mm 
Intermediate 18-22 mm 14-18 mm 
Resistent ≤17 mm < 14 mm 
Table 28: Interpretation of the data to detect antibiotic resistance in base of horizontal diffusemetry. 
 
 
2.3.1.4 Dirofilaria spp 
D. immitis and D. repens microfilariae were collected from anticoagulated canine peripheral blood 
samples referred to the Faculty of Veterinary Medicine of the University of Milan (Italy). Blood 
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samples were tested by a modified Knott’s test, and circulating microfilariae were identified based 
on morphology and morphometry (Knott, 1939; Euzeby, 1981; Soulsby, 1982; Genchi 2007), and 
counted in 20  microliters of blood. In total, 3 D. immitis blood samples, 8 D. repens positive blood 
samples and 3 blood samples with natural mixed infection were selected for the HRM analysis. 
Furthermore, a Knott’s test-negative blood sample was included as negative controls and single 
adults of D. immitis and D. repens were used as positive controls. Also, positive blood samples 
from dogs with different filarial loads (i.e., 4 mf/ml and 32250 mf/ml for D. immitis; 4 mf/ml and 
100000 mf/ml for D. repens) were examined to test the range of sensivity of the method. 
 
2.3.2 DNA extraction 
2.3.2.1 Pseudomonas 
Pigmented colonies resulted positive after plating in Agar Mascarpone were removed and diluted 
in 50 µl of sterile and demineralized water. The extraction was performed by means of alternating 
thermal cycles: 10 minutes at 95 ° C and 5 min at -80 ° C for three times. The DNA thus 
extrapolated is subjected to molecular analysis. 
 
2.3.2.2 Nosema 
Genomic DNA was isolated from each pool of 25 honeybee intestins crushing and filtered in 5 ml 
of double-distilled water. After two centrifugations at 800 g for 6 minutes, the pellets were 
resuspended in 1 ml of double-distilled water and sonicated for three cycles of 10 seconds each 
(output=2) (Branson Sonifier 250, Danbury, U.S.A). 1 ml of TNNT lysis buffer (0,5% SDS, 0.5% 
Tween 20, 0.5% Nonidet P-40, 10mM NaOH, 10mM Tris [pH 7.2]) and 8 µl of 20 mg/ml proteinase 
K were added in all samples. After incubation at 56 °C overnight, the proteinase K was inactivated 
at 95 °C for 10 min. DNA was isolated utilizing the standard basic phenol-chloroform extraction 
followed by ethanol precipitation. The extracted DNA was resuspended in 100 µl of PCR-grade 
water and then stored at −20 ◦C until tested by real-time PCR. For each sample, 1 µl of 
resuspended DNA diluited 1:10 was used as template in the real time PCR assay. 
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2.3.2.3 Staphylococcus pseudintermedius 
For each S. pseudintermedius isolate was tip-sampled from a single colony and placed in an 0,5 ml 
Eppendorf containing 50 µl of water. Samples were then subjected to three alternate cicles of 5’ at 
95 °C and 5’ at -80°C to obtain bacterial cell lysis and DNA extrusion.  
 
2.3.2.4 Dirofilaria spp 
Genomic DNA was isolated from 300 µl of each mf-positive peripheral blood sample and from 
isolated D. immitis and D. repens worms by adding  900 µl of TNNT lysis buffer (0.5% Tween 20, 
0.5% Nonidet P-40, 10mM NaOH, 10mM Tris [pH 7.2]) and 50 µl of 20mg/ml proteinase K (Lachaud 
L. et al., 2002). Samples were then incubated at 56 °C for 18 h. Proteinase K was inactivated by 
incubation at 95 °C for 10 min. DNA was isolated by standard basic phenol chloroform extraction 
followed by ethanol precipitation. The extracted DNA was resuspended in 30 µl of PCR-grade 
water and then stored at −20 ◦C until tested by real-time PCR. For each sample, 2 µl of 
resuspended DNA was used as template in the PCR assay. 
 
2.3.3. Primer design 
Regarding the HRM primers design, for all target was used the same procedure. The target genes 
sequences were obtained from GenBank (available at http://www.ncbi.nlm.nih.gov/genbank/) and 
aligned using the online version of ClustalW programme (available at 
http://www.ebi.ac.uk/Tools/clustalw2/index.htmlref). For each target, the corresponding 
sequence obtained from GeneBank are reported in Table 29, and the conserved primer sequences 
designed for the HRMA protocol after sequence alignements are reported in Table 30, 
respectively. 
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Target Gene GeneBank 
Pseudomonas 16S 
Pseudomonas putida: FN600412.1, AB598738.1, FN652910.1, FN395007.1 
Pseudomonas fluorescens: FN666564.1, AJ308306.1, FN666561.1, 
FN666563.1 
Pseudomonas aeruginosa: FJ972538.1, FJ972535.1 
Nosema 16S 
N. ceranae: FJ789797.1, FJ789789.1, FJ789785.1, FJ789799.1, FJ789786.1, 
FJ789788.1, FJ789791.1, DQ374656.2, DQ673615.1, FJ789795.1, EU045844.1, 
EU025027.1) 
N. apis: FJ789796.1, FJ789790.1 
S. pseudointermedius 
16S Ribo DNA From Becker et al 2007 
16S Ribo DNA From Becker et al 2007 
Dirofilaria 
cytochrome 
oxidase sub I 
D. immitis: AM749226.1, AM749228.1, HQ540424.1, EU169124.1 
D. repens (AM749234.1, AM749231.1) 
Table 29: resume of gene and relative gene bank tor each target 
 
Target Gene primer Sequence 
Annealing 
T° 
lengh 
Pseudomonas 16S 
16SPseudoF 5’ – GCACAAGCGGTGGAGCAT - 3’ 60 °C for 
30 sec 
167 bp 
16SPseudoR 5’ – CGGGACTTAACCCAACATCT - 3’ 
Nosema 16S 
F-NosemHRM 5’ –AGGGGCGAAACTTGACCTAT- 3’ 60 °C for 
30 sec 
N.ceranae 160 bp 
N.apis 162 bp R-NosemHRM 5’–CTCACACATACTACTAACTACG- 3’ 
S. pseudointermedius 
gyrA 
GyrAasmod F 5’-ATGAGTGTTATCGTATCTCGTGC-3 51 °C for 
30 sec 
262 bp 
GyrAasmod R 5’-CCATCGAACCGAAGTTACCTTG-3’ 
grlA 
GrlAsmod F 5’-AATACGTATGATAAACATTTTCG-3’ 51 °C for 
30 sec 
137 bp 
GrlAsmod R 5’-AGCACGTGACGTAATTTCCAGTCTT-3’ 
Dirofilaria 
cytochrome 
oxidase sub I 
COXdirHRMF 5’ –AGTATGTTTGTTTGAACTTC- 3’’ 52 °C for  
1 min 
256 bp 
COXdirHRMR 5’ –AACGATCCTTATCAGTCAA- 3 
Table 30: Primers, annealing Temperature and fragment lengh for any Target 
 
2.3.4. Conventional PCR 
2.3.4.1. Pseudomonas 
The new pair of primers was tested in conventional PCR, adding 1 µl of extracted bacterial DNA, 
0.2 mM dNTPs, 1X Buffer (Promega Corporation, Madison, WI, USA), 1U Taq (Promega 
Corporation, Madison, WI, USA), 0.2 mM of each primer and H2O to obtain a final volume of 20 µl. 
The thermal profile began with 94°C for 2 minutes, 40 cycles repetitions of: denaturation at 94°C 
for 10 seconds, annealing at 60°C for 10 sec and elongation at 72°C for 15 sec. The reaction was 
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performed on Mastercycler® Gradient thermal cycler (Eppendorf AG, Hamburg, Germany). 
Amplification products were run on 2% agarose gel. 
 
2.3.4.2. Nosema 
The new pair of primers was first tested in conventional PCR, adding 1 µl of extracted Nosema 
DNA, 0.2 mM dNTPs, 1X Buffer (Promega Corporation, Madison, WI, USA), 1U Taq (Promega 
Corporation, Madison, WI, USA), 0.3 mM of ech primer and H2O to obtain a final volume of 20 µl. 
The thermal profile began with 95°C for 2 minutes, 40 cycles repetitions of: denaturation at 95°C 
for 15 seconds, annealing at 60°C for 30 sec and elongation at 72°C for 30 sec. The amplification 
ended with a final elongation at 72°C for 7 min, and was performed on iCycler thermal cycler (Bio-
Rad Laboratories Inc., Hercules, CA, USA). Amplification products were run on 2% agarose gel and 
purified for DNA sequencing using Qiaquick™ Gel Extraction kit (Qiagen GmbH, Hilden, Germany). 
The purified amplicons were then sequenced using standard Applied Biosystems technology. 
 
2.3.4.3. Staphylococcus pseudintermedius 
The newly designed pairs of primers for gyrA and grlA respectively was first tested in conventional 
PCR through amplification in a Mastercycler® Gradient thermal cycler (Eppendorf AG, Hamburg, 
Germany). The PCR reactions were carried out in duplicate in a total volume of 20µl containing 1µl 
of S. pseudintermedius bacterial lysate, 1X Taq buffer containing 1.5mM MgCl2 and 0.2mM dNTPs, 
1.25 U Taq Promega and 0.5µM of forward and reverse primers. The thermal profile for the 
amplification was 94 ◦C for 90 sec; 35 cycles of 94 ◦C for 45sec, 51 ◦C for 30sec, 72 ◦C for 90sec and 
final elongation step at 72 ◦C for 300sec. Amplification products were run on 2% agarose gel and 
purified for DNA sequencing using Qiaquick™ Gel Extraction kit (Qiagen GmbH, Hilden, Germany). 
The purified amplicons were then sequenced using standard Applied Biosystems technology. 
 
2.3.5. Real-time PCR amplification and HRM analysis 
The real time PCR-HRMA assays for all the targets were run on an EcoTM Real-Time PCR System 
(Illumina, Inc., San Diego, CA, USA). The amount of reagents used for real-time PCR were: 7.5 µl 
Supermix SsoFast EvaGreen mix (BioRad), 0.3 µM of each primer, 1 µl of corresponding target DNA 
(2 µl for Dirofilaria target) and H2O to reach a total volume of 15 µl. The thermal protocol started 
with a denaturation-activation step at 95°C for 8 min, followed by a 40 cycles (45 cycles for 
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Nosema target) repetitions of: program denaturation at 95°C for 15 s, annealing for 30 sec (1 min 
for Dirofilaria primers) at temperature depending on the primer pair as reported in Table 30. The 
melting program comprised 3 steps: denaturation at 95°C for 15 s, renaturation at 55°C for 15 s, 
and finally melting with continuous fluorescence measurement (ramping 0.1°C/s) to 95°C, each 
step for 15 s. Eco_v4.0 software was used to analyzed the HRM curve. Raw melting-curve data 
were normalized by setting the pre-melt (initial fluorescence) and post-melt (final fluorescence) 
signals of all samples to uniform values for each target. Pre-melt signals were uniformly set to a 
relative value of 100%, while post-melt signals were set to a relative value of 0%. Double-distillate 
water was used as blank in parallel with each experiment. Each sample was tested in two 
replicates. 
 
2.3.5.1. Comparison between HRMNosem primers and 218MITOC and 321APIS primers 
The same Nosema DNA samples analyzed with the real time PCR-HRMA method were tested, in 
parallel, for N. ceranae target with the method based on the primer pair 218MITOC published by 
Martin-Hernandez et al. in 2007. This method was chosen since being the method currently 
utilized in conventional and real time PCR for N. ceranae detection and reported in COLOSS 
BEEBOOK (http://www.coloss.org/beebook/II/nosema/2/2/2/3).  
 
2.3.6. Cloning 
The efficiency, sensitivity and log range of the methodology for the identification and 
quantification of Nosema spp. was tested against reference curves built with 1:10 diluitions of the 
corresponding cloned amplicon. Briefly, conventional PCR amplification products from Nosema 
ceranae and Nosema apis DNA were run on 2% ethidium bromide agarose gel electrophoresis 
followed by UV-visualization and purified using QiaquickTM Gel Extraction Kit (Qiagen GmbH, 
Hilden, Germany). The concentration of purified amplicons was spectrofotometrically measured 
using a ND-100 Spectrophotometer. Each quantitated amplicon was ligated the plasmid pGEM T-
easy at a concentration of 50 ng/ul (Promega Corporation, Madison, WI, USA) as reported in 
manifacture's instructions. The corresponding plasmid was included in DH5α competent cells in 
3:1 concentration. The colonies used were selected by screening with conventional PCR with T7-
SP6 plasmid-specific primers and primer HRMNosem. One positive colony for each target was 
grown and the corresponding plasmidic clone was purified using QiaprepTM Spin Miniprep kit 
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(Qiagen) and spectrofotometrically quantitated. The plasmidic clones were sequenced using T7 
and SP6 primes and ABI technology in order to confirm the identity of each ligated target. The 
amplification was evaluated on ten-fold serial diluition points of the corresponding plasmid. At this 
regard, the log ranges were chosen encompassing the putative amount of each target sequence 
that could be expected in DNA prepared from honeybee intestines from 106 to 100 copies/well. 
 
2.3.7. Sequencing 
To confirm the results of HRM analysis DNA sequencing of the amplicons was performed for 
species identification (for Pseudomonas, Nosema, and Dirofilaria), mutation detection (for S. 
pseudintermedius) and cloning (for Nosema), as follows: the amplified samples were recovered 
after agarose gel electrophoresis and purified using QiaquickTM Gel Extraction kit (Qiagen GmbH, 
Hilden, Germany). The concentration of purified amplicons was spectrofotometrically measured 
using a ND-100 Spectrophotometer. The purified amplification products were then sequenced 
using standard Applied Biosystems technology on ABI Prism 310 DNA sequencer (Applied 
Biosystems). The obtained sequences were aligned to the expected target sequences using 
ClustalW programme(http://www.ebi.ac.uk/clustalw). 
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2.4. Results and discussion  
2.4.1. Pseudomonas spp 
 
The alignment performed for the design of the primer pair is reported in Figure 30. 
 
CLUSTAL 2.1 multiple sequence alignment 
 
 
FN600412.1      GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTT 
FN395007.1      GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTT 
AB598738.1      GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTT 
FN652910.1      GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTT 
FN666561.1      GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTT 
FN666563.1      GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTT 
AJ308306.1      GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTT 
FN666564.1      GCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACGCGAAGAACCTTACCAGGCCTT 
                ************************************************************ 
 
FN600412.1      GACATGCAGAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAGCTCTGACACAGGTGCT 
FN395007.1      GACATGCAGAGAACTTTCCAGAGATGGATTG-TGCCTTCGGGAACTCTGACACAGGTGCT 
AB598738.1      GACATGCAGAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTCTGACACAGGTGCT 
FN652910.1      GACATGCAGAGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACTCTGACACAGGTGCT 
FN666561.1      GACATCCAATGAACTTTCTAGAGATAGATTGGTGCCTTCGGGAGCATTGAGACAGGTGCT 
FN666563.1      GACATCCAATGAACTTTCTAGAGATAGATTGGTGCCTTCGGGAACATTGAGACAGGTGCT 
AJ308306.1      GACATCCAATGAACTTTCCAGAGATGGATGGGTGCCTTCGGGAACATTGAGACAGGTGCT 
FN666564.1      GACATCCAATGAACTTTCCAGAGATGGATTGGTGCCTTCGGGAACATTGAGACAGGTGCT 
                ***** **  ******** ****** *** * *********** *  *** ********* 
 
FN600412.1      GCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG 
FN395007.1      GCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG 
AB598738.1      GCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG 
FN652910.1      GCATGGCTGTGGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG 
FN666561.1      GCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG 
FN666563.1      GCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG 
AJ308306.1      GCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG 
FN666564.1      GCATGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCG 
                ********** ************************************ 
 
Figure 30: Alignment of partial 16S rRNA gene sequences of Pseudomonas fluorescens (GenBank accession number: FN666564.1, 
AJ308306.1, FN666561.1, FN666563.1) and Pseudomonas putida (GenBank accession number: FN600412.1, AB598738.1, 
FN652910.1, FN395007.1). Asterisks indicate identity; gray areas indicate primer sequences. 
 
When preliminarly tested on reference bacterial samples (P. fluorescens and P. putida), High 
resolution melting analysis following real time PCR allowed to discriminate the two species of 
Pseudomonas according to the different melting temperature of the corresponding amplicons 
(Figure 31A and 31B). All samples showed a robust and reproducible amplification signal after real 
time PCR, an important prerequisite for optimal HRM analysis. No amplification was obtained from 
the control negative sample, confirming the specificity of the procedure. 
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Figure 31A: Setup of the method: amplification curves obtained after real time-PCR of the positive control samples. The bunch of 
curves on the left indicate Pseudomonas spp. samples, asterisk indicates Staphylococcus spp. controls. 
 
 
Figure 31B: Setup of the method: normalized graph of the melting curves after HRMA of the positive control samples. The samples 
of Pseudomonas putida (the bunch of curves on the right, indicated by a triangle) are clearly distinguishable from the samples of 
Pseudomonas fluorescens (the bunch of curves in the centre, indicated by a circle) and from the sample of Staphylococcus spp. (the 
curve on the left, indicated by an asterisk). 
 
The agarose gel performed after the amplification and melting reaction confirmed that the  
amplicons were of the expected size, with undetectable non-specific amplication or primer dimers. 
(Figure 32). 
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Figure 32: Agarose gel electrophoresis performed after real time PCR-HRMA. S= 100 bp molecular weight marker; line 1=  
Pseudomonas putida positive control sample; line 2=  Pseudomonas fluorescens positive control sample; line 3=  Staphylococcus 
spp. control sample. 
 
When tested on bacterial samples isolated through microbiological analysis and preliminarly 
assessed as Pseudomonas spp, the procedure was able to clearly identify the species of origin. In 
the normalized plot, the P. fluorescens samples were clearly distinguishable from the P. putida 
samples, and the strain of Staphylococcus used as external control (Figure 33A). Also, the 
differential plot allowed sample classification based on clustering of samples into groups with 
similar melting curves (Figure 33B). In both plots, an additional, unexpected type of curve was 
detectable, and the DNA sequencing of the corresponding amplicons led to the identification of 
Aeromonas hydrophila (Figure 33A and Figure 33B). 
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Figure 33A: Normalized graph of the melting curves after HRMA of the positive controls and unknown samples. Black circles, P. 
putida¸; black triangles, P. fluorescens The curves on the right (black square) are related to the unexpected amplification of 
Aeromonas hydrophila. Asterisk, Staphylococcus spp 
 
Figure 33B: Differential plot of the melting curves after HRMA. The differential plot allows further analysis of the differences in 
melting-curve shapes by subtracting the curves from a reference curve (in this case, an Aeromonas hydrophila sample). From top to 
bottom, four different types of sample are distinguishable: the samples of Aeromonas hydrophila (indicated by a square), the 
samples of Pseudomonas putida (indicated by a triangle), the samples of Pseudomonas fluorescens (indicated by a circle) and the 
sample of Staphylococcus spp (indicated by an asterisk). 
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2.4.2 Nosema spp 
 
 
The alignment performed for the design of the primer pair is reported in Figure 34. 
 
 
Figure 34: Alignment of partial Nosema ribosomal 16S gene sequences of N. ceranae (FJ789797.1, FJ789789.1, FJ789785.1, 
FJ789799.1, FJ789786.1, FJ789788.1, FJ789791.1, DQ374656.2, DQ673615.1, FJ789795.1, EU045844.1, EU025027.1) and N. apis 
(FJ789796.1, FJ789790.1) Dots indicate identity; gray areas indicate primer sequences. Conserved regions with no intra-species 
variability and with maximized interspecies variability were chosen as target for the primer design 
 
The new primers designed and reported in this article, have been tested both in conventional and 
real-time PCR and have demonstrated high specificity and sensitivity for the target sequences. All 
samples showed a robust and reproducible amplification signal. The amplicons once run on 
agarose gel electrophoresis were of the expected size, 162 bp for N. ceranae and 160 bp for N. 
apis, with undetectable non-specific amplication or primer dimers. No amplification was obtained 
from Nosema-negative sample, confirming the specificity of the procedure (Figure 2). Eventually, 
the amplicons’ sequencing confirmed the identity of the Nosema sequences.  
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Figure 2: Agarose gel electrophoresis performed after real time PCR-HRMA. STD= 100 bp molecular weight marker; lines 1,2=  N. 
apis positive control samples, lines 3,4=  N. ceranae positive control samples, lines 5,6= 1:1 mixed samples; Neg= negative control. 
 
High resolution melting analysis after real time PCR allowed to discriminate clearly the two species 
on the basis of the different melting temperature of the two amplicon types. In the normalized 
plot, the N. ceranae samples were clearly distinguishable from the N. apis samples and the mixed 
samples respectively (Figure 35). Also, the differential plot allowed sample classification based on 
clustering of samples into groups with similar melting curves (Figure 36). 
 
 
Figure 35: Normalized graph of the melting curves after HRMA. The samples with N. apis infection (curve on the right, indicated by 
dot) are clearly distinguishable from the samples with N. ceranae infection (curve on the left, indicated by triangle) and from 
samples with mixed infestation (the three curves in the center, indicated by asterisks). 
 
* 
* 
* 
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Figure 36: Differential plot of the melting curves after HRMA. The differential plot allows further analysis of the differences in 
melting-curve shapes by subtracting the curves from a reference curve (in this case, the reconstructed positive mixed 1:1 sample N. 
ceranae/N. apis). From top to bottom, three different types of sample are distinguishable: the sample with N. apis infection 
(indicated by dot), the samples with mixed infection (indicated by asterisks) and the samples with N. ceranae infection (indicated by 
triangle). 
 
The specificity/sensitivity of the method for N. ceranae was also tested with referral to a 
calibration (reference) curve constructed from amplified amplicon (cloned and sequenced) of N. 
ceranae obtained as described. The straight line was built through ten-fold serial dilutions, with a 
range from 1 million copies to a single copy per sample point (Figure 37). The HRMNosem primers 
showed an efficiency of 102%. The same procedure was performed for the amplicons obtained 
using the 218MITOC primers and the calibration curve thus obtained showed an efficiency of 95% 
(Figure 38). 
 
HRMNosem 
Figure 37: Reference curve for N. ceranae using HRMANosem method 
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MITOC218 
Figure 38: Reference curve for N. ceranae using MITOC218 method 
 
 
The reference curve for HRMNosem and MITOC218 methods were used to interpolate and 
calculate the copy number of Nosema ceranae target DNA in the 55 honeybee samples for both 
methods. The corresponding values obtained with the two methods for the same samples 
underwent regression analysis in order to check the correlation of the results. The resulting plot 
showed a very good correlation between the Nosema cerane load calculated with the new HRMA-
based method and the reference single target method based on MITOC218 primer pair (Figure 39). 
 
 
Figure 39: Regression analysis of the N. ceranae load evaluated with HRMNosem and MITOC218 methods. 
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2.4.3. Staphylococcus Pseudointermedius 
 
The disc diffusion method on Muller Hinton agar showed that 12 S. pseudintermedius isolates 
were resistant to enrofloxacin and marbofloxacin, while 17 isolates resulted sensitive to both FQs 
and the one remaining (isolate n. 12) resulted as intermediate resistant (Table 31). 
 
S.pseudointermedius Enrofloxacina Marbofloxacina 
1 sensitive sensitive 
2 sensitive sensitive 
3 resistant resistant 
4 sensitive sensitive 
5 sensitive sensitive 
6 resistant resistant 
7 sensitive sensitive 
8 resistant resistant 
9 sensitive sensitive 
10 sensitive sensitive 
11 resistant resistant 
12 intermediate intermediate 
13 sensitive sensitive 
14 resistant resistant 
15 sensitive sensitive 
16 sensitive sensitive 
17 resistant resistant 
18 sensitive sensitive 
19 sensitive sensitive 
20 resistant resistant 
21 resistant resistant 
22 resistant resistant 
23 sensitive sensitive 
24 sensitive sensitive 
25 sensitive sensitive 
26 resistant resistant 
27 sensitive sensitive 
28 resistant resistant 
29 sensitive sensitive 
30 resistant resistant 
Table 31: results of the susceptibility testing for enrofloxacin and marbofloxacin for the S. pseudintermedius isolates. 
131 
 
 
When analyzing the melting curve shape obtained through HRM for the gene gyrA, it is 
appreciable that the respective melting curves have different shapes, as expectable according to 
the presence of the isolates sensitive (wild type) or resistant (with nucleotide mutation to 
fluoroquinolones. 
As expected based on the the shift in nucleotide sequence, and as appreciable from the respective 
images of the standardized curves, the amplicons containing the mutations are characterized by a 
different Tm with respect to the corresponding WT amplicons. Graphically the different melting 
temperature of the double helix corresponds to a shift of fluorescence, which occurs in a different 
way between the amplicons based on the nature of the polymorphism: in the specific case, for 
gyrA it comes to a shift of the temperature towards a lower value linked to the mutation from C 
(characterized by three hydrogen bonds) to T (characterized by two hydrogen bonds) (Figure 40). 
For grlA, it comes to a shift of the temperature again towards a lower value which is linked to the 
mutation from G to T (Figure 41). An alternative mutation Ser80Arg is also appreciable (Figure 41, 
grey bunch). 
 
 
Figure 40: HRMA normalized curve for the gene gyrA for the Ser84Leu mutation: the red samples carry the mutated codon TTG, 
while the blue samples carry the unmutated codon TCG. 
 
132 
 
 
Figure 41: HRMA normalized curve for the gene grlA for the Ser80Ile mutation: the red samples carry the mutated codon ATT, while 
the blue samples carry the unmutated codon AGT, and the gray samples carry the mutation CGT. 
 
Looking at the differentiated curves, the two different melting patterns due to the presence 
absence of mutation can be clearly appreciated. At this regard, Figure 42 shows the differentiated 
plot for the gene gyrA, and Figure 43 shows the differentiated plot for the gene grlA. 
 
 
Figure 42: HRMA differentiated plot for gyrA gene: in brown, samples carrying the Ser84Leu mutation; in blue, unmutated samples. 
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Figure 43: HRMA differentiated plot for grlA gene: in brown, samples carrying the Ser80Ile mutation; in grey, samples carrying the 
Ser80Arg mutation, in blue, unmutated samples. 
 
When comparing the results of the antibiogram with the results of HRMA screening of both 
mutation hotspots, an almost full correspondance between sensitivity/resistance and gyrA 
mutation is showed, as follows: 11 resistant isolated carried also the Ser84Leu mutation of gyrA; 
17 sensitive isolated carried the WT codon; 1 intermediate isolate carried only the Ser80Ile 
mutation of grlA gene; finally, only one resistant isolate carried the WT codon for both gyrA and 
grlA genes (Table 32). 
Thus, eleven out of twelve (92%) resistant isolates assessed by classical sensitivity testing 
(antibiogram) were also detected as resistant through HRMA method for Ser84Leu mutation of 
gyrA. Only one resistant isolate was unmutated both for gyrA and grlA codons, and in this case it is 
conceivable that resistance is mediated by other mutations/mechanisms. 
On the other hand, the mutations in grlA gene seemed non correlated to resistance, with the 
exception of the intermediate strain that carried only the grlA mutation, but not the gyrA 
mutation, that could explain partial resistance. 
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S.pseudointermedius Enrofloxacina Marbofloxacina HRMA gyrA HRMA grlA 
1 sensitive sensitive unmutated mutated 
2 sensitive sensitive unmutated unmutated 
3 resistant resistant mutated mutated 
4 sensitive sensitive unmutated mutated 
5 sensitive sensitive unmutated unmutated 
6 resistant resistant mutated unmutated 
7 sensitive sensitive unmutated unmutated 
8 resistant resistant mutated unmutated 
9 sensitive sensitive unmutated mutated 
10 sensitive sensitive unmutated unmutated 
11 resistant resistant mutated unmutated 
12 intermediate intermediate unmutated mutated 
13 sensitive sensitive unmutated mutated 
14 resistant resistant mutated unmutated 
15 sensitive sensitive unmutated unmutated 
16 sensitive sensitive unmutated unmutated 
17 resistant resistant mutated mutated 
18 sensitive sensitive unmutated unmutated 
19 sensitive sensitive unmutated unmutated 
20 resistant resistant mutated mutated 
21 resistant resistant mutated mutated 
22 resistant resistant mutated mutated 
23 sensitive sensitive unmutated unmutated 
24 sensitive sensitive unmutated unmutated 
25 sensitive sensitive unmutated unmutated 
26 resistant resistant mutated mutated 
27 sensitive sensitive unmutated unmutated 
28 resistant resistant unmutated unmutated 
29 sensitive sensitive unmutated unmutated 
30 resistant resistant mutated mutated 
 
Table 32: comparison between a conventional method of susceptibility testing for enrofloxacin and marbofloxacin with the results 
obtained in HRMA for gyrA and grIA mutation status. 
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3.4.4. Dirofilaria spp 
 
All samples showed an amplification signal robust and reproducible, this allowing an optimal 
analysis of the HRMA curves, and besides the amplicons were of the expected size (256 bp) and 
did not show nonspecific or dimers of primers; no amplification was obtained from Knott’s-
negative samples, confirming the specificity of the procedure, and sensivity range was confirmed 
for the two species by successful amplification of the highest (naturally infected blood samples of 
32250 mf/ml for D. immitis and 100000 mf/ml for D. repens) and the lowest (reconstructed blood 
samples of 4 mf/ml for each single Dirofilaria species) mf load (Figure 44).  
 
 
 
Figure 44: Agarose gel electrophoresis performed after real-time PCR–HRMA. S = 100 bp molecular weight marker; lines 1–17 = 
Dirofilaria spp samples, includingpositive controls in line 5 (D. immitis) and line 14 (D. repens), and m1–m3 mixed Dirofilaria 
samples in lines 15–17; Neg = negative control. 
 
After real time PCR amplification , HRM analysis allowed to discriminate clearly the two species 
according to the different melting temperature of the two sequences, although they have an 
identical number of bases. Figure 45 shows the normalized graph of D. immitis samples (bunch of 
curves to the right), the D. repens samples (bunch of curves to the left) and the three mixed 
samples in the centre (asterisk). Figure 46 shows the difference plot curve, that allows further 
analysis of the differences in melting-curve shapes by subtracting the curves from a reference 
curve (in this case repens 4 mf/ml), which helps to cluster samples into groups that have similar 
melting curves. Melting profiles showed minimal variability within samples from the same group. 
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Finally, the specificity of the amplification was confirmed by sequence analysis, thus proving that 
the clustering pattern presented in the curves was representing two different species, as 
effectively as DNA sequencing. 
 
 
Figure 45: Normalized graph of the melting curves obtained with the HRMA. Are clearly distinguishable the D. immitis samples (in 
blue on the right), from the D. repens samples (in red on the left) from samples with mixed infestation (in green in the center, 
indicated by an asterisk). 
 
 
Figure 46: Differential graph of the melting curves obtained with the HRMA. The three different types of sample are easily 
distinguishable: in blue D. immitis samples, in red D. repens samples and green (indicated by an asterisk) samples with mixed 
infestation.  
D. immitis 
D. repens 
* 
* 
D. immitis 
D. repens 
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3. Conclusions 
 
The present PhD project was aimed on one side to a better characterization of the foodborne risk 
linked to E. coli infection strains in the bovine model, and on the other side to the development of 
new analytical protocols based on HRMA for sensitive and effective species identification, or 
variant/mutation screening, applied to different foodborne and veterinary pathogens. Regarding 
the relationship between E. coli and the bovine host in the food safety perspective, The 
experimental hypothesis was linked to a possible expression of virulence factor by E. coli strains 
when exposed to bovine mammary environment, and at this regard a RT-qPCR study in a co-
culture model was realized after a comprehensive meta-analysis allowing to select MAC-T cell as 
the most suitable bovine mammary cell line for this purpose. In addition, with the aim to improve 
the current methodologies for foodborne risk analysis linked to E. coli, the project activity 
provided a preliminary research for the setup and validation of new real time PCR-High Resolution 
Melting Analysis (HRMA) protocols helping the identification of putative verocytotoxic status in E. 
coli strains isolated from bovine milk. The possibility to identify the presence of risk-predictive 
SNPs using these newly established HRMA-based protocols is a novel, and simpler, opportunity 
with respect to the current, and more complex, surveillance strategies that are based on the 
amplification of stx genes together with other virulence factors for the evaluation of VTEC status. 
In the future, a possible way forward of this research is represented, on one side, by the deeper 
assessment of the reciprocal modulation between E. coli mastitis-derived strains and immortalized 
MAC-T cells using high-throughput RNA sequencing, and on the other side by a large scale 
validation of the HRMA-based evaluation of risk-predictive SNPs in order to improve the current 
approaches. Besides, in the future also the assessment of the effect of co-cultivation with 
intestinal cell lines would spread more light on the possible virulentation of bovine-derived E. coli 
strains by the host interplay. With the similar aim to develop other novel applications of HRMA-
based methodology in food research, a new HRMA-based protocol was designed and tested for 
the identification of Pseudomonas spp responsible for chromatic alterations in mozzarella cheese. 
More in general, improving identification and tracking methods for these, and other, 
microorganisms in food production and processing systems through HRMA-based protocols is 
important in understanding and reducing the frequency of contamination, as well as eliminating 
niche populations in food processing systems such that contamination of food products can be 
prevented. 
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Since the applications of HRMA for the characterization of microorganisms can not be limited to 
food safety, but can be developed for a large number of issues linked to general veterinary 
diagnostics, among the objectives of this PhD project some new real-time PCR-HRMA coupled 
methods were also developed, providing a contribution to the advancement of the existing 
molecular tools. At this regard, a clear example is provided by the research activity performed 
regarding the HRMA-based assay for Dirofilaria spp. Currently, most of the existing molecular 
diagnostic protocols for canine dirofilariosis are based on species specific sets of primers or on 
additional steps after PCR amplification, thus being quite laborious or not assuring a comparable 
amplification efficacy between the two targets. Thus, a new molecular method based on real time 
PCR coupled to HRMA to detect and differentiate simultaneously D. repens and D. immitis in 
canine blood samples was designed and validated as part of the activity of the present PhD 
programme. A single pair of primers was used, as common strategy in HRMA-based assays, thus 
allowing comparable amplification efficiency between the two different targets and also 
discrimination of mixed infections. The assay tested positive also on blood samples with a very low 
mf number, confirming high sensitivity and consequently the suitability of the assay to detect 
positivity in dogs with a very low parasite load as a common finding in the field. Besides, it was 
possible to detect both single worm and mixed infections in a repeatable way, another feature 
that can be very useful in field diagnostics, since the identification of the parasite species using the 
traditional approaches sometimes can be problematic. 
Overall, the cost effectiveness of real time PCR-HRMA assays is comparable to, or cheaper than, 
conventional PCR and sequencing, with a very rapid post-amplification detection step 
(Wongkamchai et al., 2013). The availability of a real time PCR-HRMA assay in the epidemiological 
and clinical setting reduces the reagent cost, the labor time, and the contamination risk. These 
quick, sensitive and specific single step assays able to discriminate sympatric pathogen species 
(like for instance Dirofilaria and Nosema targets) or to identify molecular variants that are relevant 
for clinical management (FQ resistance in S. pseudintermedius) represent additional tools for 
epidemiological studies, routine disease assessment and therapeutical decisions. For instance, rhe 
results obtained through the HRMA-based analysis confirmed previous reports that in clinical 
settings, the main mutation site associated to FQ resistance in S. pseudintermedius is at position 
251 (Ser84Leu) of gyrA as detected in all but one the analyzed resistant isolates of the present PhD 
project. Besides, a comparable amplification efficiency for the targets of interest, as in HRMA 
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methods, is especially useful in case of simultaneous infection, as in the case of Nosema spp., 
where a quick, sensitive and specific single step assay able to discriminate the two most common 
microsporidial parasites in honeybees represents undoubtedly a valuable new tool for 
epidemiological studies and routine disease assessment in co-endemic areas for the two species. 
Furthermore, HRMA-based assays usually prove to be at least as effective as the currently used 
molecular methods, and a clear demonstration was provided in this PhD project with regard to the 
HRMNosem in comparison to the MITOC218 method, strictly specific for N. ceranae. The PCR-
HRMA method here established proved also to be able to detect unexpected species (as 
Aeromonas aerophyla detected by the HRMA assay originally developed for Pseudomonas targets, 
and previously misinterpreted by the classical micobiological approach) or molecular variants (as 
the Ser80Arg mutation in grlA gene of S. pseudintermedius by the HRMA assay originally 
developed for the detection of the Ser80Ile mutation), as examples of the potential advantages 
linked to the introduction of these new assays in the routine diagnostics. Finally, each real time 
PCR-HRMA method could be easily upgraded to include closely related target species and/or 
molecular variants. 
Overall, the results of this PhD project obtained through a large range of activities and 
experimental tools, can be considered as an appreciable contribution to a better identification of 
the risk that E. coli and other microrganisms and parasites may pone to the health of animals and 
finally humans. In particular, the HRMA approach when extensively validated would be highly 
suitable for routine diagnostics applied to field investigation, as a quick and sensitive single step 
protocol allowing specific and sensitive detection with shorter analysis time and reduced cost, in 
parallel or in alternative to the classical approaches. 
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